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Q U IL L  ON SCALPEL This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
ROUTINE OPERATIVE CHOLANGIOGRAPHY DURING 
CHOLECYSTECTOMY
During the past 15 years, operative cho­
langiography has been used increasingly in 
detecting stones in the common bile duct 
during cholecystectomy. Although most sur­
geons agree on the need for an operative 
cholangiogram after exploration of the com­
mon bile duct, not all have considered the 
procedure to be necessary during cholecys­
tectomy. Some have strongly advocated the 
routine use of operative cholangiography— 
that is, for every cholecystectomy. On page 
449 of the Journal, Nanson makes just such 
a plea and provides data to support his 
contention. The data were obtained from a 
retrospective study of 151 patients who un­
derwent biliary tract surgery, 18 for second­
ary common bile duct exploration and 133 
for cholecystectomy. Nanson describes eight 
benefits of operative cholangiography and 
concludes that the technique has taken the 
guess-work out of biliary tract surgery.
Nanson’s arguments are for the most part 
unassailable. None would question the value 
of operative cholangiography in the diag­
nosis of anatomic abnormalities, for tumours 
involving the bile ducts, and as a check after 
choledochotomy. But debate will continue 
on the first two of the benefits Nanson de­
scribes; that is, the diagnosis of unsuspected 
stones and the avoidance of negative com­
mon bile duct exploration. Is routine use of 
cholangiography required to achieve these 
benefits? Many authors would agree with 
Nanson’s affirmative answer and, more­
over, point out the simplicity and safety of 
the procedure. In fact, many surgeons have 
adopted it as a routine procedure and would 
hold that without it cholecystectomy is in­
complete. Can there be any argument to 
support the surgeon who does not use chol­
angiography routinely? For those who have 
carefully sifted the literature on the sub­
ject, a few disquieting facts remain that 
might still ruffle the enthusiasts. One con­
cerns the yield rate of common duct stones 
from patients undergoing cholecystectomy. 
The American College of Surgeons study, 
which reviewed 28 621 cholecystectomies, 
disclosed that common bile duct stones were 
found in approximately 7% of patients.1 
Colcock and Perey- in 1964 reported com­
mon bile duct stones in 7.9% of 1754 pa­
tients undergoing cholecystectomy and Col­
cock and McManus3 in 1955 gave an in­
cidence of 10.4% of 1104 patients. In the 
Hampson and Petrie4 series of 2090 cho- 
lectomies reported in 1964, stones were 
found in the common bile duct in 7.4% of 
patients. It is of interest that the use of 
operative cholangiography with cholecystec­
tomy in 25% of patients in the American 
College study did not increase the yield of 
common bile duct stones compared with the 
other series in which a cholangiogram was 
seldom done with cholecystectomy. In other 
words, not enough unsuspected stones were 
found in this study to increase the recovery 
rate of common duct stones over other 
series. Further, Bartlett5 was able to achieve 
a greater harvest of common bile duct stones 
without the aid of cholangiography. He 
found them in 16% of patients undergoing 
cholecystectomy; admittedly this accomplish­
ment required a common duct exploration 
rate of 43% . It might be anticipated that 
routine operative cholangiography would 
result in a high yield rate of common bile 
duct stones without so many common bile 
duct explorations. But enthusiasts for rou­
tine cholangiography such as Schulenburg,6 
Mehn,7 and Hermann and Hoerr8 have 
strongly recommended its use without show­
ing a higher yield rate of common bile duct 
stones. The latter benefit, though not the 
only one, is surely a major one.
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Nanson does in fact report a commend- 
ably high yield rate of common duct stones 
(14.3%), which he believes is due to fre­
quent and careful use of operative cholan­
giography. Interpretation of Nanson’s data 
reveals that 88% of patients undergoing 
cholecystectomy had an operative cholangio- 
gram, at least 20% of the patients had 
common bile duct exploration, and the yield 
rate of common bile duct stones was 14.3%. 
Thus, he has justified his first two claims for 
cholangiography: the discovery of unsus­
pected stones and the avoidance of unneces­
sary choledochotomy.
But even granting that the procedure will 
yield more common duct stones there re­
mains the question of follow-up. Do pa­
tients having a cholangiogram with chole­
cystectomy fare better in the long run than 
patients having a cholecystectomy alone? 
Nanson’s study suggests they should. But 
Madsen,9 who studied two series of chole­
cystectomies— 237 with operative cholangio­
graphy in 86%, and 237 with cholangio­
graphy in 25% — was unable to find enough 
evidence from a 5-year follow-up study to 
justify routine use of the procedure. The 
patients who did not have cholangiography 
fared surprisingly well.
Finally, one might expect a decrease in 
the incidence of secondary common bile 
duct exploration if operative cholangiography 
was performed more frequently. A recent 
study has shown only a slight decrease in the 
incidence (from 2.2 to 1.6%) ol secondary 
common bile duct exploration as the fre­
quency of operative cholangiography rose 
from zero to 36% .10
Operative cholangiography is clearly safe
and has many advantages. Nanson’s paper 
should encourage its use during cholecystec­
tomy if there is the slightest doubt concern­
ing the presence of stones in the common 
bile duct. Dogmatic insistence that it be 
done with every cholecystectomy is a posi­
tion that is still debatable.
Jo h n  H. D u f f , MD, FRCS[C]
Chairman, division o f general surgery,
University of Western Ontario,
London, Ont.
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CURRENT CONCEPTS
FRACTURE HEALING*
RICHARD L. CRUESS, MD, FRCS[C]
Summary: The sequence of events occurring 
after a fracture is now relatively well under­
stood. Healing takes place in three phases—  
inflammatory, reparative and remodelling. In 
each phase certain cells predominate and spe­
cific histologic and biochemical events are char­
acteristic. Factors that influence fracture heal­
ing are both local and systemic: the former in­
clude particularly the degree of local trauma 
and bone loss, the type of bone affected, the 
degree of immobilization and local pathologic 
conditions; the latter include age, hormones, 
local stress and electric currents. Natural 
processes of healing should be allowed to take 
their usual course and interference should be 
attempted only when there is demonstrable 
need or substantial advantages for the patient.
Resume: Aujourd’hui, nous connaissons relati- 
vement bien la succession d'evenements qui 
surviennent apres une fracture. La guerison s'o- 
pere en trois phases: une phase inflammatoire, 
une phase de reparation et la derniere de remo- 
delage. Dans chacune de ces phases, certaines 
cellules predominent et les modifications histo- 
logiques et biochimiques specifiques sont ca- 
racteristiques. Les facteurs qui jouent un role 
dans la guerison des fractures sont a la fois 
locaux et generaux. Parmi les premiers, figurent 
particulierement le degre du trauma local et la 
perte de substance osseuse, le type d'os qui 
a ete lese, le degre de I'immobilisation et les 
conditions pathologiques locales. Dans les der- 
niers, on trouve I'age du blesse, son etat hor­
monal, le stress local et les courants electri- 
ques. II faut laisser a la nature le soin de suivre 
son evolution normale vers la guerison et on 
ne devra tenter d'intervenir dans cette evolu­
tion que si on peut mettre en evidence un 
besoin particulier ou des avantages considera­
bles pour un malade donne.
*From the orthopaedic and accident services, 
Royal Victoria Hospital and McGill University, 
Montreal, Que.
Supported by Medical Research Council of Can­
ada grant MA-1571.
The material contained in this article formed por­
tion of a chapter (The Healing of Mesenchymal 
Tissues) of a book entitled “Fractures”, edited by 
Charles A. Rockwood, Jr. and David P. Green, 
published by J. B. Lippincott, Co., Philadelphia, 
1975.
Reprint requests to: Dr. R. L. Cruess, Orthopedic 
surgeon-in-chief, Royal Victoria Hospital, 687 
Pine Ave. W., Montreal, Que. H3A 1A1.
and JACQUES DUMONT, MD, FRCS[C]
T h e  musculoskeletal system is a complex 
and important portion of the human body 
and damage to it is seldom simple. The 
structures injured include bones and soft 
tissues, joints, muscles, tendons, ligaments 
and blood vessels. Other organ systems also 
may be injured, making repair complex. 
Throughout human evolution, repair pro­
cesses have developed that are predictable 
and ensure survival of the species because 
its individual members are able to return 
to a useful, functional existence; a knowl­
edge of these active repair processes is es­
sential for any surgeon who undertakes to 
treat injuries of the musculoskeletal system. 
It appears reasonable that, wherever pos­
sible, the natural processes should be al­
lowed to take their usual course and that in­
terference with them should only be at­
tempted where there is demonstrable need 
or substantial advantages for the individual 
patient.
B asic  E l e m e n t s  o f  F r a c t u r e  
H e a l in g
The sequence of events following a break 
in continuity of a bone has gradually be­
come more clearly understood, and the cel­
lular responses involved are now known to 
be quite complex. Fracture healing can con­
veniently be divided into a number of phases 
but events described in one phase persist into 
the next and events apparent in a subse­
quent phase begin before this particular 
phase predominates (Fig. 1). Thus, the 
division into phases is arbitrary, but this does 
make the overall picture clearer. These 
events have been described through the 
years in investigative reports and review 
articles.1’ 2
Inflammatory Phase
A fracture results in damage to the bone 
itself (Fig. 2). The soft-tissue envelope in­
cluding the periosteum and surrounding 
muscles tears and numerous blood vessels 
crossing the fracture line rupture. A hema­
toma accumulates within the medullary 
canal, between the fracture ends, and be-
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INFLAMMATION REPARATIVE REMODELLING
PHASE PHASE PHASE
T I M E
F'S- 1.—Relative durations of phases of inflammation, repair and remodelling in fracture healing.
neath any elevated periosteum; this blood 
rapidly forms a clot. Damage to the blood 
vessels has important effects. Osteocytes are 
deprived of their nutrition; they die as far 
back as the junction of collateral channels. 
Thus, the immediate ends of a fracture are 
dead as they contain no living cells. Severely
damaged periosteum and marrow, as well 
as other surrounding soft tissues, may also 
add necrotic material to the region.1
The large amount of necrotic material 
elicits an immediate and intense acute in­
flammatory response. Widespread vasodila­
tation and exudation of plasma lead to the
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!anized haematoma cartilage and bone)
:earty new bone 
formation
granulation tissue
acute edema seen in the region of a fresh 
fracture. Acute inflammatory cells migrate 
to the region, as do polymorphonuclear leu­
kocytes and then macrophages. As the acute 
inflammatory response becomes less intense, 
the second phase begins and gradually be­
comes predominant.
Reparative Phase
The first step in the reparative phase is 
identical to the process seen in other tissues. 
The hematoma is organized (Fig. 3) and, 
though there is some controversy as to the 
necessity of this step, it appears that it is 
inevitable in the natural process of repair.3 
The hematoma, which probably has a small 
mechanical role in immobilizing the fracture, 
serves primarily as a fibrin scaffold over 
which reparative cells act.4 The microenvi­
ronment at this stage about the fracture is 
known to be acid,"' and this may well 
provide an additional stimulus to cellular 
behaviour during the early phases of repair. 
During the reparative process, the tissue pH 
gradually returns first to neutral and then 
becomes slightly alkaline.
The cells participating directly in the 
repair of fractures are of mesenchymal 
origin and are pluripotential. During frac­
ture healing, cells, probably of common 
origin, form collagen, cartilage and bone. 
Small variations in their microenvironment 
and in the stresses to which they are sub­
jected probably account for the function that 
predominates.6 Some cells are derived from 
the cambium layer of the periosteum and 
form the earliest bone, particularly in chil­
dren in whom this layer is active and im­
portant. Endosteal cells also participate. Sur­
viving osteocytes do not take part in the re­
pair process as they are destroyed during 
resorption.7 However, the majority of cells 
directly taking part in fracture healing enter 
the fracture site with the granulation tissue 
that is seen to invade the region from sur­
rounding vessels.8 Whether these reparative 
cells are derived directly from endothelium,8 
are “wandering cells”,*' or are derived from 
nucleated red cells10 seems of less impor­
tance than the fact that repair is indivisibly 
linked with the ingress of capillary buds.
The entire vascular bed of an extremity
Fig. 3.—Early stage of repair at fracture site, with organization of hematoma, early primary new 
bone formation in subperiosteal regions and cartilage formation elsewhere.
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enlarges shortly after the fracture has oc­
curred but the osteogenic response is limited 
largely to the zones surrounding the frac­
ture itself.11 The principal origin of the 
blood vessels has been the subject of contro­
versy but it appears that, ordinarily,12' 13 
the periosteal vessels contribute the majority 
of capillary buds early in normal bone heal­
ing, the nutrient medullary artery becoming 
more important later. When the surgeon 
interferes with this natural process, either 
by excessive stripping of the periosteum or 
by destroying the intramedullary system 
through the use of medullary nails, repair 
must proceed through the participation of 
vessels derived from the surviving system.14
The cells that invade the hematoma and 
rapidly begin to produce the tissue known 
as callus—made up of fibrous tissue, car­
tilage, and young, immature fibre bone—  
rapidly envelop the ends of the bone, with 
a resulting gradual increase in stability of 
the fracture fragments. The mechanisms 
controlling the behaviour of each individual 
cell at this stage of the repair process prob­
ably derive from the microenvironment in 
which the cell finds itself. Compression or 
the absence of tension discourages the for­
mation of fibrous tissue. Variations in oxy­
gen tension undoubtedly lead to the forma­
tion of either bone or cartilage; cartilage is 
formed where oxygen tensions are relatively 
low,6 presumably because of the distance of 
the cell from its blood supply.12
Cartilage, thus formed, will eventually be 
resorbed by a process that is indistinguish­
able except for its lack of organization from 
endochondral bone formation. Bone will be 
formed per primum by those cells that have 
an adequate oxygen supply and are sub­
jected to the proper mechanical stimuli. 
Early in the repair process, cartilage for­
mation predominates and glycosaminogly- 
cans are found in high concentrations. Later, 
bone formation is more obvious (Fig. 4).
Biochemically, events follow a sequential 
pattern: a high concentration of glycosa- 
minoglycans early in the reparative process 
is followed by a gradual increase in the 
concentration of collagen, and an accumu-
Fig. 4.—Later stage of repair at fracture site, with early immature fibre bone bridging fracture 
gap; persistent cartilage seen at points most distant from ingrowing capillary buds, which, in many 
areas, are surrounded by young new bone.
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lation of calcium hydroxyapatite crystals 
constitutes a third stage (Fig. 5). The col­
lagen content (on a weight basis) tends to 
return to normal after mineralization has 
occurred.15
Mineralized tissues are highly organized 
in their internal structure, this organization 
resulting from cellular activity. The initial 
step is the formation by osteoblasts of tropo- 
collagen, which moves from an intracellular 
to an extracellular location and polymerizes 
to form collagen fibrils.16
Collagen fibrils have their own internal 
organization, and within the substance of 
the fibrils are spaces.17 The spacing of these 
“hole zones” is quite regular and is related 
to the internal structure of the collagen 
molecules (Fig. 6).
The initial appearance of mineral in this 
region18 is the consequence of an interac­
tion between metastable solutions of cal­
cium and phosphate and the groups of spe­
cific amino acid side-chains within the 
holes.19 A series of organized collagen 
fibrils develop, within and around which are 
clustered crystals of calcium hydroxyapatite.
As this phase of repair takes place, the 
bone ends gradually become enveloped in
a fusiform mass of callus containing in­
creasing amounts of bone. Immobilization 
of the fragments becomes more rigid be­
cause of this internal and external callus 
formation, and clinical “union” eventually 
is said to have occurred. But union as an 
end point does not exist, because in the mid­
dle of the reparative phase the remodelling 
phase begins, with resorption of unneeded 
or inefficient portions of the c'allus and the 
laying down of trabecular bone along lines 
of stress.
Remodelling Phase
In 1892, Wolff-0 recognized that the 
architecture of the skeletal system corres­
ponded to the mechanical need of this sys­
tem and postulated his law. Remodelling 
about a fracture occurs over a prolonged 
period. Radioisotope studies have shown 
that increased activity in a fracture bone 
takes place for many more months than had 
previously been realized.21
Osteoclastic resorption of superfluous or 
poorly placed trabeculae occurs, and new 
struts of bone are laid down corresponding 
to lines of force. The control mechanism 
modulating this cellular behaviour is now
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Fig. 5.—Summary of biochemical events following fracture. Collagen formation precedes ac­cumulation of mineral, and mucopolysaccharide concentration decreases gradually as fracture healing progresses after initial rise.
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Hole zone Hole zone
Fig. 6.—Mineralization in collagen at fracture 
site, the first mineral appearing in “hole zone”. 
(Reproduced by permission from Glimcher MJ: 
Basic architectural principle in organization of 
mineralized tissues. Clin Orthop 61: 16, 1969.)
believed to be electrical. In stressing of a 
bone, electropositivity occurs on the convex 
surface and electronegativity on the con­
cave, the current having been produced by
a piezoelectric effect.-’2 Circumstantial 
evidence indicates that regions of electro­
positivity are associated with osteoclastic 
activity and that regions of electronegativity 
are associated with osteoblastic activity.23 
Although the biophysical principles affecting 
bone structure are complex, their impor­
tance is established; moreover, Wolff’s law 
is explainable in terms of alterations in the 
electric currents generated by crystalline 
structures within the bone that have a direct 
effect on cellular behaviour. The cellular 
module that controls remodelling is the 
resorption unit; this consists of osteoclasts 
that resorb bone and osteoblasts that lay 
down new haversian systems later.24 The 
end result of the remodelling process is a 
bone that, if it has not returned to its original 
form, has been altered so that it may best 
perform the function demanded of it.
Conditions Influencing and
Affecting Fracture Healing
Healing of a fracture is a consequence of 
cellular behaviour in a living organism and, 
as such, can be modified by almost all endo­
genous or exogenous factors that affect the 
metabolic function of cells. The literature 
abounds in reports of factors that can either 
promote or retard bone healing (Table I).25 
Although most of these factors probably do 
exert an influence that can be measured in 
the laboratory, in clinical practice fracture 
healing appears to proceed with a certain 
degree of predictability and is modified by 
relatively few influences.
TABLE I.—F actors Influencing Bone Healing
Claimed to promote healing Claimed to retard healing
Factor References Factor References
Growth hormone 32, 49 - 52 Corticosteroids 46, 52, 60
T  riiodo thyronine 53 Alloxan diabetes 69, 70
Thyroxin 54 Castration 54
Thyrotropin 50 Vitamin A, high dose 58
Calcitonin 55, 56 Vitamin D, high dose 71
Insulin 57 Rachitis 71
Vitamin A 58 Anemia 72
Vitamin D 59 Aminoacetonitrile 73
Anabolic steroids 
Chondroitin sulfate
60
61, 62
p-aminopropionitrile 
Bone wax
74
75
Hyaluronidase 63 Delayed manipulation 36
Anticoagulants (dicumarol) 64 Denervation 76
Ultrasonics 65 X-ray irradiation 77
Electric currents 10 Hyperbaric oxygen 78
Hyperbaric oxygen (2 h, 66, 67 (6 h, 2 atmospheres daily)
3 atmospheres daily) 
Physical exercise 68
Anticoagulants (dicumarol) 79
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Local Factors
Degree of local trauma.—Fracture heal­
ing has been described as involving differen­
tiation of cells from a mesenchymal pool. 
Fractures associated with more local trauma 
or trauma to the soft tissues surrounding 
the bone are well known to heal slowly, un­
doubtedly because the mesenchymal cells 
are relatively few and differentiate relatively 
slowly. The soft-tissue envelope around the 
fracture, in addition to providing mesen­
chymal cells for fracture healing, must here 
aid healing of the soft tissues themselves. 
Also, the hematoma escapes into the soft 
tissues, leading to a diffusion of mesenchy­
mal cell effort. Finally, in simpler fractures 
a soft-tissue envelope is intact, at least on 
the concave side of a fracture, and this 
provides both a ready source of mesenchy­
mal cells and a tube that directs the repara­
tive efforts of these cells in the proper di­
rection early. 2 6  This tube, of course, also 
helps to immobilize the fragments. The dif­
ferences in the repair process between un­
displaced and displaced fractures are well 
documented12- 1 3  and concern a retarda­
tion of the rate, an increase in the amount 
of cartilage formed and a decrease in the 
amount of primary bone formation between 
fracture ends.
Open reduction itself increases the degree 
of local trauma and thus will ultimately re­
tard healing. Introduction of metallic im­
plants, no matter how inert, also will elicit 
tissue reaction27  that makes use of repara­
tive processes that otherwise would be di­
rected exclusively to fracture healing. There­
fore, some degree of interference with the 
normal reparative process is inevitable when 
it becomes necessary or desirable to carry 
out internal fixation of fractures—not a 
condemnation of internal fixation but a 
recognition of fact.
Degree of bone loss.—The end result 
of any metabolic function depends on the 
ability of the local cells to perform a given 
function. If the function exceeds their capa­
city, it will be performed either slowly or 
not at all. Loss of bone substance or ex­
cessive distraction of the fragments will lead 
to a condition in which the cells’ ability to 
bridge the gap will be compromised.
Type of bone affected.— Cortical and
cancellous bone respond to fractures some­
what differently. Cancellous bone unites 
rapidly, but only at points of direct con­
tact. Where cancellous bone is not in con­
tact, the gap will be filled by the spread of 
new bone from points of contact.26’ 2 8  Re­
pair in cancellous bone is rapid because 
there are many points of bony contact rich 
in cells and blood supply. Charnley has com­
mented on the lack of callus about fractures, 
which are primarily in cancellous re­
gions.26, 28
Cortical bone unites by two mechanisms, 
depending on the local conditions. If ap­
position of cortical bone is exact and if im­
mobilization is rigid, healing takes place 
end-to-end from the cortical surfaces, with 
very little external callus.25' 2 9 ~4 0  If, on the 
other hand, the fragments are widely dis­
placed, or if immobilization is not rigid, the 
standard process of repair involving external 
callus is seen.
Degree of immobilization.— This factor, 
together with the amount of soft-tissue trau­
ma, probably is of paramount importance. 
Every clinician is aware that inadequate im­
mobilization leads to delayed or nonunion. 
Experimentally, repeated manipulation re­
tards fracture healing. It is probable that 
the initial fibrin scaffolding, which is formed 
as the first step in fracture repair, is dis­
rupted if immobilization is not adequate 
and the bony bridge of external callus fails 
to form properly. If immobilization conti­
nues to be inadequate throughout the repair 
process, a cleft forms between the fracture 
ends and a false joint develops; the classical 
pseudarthrosis results.
Infections.— For fracture healing to 
proceed at a satisfactory rate, the local re­
sources must be devoted primarily to heal­
ing the break in bony continuity. If infec­
tion is superimposed on a fracture or if the 
fracture occurs as a result of the infection, 
the local defences will be mobilized, either 
all or in part, to attempt to wall off and 
eliminate the infection. Healing will be re­
tarded or may not occur at all. 41
Local malignancy.— Unless the malig­
nancy itself is treated, fractures through 
bone affected by a primary or secondary 
neoplasm usually will not heal. Subperiosteal 
new bone formation and callus can be seen 
microscopically but the presence of malig-
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nant cells precludes effective immobilization 
of the fracture. This is particularly true if 
the malignant lesion is an expanding one, 
in which there is actually extension of the 
deposit into the areas from which healing 
must take place.
Other local pathologic conditions.— Frac­
tures through bones affected by nonmalig- 
nant lesions may heal in some instances30 
but many conditions31 such as Paget’s di­
sease or fibrous dysplasia heal slowly or 
not at all. Once more, the cause is a failure 
of normal differentiation of mesenchymal 
cells, and of ingrowth of capillaries from 
the surrounding tissues.
Radiation necrosis of bone.—Irradiated 
bone heals at a greatly retarded rate and, 
in many instances, nonunion results.42 This 
is attributed to the patchy death of cells in 
the local region, to thrombosis of vessels 
and to the fibrosis of the marrow that inter­
feres with the ingrowth of capillaries.
Avascular necrosis.—Under ordinary cir­
cumstances, healing proceeds from both 
sides of a fracture, differentiation of healing 
cells occurring approximately equally on 
both sides. When one fracture fragment has 
been rendered avascular, the healing process 
depends entirely on ingrowth of capillaries 
from the living side. Fractures associated 
with avascular necrosis of one fragment will 
heal but the rate is slower and the incidence 
is lower than in situations where this does 
not occur.43 If both fragments are avas­
cular, the chance of union occurring is very 
poor indeed.26
Intra-articular fractures.—Intra-articular 
fractures pose a more difficult problem. 
Synovial fluid contains fibrinolysins,44 
which are capable of lysing the initial clot 
and thus retarding the first stage in frac­
ture healing. As with avascular necrosis, 
these fractures will heal, but the difficulties 
encountered are greater than those in cases 
of extra-articular fractures.
Systemic Factors
Age.— Fractures in the young heal rapid­
ly, and the older the child the more the 
rate of healing resembles that of an adult. 
Also, the rapid remodelling that accompa­
nies growth allows the young to correct 
greater degrees of deformity. Experimental 
work45 with tritiated thymidine reveals a
more rapid differentiation of cells from the 
mesenchymal pool in the young, so that 
more are available for the reparative pro­
cess. In animals, fractures in elderly adults 
heal more slowly than those in younger 
ones; in clinical practice, this is difficult 
to document.
Hormones.— 1. Corticosteroids: Both ex­
perimentally and clinically, corticosteroids 
greatly retard fracture healing.46 They in­
hibit the differentiation of osteoblasts from 
mesenchymal cells47 and decrease the rates 
of synthesis of the major components of 
bone matrix48 necessary for repair.
2. Growth hormone: Although altera­
tions in the concentration of circulating 
growth hormone probably have little effect 
on fracture healing clinically, experimental 
work has shown that the rate of repair can 
be profoundly influenced by this sub­
stance.32’ 40 51 Growth hormone is a potent 
stimulator of fracture healing.
3. Other hormones: Thyroid hormone, 
calcitonin, insulin, vitamins A and D in 
physiologic dosages, and anabolic steroids 
have been reported in experimental situa­
tions to enhance the rate of fracture healing 
(Table I 10- 32- 36' 46- 4»-70). Diabetes, cas­
tration, hypervitaminosis D, hypervitamino- 
sis A, as well as the rachitic state, have been 
shown to retard fracture healing in experi­
mental situations (Table I). Rarely in clinic­
al practice do these substances or situations 
pose a serious problem.
Exercise and local stress about the frac­
ture.—Denervation retards fracture healing, 
probably by diminishing the stress across 
the fracture site.76 Exercise increases the 
rate of repair.68 Clinicians have known that 
use of a fractured extremity promotes re­
pair, and the recent development of weight­
bearing techniques have confirmed this con­
viction. It is probable that bone formation 
is stimulated by forces acting across the 
fracture site, perhaps by initiating piezoelec­
tric effects, which leads to accelerated rates 
of bone formation.
Electric currents.—The application of 
local electric current can stimulate healing 
in a fracture that has previously failed to 
respond to adequate treatment.80’ 81 This 
represents a clinical application of experi­
mental work22’ 82 and may prove to be an 
important factor in the future.
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R EV IEW  A R T IC L E
CHOICE OF GASTRIC DRAINAGE PROCEDURES *
M AX M. COHEN, MB, ChB, FRCS(Edin), FRCS[C]t
Summary: The need for drainage after truncal 
or selective vagotomy is well accepted, but 
there is no agreement on the most suitable type 
of drainage procedure. A review of the litera­
ture, particularly of papers published in the last 
3 years, suggests that whereas vagotomy with 
gastroenterostomy is followed by a relatively 
high incidence of bile vomiting, vagotomy with 
pyloroplasty carries a significantly higher risk 
of recurrent ulceration. The surgeon, therefore, 
should not hesitate to perform gastroentero­
stomy if the pyloroduodenum is severely 
scarred. As pyloroplasty is irreversible, gastro­
enterostomy is probably the drainage procedure 
of choice.
Resume: On admet generalement le besoin de 
recourir a un drainage apres une vagotomie se­
lective ou tronculaire, mais I'accord n'est pas 
fait sur la methode de drainage la plus conve- 
nable. Apres une revue de la litterature perti- 
nente, surtout des articles publiees depuis les 
3 dernieres annees, on peut conclure que, dans 
les cas ou la vagotomie avec gastroenterosto- 
mie est suivie d'une frequence relativement ele- 
vee de vomissement biliaire, la vagotomie avec 
pyloroplastie comporte un risque assez conside­
rable d'ulceration recidivante. Le chirurgien ne 
devra done pas hesiter a pratiquer une gastro- 
enterostomie si la region pyloro-duodenale est 
le siege de lesions cicatricielles severes. Comme 
la pyloroplastie est irreversible, la gastroente- 
rostomie est probablement la methode de drai­
nage par excellence.
The introduction of vagotomy in the treat­
ment of duodenal ulcer, by Dragstedt and 
Owens in 1943,1 led rapidly to the realiza­
tion that unless the stomach was drained 
simultaneously many patients would develop 
prolonged gastric stasis and require reopera-
*Presented at the annual meeting o f the Royal 
College o f Physicians and Surgeons of Canada, 
Winnipeg, Man., January 1975.
tAssistant professor, department of surgery, Uni­
versity o f British Columbia, Vancouver, BC.
Reprint requests to: Dr. M. M. Cohen, Depart­
ment o f  surgery, University of British Columbia, 
700 W. 10th Ave., Vancouver, BC V5Z 1L5.
tion. The need for drainage after truncal or 
selective vagotomy is not questioned, and in 
this paper I shall discuss the choice of 
drainage procedures available.
D e v e l o p m e n t  o f  P r o c e d u r e s  f o r
D r ain a g e
The first pyloroplasty was performed by 
Heineke in 1886 and was popularized by 
Mikulicz.- The original Heineke-Mikulicz 
incision (length, 5 cm) was closed with sev­
eral rows of interrupted cotton. This caused 
too much inversion and, as a result, pyloric 
obstruction, recurrent ulceration and leaks 
were common. The operation was con­
demned and forgotten until 1956, when 
Weinberg modified the original procedure 
by lengthening the incision slightly and 
suturing it transversely with a single layer 
of interrupted cotton sutures (Fig. I).3 
Weinberg emphasized using nonabsorbable 
suture material, not incorporating the mu­
cosa in the suture, and making no attempt 
to invert the inevitable dog-ears produced 
at each end of the sutured pyloroplasty. 
This technique of pyloroplasty is probably 
now the most widely practised, although 
many surgeons use absorbable sutures. I 
have seen several patients with recurrent ul­
ceration after pyloroplasty at the site of silk 
sutures and for this reason I now use ex­
clusively a single layer of interrupted poly- 
glycolic acid sutures.
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Judd4 recommended excising the anterior 
two-thirds of the pyloric sphincter, including 
any anterior ulcer that may be present, 
before closing the pyloroplasty in the usual 
manner. Like the Heineke-Mikulicz pylo­
roplasty, this pylorectomy was originally in­
troduced as the sole treatment for peptic 
ulcer, but this also fell into disrepute. It has 
recently been revived as an adjuvant to 
vagotomy.
The gastroduodenostomy is a compromise 
between pyloroplasty and gastroenterostomy. 
There are two main types of gastroduode­
nostomy: that described by Finney,5 in 
which the incision passes through the py­
lorus, and that described by Jaboulay,6 in 
which the anastomosis is subpyloric.
The Finney gastroduodenostomy (Fig. 2), 
if properly done, is more than a simple py­
loroplasty. It requires complete mobilization 
of the duodenum, which is incised beyond 
the ampulla of Vater. If, for any reason, 
complete mobilization proves impossible, an 
alternative drainage procedure should be 
performed. The Finney operation provides 
a wide stoma between stomach and duo­
denum; the stoma extends from the pylorus 
to the full extent of the second part of the 
duodenum. The anastomosis is usually per­
formed in two layers as for gastroentero­
stomy.
The Jaboulay gastroduodenostomy (Fig. 
3) is similar to the Finney operation and 
also requires mobilization of the duodenum, 
but the incision does not pass through the 
pylorus, which is bypassed rather than in-
Fig. 3.—Jaboulay gastroduodenostomy.
corporated in the stoma. It requires less 
mobilization than the Finney procedure, and 
Finney himself advocated its use when 
mobilization was difficult.7
The only prospective study of these vari­
ous drainage procedures was reported by 
Thompson and Read.8 In a randomized 
prospective study of 100 male patients with 
peptic ulcer in whom vagotomy plus either 
Heineke-Mikulicz or Finney drainage were 
carried out, no difference was found either 
in the rate of recurrent ulceration (12% 
and 11%, respectively) or in the incidence 
of dumping or diarrhea.
Gastroenterostomy was introduced in 
1881 by Wolfler,1' who used an anterior 
antiperistaltic gastrojejunostomy. Numerous 
variations have since been proposed but es­
sentially the operation is antecolic (mainly 
as palliation for cancer) or retrocolic, and 
the stoma is fashioned in an antiperistaltic 
or isoperistaltic manner (Figs. 4 and 5).
Of all these procedures the pyloroplasty 
has been widely adopted since its reintro­
duction by Weinberg and is now probably 
the most common; it can be performed 
somewhat more rapidly than a gastrojeju­
nostomy and is seemingly the more anatomic 
and physiologic choice. These considerations 
have outweighed for most surgeons the ir­
reversible destruction of the pyloric sphinc­
ter that results.
R eview  of the Literature
Until recently no good data were avail­
able on which to base the choice of gastric 
drainage procedure. The literature pub-
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Fig. 4.—Posterior antiperistaltic gastroenterostomy.
lished up to 1967, collected by Cox,10 con­
sisted of retrospective reviews, and these 
revealed no difference in mortality or in­
cidence of recurrent ulceration, but a slight
Fig. 5. —Posterior isoperistaltic vertical gastro­
enterostomy.
TABLE I.—Comparison of R esults of Vagotomy 
P lus Pyloroplasty or Gastroenterostomy from 
R etrospective Studies R eported up  to 1967
Vagotomy and
Vagotomy and gastro-
bvloroplastv enterostomy
(%) (%)
Operative mortality 0.6 1.0
Recurrence rate 5.5 5.6
Dumping 12.0 9.0
Bile vomiting 
“Good” results
6.0 14.0
89.0 90.0
increase in the incidence of bile vomiting 
after gastroenterostomy (Table I). However, 
more recently a number of studies have 
been reported that provide more informa­
tion.
In 1973, two British papers11' 12 reported 
the results of prospective randomized 
trials of pyloroplasty versus gastro­
enterostomy. Both groups selected in­
cluded only patients with duodenal ulcer 
in whom, at laparotomy, either procedure 
was considered feasible, thus excluding from 
the trials any patient with a severely scar­
red duodenum. The overall results of these 
two trials, from Glasgow and Belfast, are 
presented in Table II.
The Glasgow and Belfast trials were dif­
ferent in certain details. These differences 
were as follows:
1. Numbers of patients. The Glasgow 
series comprised 200 and 204 patients in 
the operative subgroups over a 6-year pe­
riod whereas the Belfast series included only 
50 in each in a 2-year period.
2. Types of operations. The Glasgow sur­
geons used truncal vagotomy and a Heineke- 
Mikulicz, single-layer, catgut closure, but 
the Belfast surgeons performed a modified 
Finney pyloroplasty with the gastroentero­
stomy being positioned nearer the pylorus.
3. Surgeons’ expertise. In Glasgow, most 
of the 45 surgeons who operated on the 
patients were residents, but in Belfast only 
2 surgeons, both of whom were consultants, 
operated on the patients.
4. Follow-up. The Glasgow patients were 
observed for a minimum of 2 years and 
were seen at a peptic ulcer clinic; the Bel­
fast patients were followed up for 3 Vi 
years, by a physician who had no knowl­
edge of the operation performed.
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The Glasgow authors reported that re­
current ulceration was more common after 
pyloroplasty, though the difference was not 
significant. The incidence of dumping and 
of results that were good or excellent was 
similar in both subgroups, but there was a 
significantly higher incidence (P <  0.001) 
of bile vomiting following gastroentero­
stomy. The Glasgow group concluded from 
this study that the choice of drainage proce­
dure should be determined at exploration 
and that “the surgeon should not hesitate 
to select the more easy gastrojejunostomy in 
circumstances when a pyloroplasty seems 
likely to be more difficult and, therefore, 
more hazardous to the patient”. They 
pointed out that an anastomotic leak is a 
much more serious complication than bile 
vomiting.
The Belfast authors found no significant 
difference between the two groups with re­
spect to recurrent ulceration or other disabil­
ity, although there was a marginal advan­
tage on the clinical grading in those pa­
tients who received gastroenterostomy. The 
authors concluded that as gastroenterostomy 
is reversible it is the drainage procedure of 
choice.
The results of both the Glasgow and Bel­
fast trials combined with respect to the two 
procedures (vagotomy and pyloroplasty, and 
vagotomy and gastroenterostomy) are sum­
marized in Table III. Though dumping and 
recurrent ulceration are more common after 
pyloroplasty, even with the combined data 
these factors do not achieve statistical sig­
nificance.
There have been two other major studies 
of gastric drainage procedures, neither of 
which was truly a randomized, prospective 
study. Goligher and associates from Leeds13 
reported the findings in 164 patients fol­
lowed up for 5 to 8 years after vagotomy 
(truncal type) and pyloroplasty (Heineke- 
Mikulicz). The results have been compared 
with those following truncal vagotomy and 
gastroenterostomy, the latter being per­
formed as part of a well-known, prospect­
ive, controlled trial of elective surgery for 
duodenal ulcer by the same group. They 
found that while recurrent ulceration and 
overall poor results were more common 
after vagotomy and pyloroplasty than any 
other operation, there was no statistically 
significant difference compared with vago­
tomy and gastroenterostomy. Table IV
TABLE II.—Details of Glasgow and Belfast Trials
Glasgow trial Belfast trial
Vagotomy and 
pyloroplasty
Vagotomy and 
gastroenterostomy
Vagotomy and 
pyloroplasty
Vagotomy and 
gastroenterostomy
No. % No. % No. % No. %
No. of patients.............. 204 200 50 50
No. of patients followed
up* (and %).............. 166 81 166 83 46 92 48 96Operative deaths.......... 0 1 0 0
Recurrent ulcer............. 8 5 5 3 2 4 1 2
Dumping........................ 45 25 36 22 18 39 12 25Bile vomiting............... 9 6t 25 16f 4 9 5 10“Good” results.............. 146 88 143 86 40 87 44 92
♦Glasgow trial, >  2 yr; Belfast trial, 3XA  yr. 
(Difference significant, P <  0.01.
TABLE III .—Combined Glasgow and Belfast Trials
Vagotomy and pyloroplasty 
No. %
Vagotomy and gastroenterostomy 
No. %
Total no. of patients followed up. . .  . 212 214
Proven recurrence................................. 10 5 6 3
Dumping................................................. 63 30 48 22Bile vomiting*....................................... 13 6 30 14
*P < 0.01.
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TABLE IV.—Glasgow, Belfast and Leeds T rials Combined
Vagotomy and pyloroplasty Vagotomy and gastroenterostomy 
No. %  No. %
No. of patients.........................................  466
No. of patients followed up.................. 376
Recurrent ulcer........................................  21
Dumping...................................................  86
Bile vomiting*..........................................  29
*P <  0.01.
shows the combined results from the Glas­
gow, Belfast and Leeds studies. The inci­
dence of dumping and the good-to-excellent 
results are identical following the two oper­
ations and, as expected, there was a highly 
significant increase in the incidence of bile 
vomiting after vagotomy and gastroentero­
stomy.
The final study that merits comment is 
the multihospital veterans’ administration 
study reported by Postlethwait.14 A total 
of 1357 men were randomly allocated to 
four treatment groups, one of which was 
vagotomy and drainage. The surgeon was 
free to choose the drainage procedure he 
preferred. On this basis, 135 pyloroplasties 
and 106 gastroenterostomies were per­
formed, and 85% of patients were followed 
up for 5 years. Unfortunately, the only com­
parative data given for these operations is 
the recurrent ulceration rate, which was 
8.9% for pyloroplasty and 5.7% for gas­
troenterostomy. Once again the rate of re­
current ulceration was higher after vagotomy 
and pyloroplasty, but the difference was 
not statistically significant. If, however, the 
results from this study are combined with 
those from the three British centres, it is ap­
parent that recurrent ulcer is almost twice 
as common after pyloroplasty as after gas­
troenterostomy (Table V). If we assume 
that the patients in all these studies are suf­
ficiently similar to permit combined statis­
tical analysis, then the difference in the rate 
of recurrent ulceration is significant. To
376
333
6 9 3
23 77 23
8 48 14
prove this point conclusively, a single pro­
spective study of about 1000 patients would 
be required.
C o n c l u sio n
A review of the recent literature sug­
gests that whereas vagotomy with gastroen­
terostomy is followed by a relatively high 
incidence of bile vomiting, vagotomy with 
pyloroplasty carries a significantly higher 
risk of recurrent ulceration. The surgeon, 
therefore, should not hesitate to perform 
gastroenterostomy if the pyloroduodenum 
is severely scarred. As pyloroplasty is irre­
versible, gastroenterostomy is probably the 
drainage procedure of choice.
I am indebted to Miss Patricia Parsons, depart­
ment of medical illustration, University of British 
Columbia, for the illustrations.
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DAVIS & GECK SURGICAL ESSAY AWARD
FOR RESIDENTS
The Canadian Journal of Surgery announces the institution of an award of $1000.00 
for the best paper on a surgical topic submitted by a surgical resident. To be given annu­
ally by Davis & Geek, this award is intended to promote scientific and literary excellence 
among Canadian surgeons in training. The first award will be presented in 1976.
The conditions of entry for the award for 1976 are the following: -—-
1. Candidates shall be currently engaged in a recognized surgical residency program 
leading to eligibility for the Fellowship of the Royal College of Physicians and 
Surgeons of Canada in one of the surgical specialties (cardiovascular and thoracic 
surgery, general surgery, neurosurgery, obstetrics and gynecology, ophthalmology, 
orthopedic surgery, Otolaryngology, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript relating to 
work in which a surgical resident is or has been the prime or major investigator. 
Prior oral presentation at a Royal College meeting or a Surgical Forum meeting 
will not be a disqualification, but prior publication as a formal paper in a 
journal will. The paper should relate to any field of surgical interest. The manu­
script must conform to the style requirements of the Journal and must not 
exceed 3000 words of text and six tables and/or six figures.
Coauthors are permitted on the understanding that the candidate shall be the 
first author and that only the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than June 30, 1976. 
Each entry must be submitted to Dr. D. A. E. Shephard, MB, FRCP(C), Asso­
ciate Editor, Canadian Journal of Surgery, P O Box 8650, Ottawa, Ontario, 
K1G 0G8, with a letter stating that the paper is being submitted as an entry 
for the Davis & Geek Essay Award.
4. The award-winning paper shall be published in the Canadian Journal of Surgery 
and shall be the property of the Journal.
All papers submitted will be judged by an independent committee comprising at 
least one member of the editorial board of the Journal, one Fellow of the Royal College 
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical 
Association, together with other Fellows invited to serve at the discretion of the three 
permanent members of the committee. For the purpose of judging, the candidates will 
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced 
in the November 1976 issue of the Journal.
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SELF-ASSESSMENT
SESAP II QUESTION
Beginning with this issue of the Journal, your coeditors institute a new feature—in­
clusion of a multiple-choice question related to one of the papers published in the Journal. 
The question has been taken, by permission of the American College of Surgeons, from 
“SESAP II Syllabus: Surgical Education and Self-assessment Program No. 2”.
The American College of Surgeons, through its Committee on Continuing Education, 
during the past several years has constructed two self-assessment programs—SESAP I and 
SESAP II. The SESAP II program is accompanied by a volume devoted to an explana­
tion or critique of each of the items. This critique discusses each of the choices, both right 
and wrong, as the choices relate to the item stem. The SESAP II program and the book 
of critiques are available in syllabus form on application to the American College of Sur­
geons.
Subscriptions to and enrolment in SESAP II will continue for approximately 2 Vi 
more years, and application may be obtained by writing to SESAP, American College of 
Surgeons, 55 East Erie St., Chicago, IL 60611, USA.
You are invited to participate by examining this item, which deals with issues raised 
by the paper entitled “Hyperparathyroidism: Evaluation of Four Decades of Parathyroid 
Surgery” by E. E. Mason, J. Hoines and J. B. Freeman on page 422 of this issue of the 
Journal. On page 447 you will find a critique of the item with a discussion of the correct 
answer as well as reasons for the incorrectness of the other answers.
533. A 45-year-old man is referred for evaluation because of persistent hypercalcemia 
(calcium concentration 12.8 mg/100 ml) and hypophosphatemia (phosphorus concentra­
tion 1.5 mg/lOO ml) developing after removal of a parathyroid adenoma which measured 
6 by 2.5 by 1.5 cm and is said to have been located inferiorly in the prevertebral space in 
the left side of the neck. Arteriograms of the thyroid and the results of multiple selective 
venous parathyroid hormone assays are shown . . .  At reexploration of the neck the most 
likely finding would be
(A) hyperplasia of three remaining parathyroids, the glands varying in size
(B) adenoma of the upper right parathyroid in an ectopic position without enlargement 
of the other two parathyroids
(C) adenoma of the thyroid with moderate enlargement of two parathyroids on the right 
and one on the left
(D) two small, apparently normal parathyroids adjacent to the lower pole of the thy­
roid bilaterally
(For the critique of Item 533 see page 447)
September 1975 T H E  C A N A D IA N  JO U R N A L  O F SU R G E R Y 421
1—  Inferior Vena Cava Below
Renals 0.267 ng/m
2—  High Internal Jugular, Right 0.304
3—  Superior Thyroid, Right 0.476
4—  Low Internal Jugular, Right 0.248
5—  Subclavian Lateral to Internal
M ammary 0.259
6—  Right Innominate 0.285
7—  Superior Vena Cava, Middle 0.35
8—  Left Subclavian Lateral to Internal
M am m ary 0.316
9— Subclavian Close to Left In ternal
Jugular 0.311
10— Middle Left Innominate 1.23
11— Left External Jugular 0.368
12— Left Thyroid 0.296
13— Thyroid ima 3.98
14— Azygous 0.284
15— High Internal Jugular, Left 0.316
16— Low Internal Jugular 0.290
17— Low Superior Vena Cava 0.368
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HYPERPARATHYROIDISM: EVALUATION OF FOUR DECADES OF 
PARATHYROID SURGERY*
E. E. MASON, MD, PhD, J. HOINESt and J. B. FREEMAN, MD, FRCS[C]
Summary: A  review of 98 patients with hyper­
parathyroidism operated on at the University of 
Iowa during a 45-year period reveals a very 
great increase in the frequency of the clinical 
diagnosis. More patients are being operated on 
each year and more glands are being removed 
or biopsied. The proportion of patients in whom 
light microscopic examination of the parathy­
roid reveals hyperplasia remains less than 25%. 
Better methods are needed for identification of 
hyperplasia. Clinically, a few patients in whom 
the diagnosis of adenoma is made appear later 
to have more diffuse parathyroid disease. A t 
present, however, when an adenoma is found, 
the decision to perform subtotal removal of 
apparently normal parathyroid tissue is made 
only reluctantly. The conclusion drawn from 
this review is that patients with hyperparathy­
roidism must be studied more intensively and 
followed for many years, whether or not an 
operation is performed. Although the diagnosis 
of hyperparathyroidism is now made readily 
and operative treatment seems to be more ef­
fective, much has yet to be learned about 
hyperparathyroidism.
Resume: La revue des dossiers des 98 patients 
souffrant d'hyperparathyroidisme qui ont ete 
operes a I'Universite de Tlowa durant une pe- 
riode de 45 ans revele une enorme augmentation 
de la frequence du diagnostic Clinique. Chaque 
annee, le nombre de malades operes augmente 
et il en est de meme des glandes excisees ou 
soumises a la biopsie. La proportion de 
malades ou I'examen de la parathyroide 
par microscope optique revele un hyper- 
plasie reste inferieure a 2 5 % . II faut recourir 
a des meilleures methodes pour identifier I'hy- 
perplasie. Quelques malades, chez lesquels on 
avait pose un diagnostic clinique d'adenome 
ont presente ulterieurement une affection para- 
thyroidienne plus diffuse. Presentement toute- 
fois, en presence d'un adenome, la decision de 
pratiquer une ablation subtotals d'un tissue 
parathyroidien apparemment normal n'est prise 
qu'avec reticence. La conclusion qu'on peut
*From the department of surgery, University of 
Iowa, Iowa City, IA 52242, USA.
Presented at the annual meeting of the Royal Col­
lege of Physicians and Surgeons of Canada, Win­
nipeg, Man., January 1975.
t Medical student.
Reprint requests to: Dr. Edward E. Mason, De­
partment of surgery, University of Iowa, Iowa 
City, IA 52242, USA.
tirer de cette revue est qu'il est imperieux d'e- 
tudier plus a fond les malades atteints d'hyper- 
parathyroidie et de les suivre pendant plusieurs 
annees, qu'ils aient ete operes ou non. Meme 
si le diagnostic d'hyperparathyroidie est au- 
jourd'hui plus aise et le traitement chirurgical 
plus efficace, il faut admettre qu'il reste beau- 
coup a apprendre sur I'hyperparathyroidie.
A n  excellent illustration of serendipity, the 
prepared mind, and the dictum that what 
you know is what you find, is given by the 
history of hyperparathyroidism. The first 
adenoma detected at the University of Iowa 
was removed in 1929, only 4 years after 
Mandl’s report,1 and the case was the sixth 
reported in the literature.- In those days the 
disease was severe, with deforming bone 
disease and progressive destruction of the 
kidneys. It was also rare, but if the adenoma 
could be found and removed the disease 
was thought to be cured. Today, however, 
the disease appears to be decreasingly sev­
ere and, in addition, demands for operative 
treatment of hyperparathyroidism are in­
creasingly frequent. These observations 
stimulated a review of 45 years’ experience 
at the University of Iowa and a survey 
of evolving attitudes toward the etiology, 
pathology, management and prognosis of 
hyperparathyroidism.
C hanges in C linical Pattern
In 1934, Albright, Aub and Bauer3 re­
ported an astonishing series of hyperpara­
thyroidism in 17 patients, in all of whom 
the disease was confirmed at operation. In 
eight of these patients the disease had been 
discovered through the deliberate invest­
igation of patients with renal stones. The 
late Dr. F. R. Keating spent a year in Bos­
ton learning all he could about the activities, 
thoughts and organization that had led to 
the finding of such a relatively large num­
ber of patients with hyperparathyroidism, 
and he then returned to the Mayo Clinic 
where, by 1945, he and Cook4 had recog­
nized new cases of the disease in 24 patients 
in 2Vi years— in contrast to its occurrence 
in only 14 patients in 14 years before this 
intensive interest.
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At the University of Iowa, where the ex­
perience has been similar to that of other 
centres, the increase in frequency of diag­
nosis was first noted in 1960. The type of 
disease that was discovered suggests that the 
increase was related to the intensive study 
of patients with renal stones, together with 
an occasional discovery because of the pre­
sence of peptic ulcer, pancreatitis, or mul­
tiple glandular disease. Notable was the 
occasional finding of the disease in a patient 
who had no bone or renal disease but who 
had vague symptoms; moreover, the vague­
ness made such a patient’s case an enigma 
until some thoughtful medical student or 
physician considered the possibility of hy­
perparathyroidism and requested the ap­
propriate laboratory tests. But recently, be­
cause of automated laboratory screening, an 
ever-increasing number of patients with sus­
pected hyperparathyroidism is being seen. 
Since only patients are being screened we 
do not know, even now, the precise fre­
quency of hyperparathyroidism.
Table I shows the University of Iowa 
experience divided into four nearly equal 
groups. The first 22 patients were seen in 
a period of 30 years, the second 22 were 
seen in a single decade, the third 26 patients 
were seen in a brief 4-year span, and the last 
25 patients were operated on during 1974. 
During each of the first 3 decades, the num­
bers of patients operated on were 10, 7 and 
5 patients respectively. This experience sug­
gests that there were a few patients with 
long-standing, severe disease and that, when 
the disease was first recognized, all of these 
patients were treated, and that this was fol­
lowed by a disappearance of those forms of 
the disease that were relatively severe and, 
clinically, most easily diagnosed. There fol­
lowed a decade of treating patients with 
predominantly renal manifestations of the
°  Neither Stone nor
No. of Pts. 10 7 5 22 51
Fig. 1.— Changing pattern of hyperparathy­
roidism. Note early predominance of bone disease, 
then renal stone disease and more recently asym- 
tomatic disease.
disease. Now, more patients are being 
treated with chemical abnormalities but with 
minimal evidence of bone or renal disease, 
as well as, increasingly, patients with no 
symptoms (Fig. 1).
E t io l o g y
Our understanding of the etiology re­
mains little more than passive astonishment 
at the increase in number of patients. It is 
a disease with an insidious onset, progress­
ing slowly in most patients, and symptoms 
are present for a long time before they re­
quire a diagnosis, though this duration is 
decreasing (Fig. 2).
Several differences between men and 
women could have a bearing on current
TABLE I.—N umbers of P atients Operated on for H yperparathyroidism, and Serum  Calcium 
R anges, in  Four P eriods Betw een  1929 and 1974
Serum  calcium 
0mg/dl) 1929 to 1959 1960 to 1969 1970 to 1973 1974 1929 to 1974
16............................................... 4 2 1 0 7
14.1 — 16................................. 9 4 3 0 16
12.1 — 14................................. 2 6 5 10 23
10.5— 12................................. 7 10 17 15 49
T o ta l................................. 22 22 26 25 95
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I929-I969 1970- 1974
Gland examined
-Hyperplasia
Fig. 2.—Proportions of patients from whom 
more than one gland was examined and from 
whom hyperplastic glands were found during 
periods 1929 to 1969 and 1970 to 1974.
differences in frequency and severity of the 
disease between the sexes (Table II). Keat­
ing reported a higher normal serum calcium 
concentration in men, especially in the first 
half of life.5 It is possible that hyperpara­
thyroidism in either sex is not a primary 
neoplasm but rather a disruption of normal 
calcium homeostasis. From studying the 
disease in the many patients with renal in­
sufficiency and secondary hyperparathy­
roidism or tertiary hyperparathyroidism, we 
know that a disease very similar to so-called 
primary hyperparathyroidism can result 
from unusual demands on calcium regula­
tory organs.
Intrinsic defects in homeostasis, as in the 
families with multiple glandular syndrome, 
are rare. There are probably other instances 
of disturbed cell growth producing benign 
neoplasms, and these rarely give rise to a 
functioning carcinoma. The majority of pa­
tients with hyperparathyroidism, however, 
probably have a form of tertiary disease; but 
we have not yet made the necessary obser­
vations, such as have been made in patients 
with renal insufficiency, that would permit 
us to discern the sequence of events. In con­
trast to the situation with other endocrine 
organs, the feedback is a direct action of 
calcium on the parathyroid, with no hypo­
thalamic or pituitary involvement. Yet 
control of calcium and phosphorus meta­
bolism is far from simple. Parathormone is 
active in three major sites: the kidneys, 
bones and gastrointestinal tract. It is syner­
gistic in its actions with vitamin D. Fur­
thermore, parathormone is probably respon­
sible for the conversion of 25-dihydroxy- 
vitamin Dij to its biologically active meta­
bolite, 1,25-dihydroxyvitamin D3, and the 
latter, in turn, acts as a feedback inhibitor 
of parathormone secretion. Thus, plasma 
levels of both calcium and vitamin D3 are 
controlled by, and also inhibit, the secretion 
of serum parathormone. In bone, the effects 
of parathormone are offset by calcitonin, 
which tends to enhance osseous formation 
and to decrease resorption. Finally, both the 
serum albumin and the acid-base status af­
fect serum calcium concentrations.
To determine the relationships between 
normal calcium metabolism and the dis­
turbances that lead to hyperparathyroidism, 
it may be helpful to obtain information 
about calcium homeostasis in persons in 
whom the disease is developing under cir­
cumstances much less obvious than chronic 
renal failure. Studies of such patients once 
identified should be designed to reveal the 
cyclical and circadian rhythms for blood 
concentrations not only of calcium and 
phosphorus but also of parathyroid hormone 
and possibly calcitonin as well.
TABLE II.—D ifferences in F eatures of Hyperparathyroidism in M ales and F emales Treated 
Surgically During Periods 1929 to 1969 and 1970 to 1974
Female Male
1929-1969 1970-1974 1929-1969 1970-1974
No. of patients.................................................. 23 37 20 18*
Average age (yr)............................................... 51 47 39 47
Duration of symptoms > 3 yr, %................. 57 35 85 50
Calcium >  14 mg/dl, %................................. 43 5 45 11
Renal stones, % ................................................ 57 38 55 56
Bone disease, %................................................ 43 8 35 11
*Includes 4 patients from Veterans’ Administration Hospital, Iowa City.
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Serum chloride concentrations tended to 
be high in our patients. Wills and Mc­
Gowan6 have contrasted the hyperchloremia 
of hyperparathyroidism with the hypochlo- 
remia commonly noted in patients with hy­
percalcemia from other causes. The serum 
chloride concentration in our patients 
ranged from 96 to 112 mmol (=  meq)//, 
the median and average both being 105 
mmol//— certainly not sufficiently abnormal 
to be of diagnostic assistance, though such 
a finding perhaps might constitute another 
avenue for study of the developmental 
course of the disease. Tubular phosphate 
reabsorption is inhibited by parathyroid hor­
mone and, at the same time, phosphate ex­
cretion in its varying degrees of ionization 
is a factor in the regulation of acid-base 
balance. Hyperchloremic acidosis may be 
the consequence of impaired renal acid-base 
regulation in hyperparathyroidism, but such 
a conclusion does not indicate whether ex­
cess parathyroid hormone is the cause of 
abnormal acid-base balance or an effect.
Pathology
At first, hyperparathyroidism was always 
considered as resulting from the effects of 
a benign functioning neoplasm of which, 
once found and removed, the patient could 
be considered cured. This was the case in 
the first patient treated at the University of 
Iowa: This patient had such an adenoma, 
and when the adenoma was removed in 
1929 the other parathyroid glands were in­
spected and declared to be normal. In 1943 
a second adenoma was removed, and in 
1947 this patient died from renal failure. 
In patients who do not have hyperplasia, 
removal of a single adenoma is usually cura­
tive. There is increasing evidence, however, 
that hyperparathyroidism, even in patients 
who appear to have adenomatous disease, 
may reflect hyperplasia of all parathyroid 
tissue.7 Our inability to diagnose this form 
of the disease is accounted for by the great 
variability in glandular size in cases of para­
thyroid hyperplasia. Hence an “adenoma” 
may represent a rather large hyperplastic 
gland, whereas a “normal-sized gland” may 
represent a small hyperplastic gland. That 
there are patients who have no adenoma, 
but moderate and varying enlargement of 
several or all glands is unequivocal. There
are also patients in whom all parathyroids 
appear normal grossly and by light micro­
scopy but in whom there are subcellular 
abnormalities suggestive of functional over­
activity by electron microscopy.8 To add 
to the mystery, there are patients with renal 
insufficiency and secondary hyperparathy­
roidism in whom there develops what ap­
pear to be adenomas. Today, therefore, we 
see cases of a disease that is usually mild 
(or even totally asymptomatic) yet much 
more common— and much less well under­
stood in terms of etiology and pathology.
Although our pathologists now examine 
many more glands and biopsies of glands 
(Fig. 2), the frequency of diagnosis of hy­
perplasia has not increased. At times, recur­
rent adenoma formation occurs whereas at 
other times an initial diagnosis of hyper­
plasia is followed by that of an adenoma later. 
Better microscopic diagnosis is necessary 
and, without this, operative treatment is like­
ly to be inappropriate and the prognosis 
guarded. This raises the question regarding 
prolonged observation as an alternative form 
of management to early operation. When 
hyperparathyroidism was known only as a 
morbid and potentially lethal disease, there 
was no excuse for delay in treatment: every 
day a patient has severe hypercalcemia, the 
greater the number of nephrons destroyed 
and the greater the loss of bone minerals; 
also, the more he is predisposed toward pep­
tic ulcer or pancreatitis and the more he is 
exposed to the risk hyperparathyroid crisis 
and death from this and from other com­
plications of the disease.
Indications for Operation
For patients without symptoms and for 
those in whom the serum calcium concen­
tration is less than 11.5 mg/dl, the question, 
“Is prolonged preoperative observation per­
missible?” must be asked. Conversely, one 
must ask , “Can we justify early operation 
for all patients with mild disease that, pre­
viously, never would have been discovered?” 
Obviously, because the asymptomatic pa­
tients include those with early but progres­
sive and ultimately severe disease, all those 
patients must be followed, if not operated 
on. To say that the disease could be due to 
a malignant neoplasm does not appear to 
be justified. Only two patients with para-
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thyroid cancer have been seen in 45 years 
at the University of Iowa.
Since every patient should be followed, 
even after a successful operation, more of 
the observation, in patients with mild di­
sease, should be preoperative. We often fol­
low patients with suspected hyperparathy­
roidism until enough repeated chemical an­
alyses have been obtained to convince us 
that the disease is present. We can now 
make the diagnosis even when the serum 
calcium concentration is not appreciably 
elevated because of a serum parathyroid 
hormone that is too high for the simultane­
ously sampled level of serum calcium.9 Al­
though automated laboratory procedures 
have made diagnostic acumen relatively less 
important, the earlier and more frequent 
diagnosis in patients with mild disease makes 
clinical judgement more important in fol­
lowing up these patients, in withholding 
operation until there is some indication of 
increasing severity, or appearance of symp­
toms, and in ascertaining more exactly 
what it is that we are treating.
Ideally, prolonged observation without 
operation should be in accordance with a 
definite protocol and the data pooled so that 
we could learn as much as possible as quick­
ly as possible. Purnell and colleagues10 in­
stituted one such study and it appears that 
in the majority of their patients the disease 
has not progressed and that avoidance of 
operation is not harmful. Of course, any 
patient in whom symptoms develop that are 
consistent with hypercalcemia or in whom 
the serum calcium concentration increases 
progressively, or remains above 11.5 mg/dl 
should be treated surgically. This, however, 
leaves an ever-increasing number of asymp­
tomatic patients with serum calcium values 
below 11.5 mg/dl who must be followed and 
only operated on if their disease becomes 
more severe.
surgeons began removing most of the para­
thyroid tissue; moreover, the pathologists in 
that particular institution were more often 
able or willing to make a diagnosis of hy­
perplasia than are, for example, those at 
ours. It is certainly no longer acceptable to 
terminate the operation as soon as an 
adenoma has been found and removed.
With the more recent search for all of the 
parathyroid tissue, the greater use of biopsy 
and frozen section and the removal of more 
glands, serum calcium values seem to have 
been restored to normal in a greater pro­
portion of patients (Fig. 3). At the same 
time, however, there are more patients in 
whom the disease is milder and in whom 
the period of postoperative observation is 
shorter, so that we cannot be sure that the 
more aggressive operative treatment is more 
effective. Furthermore, the risks of perma­
nent hypoparathyroidism after subtotal 
parathryoidectomy are not insignificant.
We need improved methods of finding all 
parathyroid tissue at operation. A safe and 
effective stain or a radioactive tag that 
could be taken up by parathyroid tissue 
would help; and if the intensity of the up­
take were related to the production of para­
thyroid hormone it would be even better. 
All the parathyroid glands should be located 
to rule out multiple adenomas or hyperpla-
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O perative Procedure
How much parathyroid tissue should be 
removed at operation? Paloyan, Lawrence 
and Straus11 recommend subtotal parathy­
roidectomy, leaving only about 50 mg of 
the gland that appears most normal and ac­
cessible. These authors reported that the 
majority of the patients had had hyperpla­
sia, though this was not known until the
Median
c ,. 3. 75 yrFollow-up 1 .75 yr
Calcium | | | | J
Follow-up >10.5 8.5-10.5 <8.5
(mg /d I)
Fig. 3.—Frequency of normal serum calcium 
concentrations during 1970 to 1974 in compari­
son with concentrations recorded for 1929 to 
1969.
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sia. Obviously normal glands should be 
biopsied and marked with a metallic clip, 
or suture, taking care to preserve blood 
supply. Obvious adenomas should be re­
moved.
If there is no single adenoma, if there is 
hyperplasia or if there is any likelihood of 
hyperplasia even with an apparent adenoma, 
subtotal parathyroidectomy is indicated. The 
tissue to be left then becomes of primary 
concern. No parathyroid tissue should be 
removed until an estimated 50 mg of the 
gland that appears most normal, well-vas- 
cularized and accessible has been selected, 
marked and established as the patient’s 
probable lifetime solitary source of parathy­
roid hormone. To remove three or even two 
normal parathyroid glands from the neck 
during exploration and before all glands 
have been located is a frequent temptation, 
particularly during a prolonged, frustrating 
search. This temptation must be resisted if 
the development of hypoparathyroidism is 
to be prevented in some of those patients 
who present the more difficult diagnostic 
and therapeutic problems. If no abnormal 
tissue can be found, thyroid lobectomy 
should be performed on the side of the miss­
ing gland. Transcervical thymectomy and 
exploration of the superior mediastinum is 
a particularly important aspect of the opera­
tion when one or both inferior glands have 
not been located. If all glands appear normal, 
removal of 3 or 3 Vi glands is a reasonable 
procedure. Persistent hypercalcemia after 
such a procedure may result from the exist­
ence of an adenoma in a fifth parathyroid 
that was never located or from another 
lesion.
N eed for  P rolonged  O bservation
A f t e r  O peratio n
A final question concerns the length of 
follow-up of patients treated surgically. De­
spite the long period of interest in this di­
sease, the patients at the University of Iowa 
have not been followed with the frequency 
and for the length of time that appears now 
to be indicated, and this is probably the ex­
perience throughout most of the country. 
Today there is really only one way of de­
termining the correctness of diagnosis and 
treatment in a particular individual: each 
patient must be observed for the rest of his
life. The course of the first patient with hy­
perparathyroidism seen at the University 
of Iowa exemplifies this point: he died at 
the relatively young age of 36 from recru­
descence of hypercalcemia and its conse­
quences 17 years after removal of an ade­
noma. His disease was severe when it was 
first diagnosed. By contrast, mild disease 
will probably remain mild. Unless we be­
come as aggressive about observing our 
patients as we have thus far been in oper­
ating on them, we will never fully under­
stand the disease.
Records of patients studied at the Uni­
versity of Iowa in the early decades are 
filled with data regarding urinary excretion 
of calcium and phosphorus.2 We now have 
available investigative procedures that were 
not previously available yet we are not stu­
dying the patients with the intensity that 
those early patients stimulated. Maybe the 
diagnosis today is too easy.
F u tu r e  N eeds
We need much more information about 
the course of hyperparathyroidism both 
with and without operation. When an oper­
ation has been performed it might be of help 
to measure combined serum calcium and 
parathyroid hormone concentrations after 
the serum calcium and phosphorus concen­
trations have stabilized. We need more elec­
tron microscopic studies of parathyroid tis­
sue that appears normal both grossly and 
by light microscopy, and that has been re­
moved from patients diagnosed as having 
adenomas, to see if a prediction can be 
made from the microscopic findings as to 
whether overactive parathyroid tissue will 
cause a persistence or recurrence of hyper­
calcemia.8 We need parathyroid hormone 
assay of adenomatous, hyperplastic and 
grossly normal tissue removed from these 
patients. We need tests of the parathyroid 
hormone levels at lowered serum calcium 
concentrations to determine the secretory 
capacity of remaining tissues. Such hypo- 
calcemic stress tests should be done re­
peatedly in the same patient over many 
years.
Finally, our obligation to these patients, 
since we are so uninformed about all 
aspects of their disease, is to continue ob­
serving them at appropriate intervals for as
The sooner your patient can feed his goldfish,
the better.
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long as possible, whether they undergo an 
operation or not. Hyperparathyroidism is 
commonly a mild disease that can be safely 
observed; it can also be a rapidly lethal di­
sease or a debilitating chronic disease. If the 
patient remains asymptomatic and with a 
serum calcium concentration of below 11.5 
mg/dl, observation is reasonable and, per­
haps, the preferred course. We believe that 
neck exploration is indicated both in the 
patient with symptoms and in the patient 
with no symptoms in whom the serum cal­
cium value is 11.5 mg/dl on three occasions 
or more over a period of 6 months.
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EFFECT OF SYMPATHETIC INHIBITION ON MAXIMAL MUSCLE 
BLOOD FLOW IN THE NORMAL AND ATHEROSCLEROTIC
HUMAN LEG*
CHARLES J. WRIGHT, MB, FRCS, FRCS(Edin), FRCS[C]
Summary: The control of blood flow in skeletal 
muscle is incompletely understood, and for this 
reason the effect of sympathetic inhibition on 
muscle blood flow in the leg was studied. One 
group of patients selected for study comprised 
20 patients without evidence of vascular di­
sease; a second comprised 20 with peripheral 
occlusive arterial disease, in whom the site of 
occlusion varied from the aorta to the lower leg 
arteries. None had undergone previous vascular 
surgery or sympathectomy. Variables studied 
included resting muscle blood flow; maximal 
muscle blood flow; interval from tourniquet 
release to onset of peak flow; duration of peak 
blood flow; muscle blood flow after tourniquet 
release; and skin temperature in the foot. M us­
cle blood flow was calculated from xenon-133 
clearance. The variables were studied before 
and after ischemia (thigh tourniquet) and be­
fore and after sympathetic inhibition (immer­
sion of hands and wrists in water at 45°C). 
The significant differences between the two 
groups related to peak flow after ischemic exer­
cise, the interval from tourniquet release to 
peak flow and duration of peak flow. Sympa­
thetic inhibition was followed by no significant 
changes in maximal muscle blood flow, though 
there was a significant decrease in resting 
muscle blood flow. The results of the present 
study, in which noninvasive sympathetic block­
ade was used, confirm the findings of others 
that muscle blood flow does not change after 
operative sympathectomy.
Resume: On ne comprend encore qu'imparfai- 
tement le mecanisme de la circulation sanguine 
dans le muscle strie du squelette. C'est pour- 
quoi nous avons etudie I'effet de I'inhibition du 
sympathique sur la circulation de la jambe. 
Cette etude a porte sur deux groupes de 20 
malades: dans le premier, les sujets ne presen- 
taient aucun signe de maladie vasculaire; le 
second comportait des malades souffrant d 'oc- 
clusion arterielle, dont le siege variait de I'aorte 
aux arteres inferieures de la jambe. Aucun de
*From the department of surgery, University of 
Saskatchewan, Saskatoon, Sask.
Presented at the annual meeting of the Royal 
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ces malades n'avait subi auparavant d'opera- 
tion vasculaire ni la sympathectomie. Parmi les 
examens et les observations pratiques, figu- 
raient: la circulation du muscle au repos, la cir­
culation musculaire maximale, I'intervalle sepa- 
rant la liberation du tourniquet et le debut de 
la circulation de pointe, la duree de celle-ci. la 
circulation musculaire apres I'abandon du tour­
niquet et la temperature cutanee du pied. Pour 
calculer la circulation musculaire, nous avons 
utilise la clearance du xenon-133. Les variations 
ont ete etudiees avant et apres ischemie (tour­
niquet applique sur la cuisse), de meme qu'a- 
vant et apres inhibition du sympathique (im m er­
sion des mains et des poignets dans de I'eau a 
45°C). Les differences marquees entre les deux 
groupes portaient sur la circulation de pointe 
apres ischemie, I'intervalle entre I'abandon du 
tourniquet et de la circulation de pointe et la 
duree de celle-ci. L'inhibition du sympathique 
n'a entraine aucune modification notable dans 
la circulation maximale du muscle, sauf une 
diminution significative dans la circulation du 
muscle au repos. Les resultats de la presente 
etude, au cours de laquelle le blocage du sym ­
pathique a ete effectue sans aucun moyen de 
penetration interne de I'organisme, confirment 
les recherches d'autres auteurs: la circulation 
sanguine du muscle ne change aucunement 
apres une sympathectomie operatoire.
It has been known since the work of Ber­
nard in 18521 that sympathetic outflow to 
cutaneous vessels causes vasoconstriction. 
The control of blood flow in skeletal mus­
cle, however, is complex and is not yet com­
pletely understood. Vasoconstrictor and 
vasodilator fibres have been identified in 
skeletal muscle blood vessels,2- 3 but dur­
ing exercise the effect of vasodilator meta­
bolites produced locally is the predominant 
factor in the large increase in blood flow.4- 5 
Both lumbar sympathectomy and sympathe­
tic blockade have been widely used in the 
treatment of peripheral arterial disease6"8 
and are still frequently performed when di­
rect arterial reconstruction is either contra­
indicated or technically impossible. Al­
though the main indication for sympathetic 
ablation is skin ischemia with rest pain, it is 
not unusual for patients in whom sympathe­
tic ablation has been performed also to
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experience improvement in walking distance 
without claudication.
This study was designed to examine the 
effect of sympathetic inhibition on muscle 
blood flow in the leg.
Patients and Methods
Patients
Forty patients were studied, of whom 20 
had no historical or clinical evidence of vas­
cular disease (mean age, 59 ±  12 years) 
(group 1) and 20 had peripheral occlusive 
arterial disease (64 ± 1 2  years) (group 2). 
In the atherosclerotic group, the main site 
of occlusion varied from the aorta to the 
lower leg arteries. Some patients had pre­
sented with intermittent claudication and 
some with foot pain or paresthesias, but 
none had actual or impending gangrene. No 
patient who had undergone any previous 
vascular surgery or sympathectomy was in­
cluded in the study. Three of the patients in 
group 2 had diabetes. Informed consent was 
obtained from each patient.
Experimental Procedure
The studies were conducted in an air- 
conditioned room (21 °C). Patients were 
resting supine, and, after a wide sphygmo­
manometer cuff had been placed around the 
thigh, the leg to be studied was cradled in 
a foam mould. A thermistor probe was at­
tached to the sole of the foot and wired to 
a telethermometer (Yellow Springs Instru­
ment Co.). Temperature readings were 
taken at 5-minute intervals throughout the 
experiment. After a 30-minute rest period, 
capillary blood flow in the anterior tibial 
muscles was measured by the xenon-133 
clearance technique. Then, 30 p,Ci of 
133Xe dissolved in 0.1 ml of sterile saline 
was injected directly into the muscle mass 
and the isotope clearance curve charted by 
a scintillation counter, rate meter and re­
corder. Muscle blood flow (m l/100 g* min) 
was calculated from the clearance curve by 
means of the formulas derived by Lassen, 
Lindbjerg and Munck.9
After the thigh tourniquet had been in­
flated to a pressure exceeding the systolic 
pressure in the arm, the patient exercised the 
ankle until forced to stop by pain. No pa­
tient exercised for less than 2 minutes. The
tourniquet was then released and the fol­
lowing measurements were recorded: peak 
muscle blood flow; time elapse from re­
lease of the tourniquet to onset of peak 
flow; duration of peak blood flow; and 
muscle blood flow at 1-minute intervals for 
5 minutes after tourniquet release.
To block sympathetic outflow to the legs, 
both of the patient’s hands and wrists were 
then immersed in water at 45 °C; with the 
patient lying supine the temperature of the 
foot was measured for further 5-minute in­
tervals until no more increase in skin tem­
perature was recorded. Then, all the meas­
urements already described were repeated 
before and after reinflation of the tourni­
quet.
A typical pattern of clearance of 133Xe 
is shown in Fig. 1. After injection of the 
bolus of 133Xe into the muscle mass, resting 
blood flow is measured by drawing a line 
through the slope and applying the standard 
formula. As the records are made from a 
logarithmic output, the slope of 133Xe 
clearance when the flow is stable is a 
straight line. When the thigh tourniquet is 
applied, blood flow ceases and the radio­
activity in the muscle remains constant. On 
release of the tourniquet the blood flow 
increases rapidly; in this particular example 
it became maximal after about 30 seconds. 
The muscle blood flow at any moment may 
be determined by drawing the straight line 
tangent to the clearance curve at that point. 
In this example, the steepest slope and thus 
the maximal blood flow was found in the 
interval between B and C, and the low level 
of normal resting flow was reached after ap-
Flg. 1.—Clearance of i3  3Xe from anterior 
tibial muscle after ischemic exercise. Blood flow 
is calculated at any point from the slope of the 
tangent to the curve. Tourniquet is released at 
point A; blood flow is maximal after 30 seconds 
(at B), reaching a maximum between B and C, and 
a low level or normal at D, at 5.1 minutes. Ab­
solute radioactive counts are not relevant. (Pen 
moves across paper from left to right).
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TABLE I.—Muscle Blood F low Before and After Sympathetic Inhibition*
Group 1 Group 2
(Patients without atherosclerosis) (Patients with atherosclerosis)
Variable Before After Before After
Resting blood flow (ml/100 g-
min)......................................... 3.3 ±  1.2* 2.3 ±  1.3* 3.5 ±  1.8b 2.1 ±  1.2»
Peak flow (ml/100 g-min)........ 69.2 ±  22.8* 64.4 ±  18.3d 23.9 ±  12.6“ 22.8 ±  12.l d
Interval to peak flow (s).........  14.8 ±  11.9e 13.2 ±  10.9f 81.1 ±  59.0e 88.1 ±  62.2*
Duration of peak flow (s)........ 89.4 ±  37.2g 75.9 ±  26.9h 166.8 ±  67.8g 181.8 =fc 75.1h
*Differences are significant for pairs of results as follows: a: P <  0.005, b: P < 0.001, c: P <  0.01, d: P <  
0.01, e: P <  0.01, f: P <  0.05, g: P <  0.01, h: P <  0.01. Other differences within and between groups are 
not significant.
proximately 5.1 minutes. Blood flow was 
also measured in each experiment at 1- 
minute intervals from tourniquet release by 
drawing the tangents to the curve at the ap­
propriate points (Fig. 1). In each patient, 
therefore, 133Xe was injected only twice, 
once before and once after sympathetic in­
hibition.
For statistical analysis, the paired Stu­
dent’s t test was used in comparing results 
before and after sympathetic inhibition in 
each group, and the unpaired t test was 
used in comparing the results for the two 
groups with each other.
R esu lts
Comparison of Muscle Blood Flow in
Atherosclerotic and Normal Limbs
An overall comparison of results is pro­
vided in Table I. Resting muscle blood flow 
was 3.3 ±  1.2 ml/100 g-min in the pa­
tients in group 1 (no vascular disease) and
Fig. 2. —Muscle blood flow after ischemic exer­
cise. Comparison of responses in normal and 
atherosclerotic limbs. (O =  normal limbs [group 
1]; X =  atherosclerotic limbs [group 2]).
3.5 ±  1.8 ml/100 mg • min in those in group 
2 (atherosclerosis). Peak flows after ischemic 
exercise were 69.2 ±  22.8 and 23.9 ±  12.6 
ml/100 g-min, respectively. The interval 
from tourniquet release to peak flow and the 
duration of peak flow were both significantly 
longer in the atherosclerotic group. Muscle 
blood flow measurements at 1-minute inter­
vals after ischemic exercise are plotted in 
Fig. 2. Blood flow in the two groups after 
sympathetic inhibition shows little change 
except that resting flow is lower in both 
groups.
Effects of Sympathetic Inhibition on
Muscle Blood Flow
Group 1.— Resting muscle blood flow 
decreased significantly (P < 0.005) from 
3.3 ±  1.2 to 2.3 ±  1.3 ml/100 mg -min after 
sympathetic inhibition, but there was no 
change in peak muscle blood flow, time 
elapse to peak, duration of peak flow, or 
flow at 1-minute intervals following the 
tourniquet release (Table I, Fig. 3).
Fig. 3.—Muscle blood flow at 1-minute intervals 
after tourniquet release in patients with no vas­
cular disease (group 1).
M
u
sc
le
 B
lo
od
 F
lo
w
 
( 
m
l/
10
0 
g/
m
in
 )
434 THE CANADIAN JOURNAL OF SURGERY Vol. IS
Group 2 .— As in group 1, there was a 
highly significant decrease in resting muscle 
blood flow after sympathetic inhibition, from 
3.5 ±  1.8 to 2.1 ±  1.2 ml/100 g-min 
(P < 0.001) and no change in the other 
variables (Table I, Fig. 4).
Temperature Change in Foot Skin
During sympathetic inhibition the mean 
increase in foot skin temperature was 4.94 
±  3.08°C in group 1 and significantly less 
(P <  0.05) at 1.65 ±  1,67°C in group 2 
(Table II). There was no significant dif­
ference between the groups in the interval 
from commencement of upper limb heating 
to the recording of maximal foot skin tem­
perature; no differences were noted among 
the diabetics. The chart of a typical experi­
ment showing the sequence of events in re­
lation to the foot skin temperature changes 
is presented in Fig. 5.
D iscussion
The results of this study reveal that there 
is no change in maximal muscle blood flow 
after sympathetic inhibition. The method of 
blocking sympathetic outflow by heating the 
upper limbs10 is known to depend on a 
central effect. The vasomotor centre is sen­
sitive to a change in the temperature of its 
perfusate of as small as 0.1 °C. The major 
effects of inhibition of the vasomotor centre 
are, of course, on the skin (Fig. 5) but ske­
letal muscle has a sympathetic supply 
also,2- 3 even if its function has not yet been 
precisely defined. The consistent significant 
decrease in resting muscle blood flow after 
sympathetic blockade reported by Wright
TABLE II.—T emperature Increases in Foot 
Skin
Group 1 Group 2
Temperature
increase (°C) 4.94 ±  3.08* 1.65 ±  1.67*
Interval to peak
temperature
(min) 29.2 ±  9.6 35.5 ±  7.9
*Difference significant, P < 0.05.
and Cousins11 was demonstrated also in the 
present study. The recorded effects on rest­
ing muscle blood flow suggest that sympa­
thetic inhibition is effectively produced by 
upper limb heating, and this has been con­
firmed by others.12 One must conclude that 
the lack of response of maximal muscle 
blood flow to sympathetic inhibition in this 
study is because maximal muscle blood flow 
is entirely under the control of local factors; 
this does not mean that the method of 
achieving sympathetic inhibition was inef­
fective.
The extent of the increase in muscle blood 
flow caused by ischemic exercise was sim­
ilar to that reported from other centres,13'13 
and the differences in response between 
normal and atherosclerotic limbs (Table I, 
Fig. 2) have also been documented. It is not 
surprising that the flow response to exercise 
in the normal legs (Fig. 3) was greater than 
that observed in patients with arterial di­
sease (Fig. 4) and that the sympathetic 
blockade had no influence on the results in 
either group. Attempts have been made to 
correlate the site and severity of arterial 
disease and the exercising blood flow
Fig. 4.—Muscle blood flow at 1-minute inter­
vals after tourniquet release in patients with 
atherosclerosis (group 2).
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Fig. 5.—Foot skin temperature changes during 
one experiment.
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changes,13’ 14 but the individual variation 
is too large for this to be clinically useful. 
Arteriographic findings in conjunction with 
the clinical and historical data remain the 
critical method of assessment when recon­
structive arterial surgery is contemplated.
Others1617 have reported the absence of 
any change in exercising muscle blood flow 
following operative sympathectomy, and the 
present study confirms these findings using 
a noninvasive technique of sympathetic 
blockade. The improvement in claudication 
distance that patients sometimes observe 
after sympathectomy or chemical sympa­
thetic blockade requires some other ex­
planation. It is notoriously difficult to 
standardize conditions for measuring claudi­
cation distance, and the improvement may 
be the result of a placebo effect. Another 
possibility is a disruption that sympathetic 
ablation causes of afferent neural pathways 
that are partially responsible for the is­
chemic muscle pain. On the other hand, the 
benefit of sympathetic ablation in patients 
with rest pain or paresthesias in the foot is 
well known. The increase in foot skin tem­
peratures (Table II, Fig. 5) is due in part 
to the existence of superficial arteriovenous 
communications that carry increased flow 
after sympathectomy, but the large increase 
in total limb blood flow at rest in relation 
to the relatively small flow in skin arterio­
venous communication18’ 19 suggests that 
nutritive blood flow in skin capillaries is also 
increased. The infrequent occurrence of 
“paradoxical gangrene” after sympathec­
tomy20 probably relates to a critical de­
crease in distal perfusion pressure in some 
cases.
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an em erging problem
“Bacteroides species are often over- “Our experience with this series of seriously 
looked as a cause of serious infec- ill patients provides clinical confirmation to 
tion both by clinicians and micro- complement recent in vitro evidence that 
biologists.They are most commonly clindamycin is the antibiotic of choice for 
associated with intra-abdominal use in bacteroides infections. Not only was 
and pelvic sepsis following gastro- the response in 17 of the 18 patients favour- 
intestinal surgery.” able, but in several it was dramatic.”
Tracy, 0.,et al. (29 Jan.’72). Haldane, E.V.and van Rooyen,C.E. (1972).
Brit. med.J.,p. 280. C.M.A.J.,p. 1177.
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bacteroides infection
•  I.M. injection or I.V. infusion 
achieves prompt and high peak 
serum levels of active clindamycin
•  well tolerated locally and sys- 
temically following I.M. injection 
or I.V. infusion
U p jo h n
ANTIBIOTIC
RESEARCH
DaiacJnc
PiM M nte&s.a new solution
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Daiacin c Phosphate s.s.
in anaerobic infections
Indications: Daiacin C Phosphate has been found effective in the 
treatment of certain infections due to anaerobic bacteria, including 
Bacteroides species, Peptostreptococcus, anaerobic streptococci, 
Clostridium species and microaerophilic streptococci. It is also in­
dicated in infections due to sensitive Gram-positive organisms, par­
ticularly staphylococci, streptococci and pneumococci. As with all 
antibiotics, in vitro susceptibility studies should be performed.
DOSAGE AND ADMINISTRATION 
Adults:
Intramuscular-600 to 2400 mg*/day in 2, 3, or 4 equal doses. In­
tramuscular injections of more than 600 mg in a single site are not 
recommended.
Intravenous-900 to 4800 mg*/day by continuous drip or in 3 or 
4 equal doses, each infused over 20 minutes or longer. Administration 
of more than 1200 mg in a single one hour infusion not recom­
mended.**
Children (over one month of age):
Intramuscular-10 to 30 mg*/kg/day in 2, 3, or 4 equal doses. 
Intravenous-15 to 40 mg*/kg/day by continuous drip or in 3 or 
4 equal doses, each infused over 20 minutes or longer.**
* Depending on the severity of the infection.
**Dalacin C Phosphate Sterile Solution should not be given un­
diluted intravenously; always administer in an infusion. See product 
monograph supplied with each package for complete dosage infor­
mation and infusion rates.
Cautions: Generally well tolerated. Known and usual antibiotic 
administration route side effects have been reported. Pain at the 
injection site, induration and sterile abscess have been reported 
following intramuscular injection. Thrombophlebitis, erythema, 
swelling and pain at the infusion site have been observed following 
intravenous infusion.
Warning: Some cases of severe and persistent diarrhea have been 
reported during or after therapy with clindamycin. This diarrhea 
has been occasionally associated with blood and mucus in the stools 
and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane for­
mation.
If significant diarrhea occurs during therapy, this drug should be 
discontinued or, if necessary, continued only with close observation. 
Significant diarrheaoccurringuptoseveral weeks post-therapy should 
be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing 
minimal mucosal changes may respond to simple drug discontin­
uance. Moderate to severe cases, including those showing ulceration 
or pseudomembrane formation, should be managed with fluid, elec­
trolyte, and protein supplementation as indicated. Corticoid retention 
enemas and systemic corticoids may be of help in persistent cases. 
Anticholinergics and antiperistaltic agents may worsen the condition. 
Other causes of colitis should be considered.
Abnormalities in liver function tests have been reported occasionally. 
Usual antibiotic side-effects-rash, urticaria, pruritus, fever, leukocy­
tosis, nausea, diarrhea, changes in blood pressure, shortness of breath 
and bad or bitter taste in mouth have been reported.
Not indicated in patients who have demonstrated sensitivity to clin­
damycin or lincomycin. Safety in infants below 30 days of age or 
in pregnant women not established. Use with caution in patients 
with a history of asthma and other allergies. As with other antibiotics, 
periodic liver function tests and blood counts should be performed 
during prolonged therapy.
Detailed information available upon request.
A vai lability:
Daiacin C Phosphate Sterile Solution -  Each ml contains clindamv- 
cin-2-phosphate equivalent to clindamycin base 150 mg in 2 ml and 
1 ml paediatric ampoules.
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GLIMPSES OF SURGICAL HISTORY:
E FOR EDISON, THE ELECTRIC LAMP 
AND ENDOSCOPY
D. A. E. SHEPHARD
Thomas Edison (1847-1931), like his contem­
porary Alexander Graham Bell, influenced med­
icine and surgery in many ways, both general 
and specific. In a general sense, Edison’s invention 
of the electric lamp in 1879 altered the pattern 
of everyone’s lives; for surgeons, electric illumin­
ation o f the operating room and the operative 
field made surgical work easier, more accurate 
and safer. Edison's influence was profound be­
cause the introduction of the electric lamp ini­
tiated a new era and a new way of seeing things.
Physicians of all specialties could now look at 
the body in a new light. Not only could they 
illuminate the surface of the body reliably and 
brightly, but also they could examine the body’s 
orifices— and even the cavities of the body. 
Physicians could literally look within (endoscopy 
— endon, within; skopein, to examine).
Electric endoscopy is an excellent example of a 
surgical technique that was influenced specifical­
ly by Edison’s work. Endoscopy of the urethra 
and bladder developed in three periods. In 1805 
Bozzini of Germany invented a light conductor, 
but the illumination provided was insufficient. 
The essential idea, however, caught on. During 
the next 50 years various people worked towards 
a practical endoscope, but it was Desormeaux of 
France who made the first practical endoscope. 
When he exhibited it in Paris in 1853 he ushered 
in the second period of endoscopy. Desormeaux’ 
endoscope made use of an alcohol wick flame and 
a mirror, and his instrument was soon modified 
by others. But endoscopes of this period were un­
satisfactory because they required the use of day­
light or a burning flame as the source of illu­
mination; even the diaphanoscope of Bruck, which 
opened the electric period of endoscopy, with its 
electrically heated platinum wire, was clumsy, 
requiring a large battery and a water cylinder 
for cooling.
The incorporation of a miniature electric lamp 
in the endoscope was a real advance. As a Lan­
cet editorial o f 1892 put it, “ The introduction of 
the electric light . . . gave a fresh impulse to in­
vention, and marks an entirely new departure.” 
The great advance, as noted in the Canadian 
Medical Association Journal for 1911, was that 
“ . . . the lamp could be placed at the bottom of 
the tube instead of having the light reflected into 
it . .  . it made possible the application of lenses 
to magnify the field and a window to dilate the 
canal with air” .
And so Edison’s major invention, like so many 
others of surgeons’ nonmedical confreres, war 
one of numerous technical developments that have 
advanced the art of surgery.
Upjohn T H E  U P J O H N  C O M P A N Y  O F  C A N A D A
865 Y O R K  M IL LS  R O A D / D O N  M IL L S ,  O N T A R I O
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VOLVULUS OF THE GALLBLADDER: CASE REPORT AND REVIEW OF THE LITERATURE*
VINCENT ECHAVE, MD and LAWRENCE G. HAMPSON, MD, FRCS[C], FACS
Summary; Volvulus of the gallbladder is a rare 
abdominal emergency: only 250 cases have been 
reported. A correct preoperative diagnosis is 
rarely made. However, it is most common in 
elderly women, and acute volvulus should be 
considered in the differential diagnosis of upper 
abdominal pain, particularly in elderly women 
with right upper quadrant pain. The treatment is 
early cholecystectomy.
Resume: Le volvulus de la vesicule bil’iaire est 
une rare urgence abdominaie. On n'en trouve 
que 250 cas rapportes dans la iitterature. On 
pose rarement un diagnostic preoperatoire 
exact. Cette pathologie est cependant tres fre- 
quente chez les femmes agees, de sorte qu'il 
faudrait songer a un volvulus aigu dans le 
diagnostic differentiei' d'une douleur abdominaie 
du quadrant superieur droit, surtout si la malade 
est une femme agee. Le traitement consiste a 
pratiquer rapidement une cholecystectomie.
Volvulus of the gallbladder is rare, only 
about 250 cases having been reported. 
Acute torsion of the gallbladder was first 
described by Wendel in 1898;1 his patient 
was a young woman who had a mobile 
abdominal mass. The majority of cases 
reported since have occurred in elderly 
women. Its occurrence in children was 
first reported in 193 9 2 but few cases 
have been reported in the young since.3- 4 
The reports in the world literature have 
been largely of isolated cases occurring in 
many countries, which is consistent with 
the rarity of this clinical entity. To our 
knowledge this condition has been reported 
only twice previously in the Canadian litera­
ture.8- 5 This paper is the third report in the 
Canadian literature.
C ase  R e po r t
An 87-year-old woman was admitted to hospital because of the relatively sudden onset of severe colicky pain in the right upper ab-
*From the department of surgery, The Montreal General Hospital, Montreal, Que.
Reprint requests to: Dr. L. G. Hampson, Depart­ment of surgery, The Montreal General Hospital, 1650 Cedar Ave., Montreal, Que. H3G 1A4.
dominal quadrant. The abdominal pain began a few days before admission and was as­sociated with nausea but no vomiting. There was no history of jaundice, but she was known 
to have had gallstones for the previous 20 years; these had produced no symptoms except postprandial pain occasionally. On the day 
of admission the pain had become more severe and she had vomited once.
She was thin and in moderate abdominal discomfort. Blood pressure and pulse were normal; her oral temperature was 37.1°C.
Examination revealed guarding in the upper abdomen, particularly in the right upper quad­rant, and a positive Murphy’s sign. No masses 
were palpable, bowel sounds were heard and there were no signs of peritoneal irritation.Chest radiography revealed an elevated right 
hemidiaphragm, calcification of the aorta and degenerative changes in the spine; both lung fields were clear. Abdominal radiographs 
visualized a single calculus in the region of the gallbladder, and feces and air in the colon; there was no evidence of bowel obstruction 
and the retroperitoneal shadows were normal. The leukocyte count was 9.5 x 109/I (differen­tial, normal); the total serum bilirubin con­
centration was 1 mg/dl; and the results of other investigations (serum electrolytes, alka­
line phosphatase, serum glutamic oxaloacetic 
transaminase and lactic dehydrogenase) were normal.
Initial treatment consisted of nasogastric 
suction and intravenous administration of fluids. Her condition during the following days did not change appreciably: a low-grade fever 
persisted, her pulse rate slowly increased, and 
the pain remained localized to the right upper quadrant. As no improvement was evident a 
laparotomy was performed on the 5th hospital day. The gallbladder was greatly distended and 
completely gangrenous; it was also excessively mobile with little surrounding inflammation. 
Careful inspection revealed a counterclockwise torsion of 270° at the level of the cystic duct; an elongated gallbladder mesentery arising 
from a short base in the liver bed had made torsion possible. Detorsion was effected and the gallbladder was removed easily. She re­covered well and was discharged 10 days after operation.
Pathological examination showed evidence of gangrene of the gallbladder and choleli­thiasis.
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D isc u ssio n
Three anatomic abnormalities may lead 
to volvulus of the gallbladder. The gallblad­
der may lie free in the peritoneal cavity, 
connected to the biliary tree by the cystic 
duct only; this anatomic variation is con­
genital and explains the rarity of cases of 
acute volvulus in children.2' 4 As a true 
mesentery is congenital in less than 5% of 
the population, it is possible that in some 
cases acute torsion of the gallbladder is 
associated with an acquired mesentery, the 
second anatomic abnormality. This condi­
tion usually occurs late in life and it is 
therefore logical to presume that, with 
ageing, the supporting fatty tissue surround­
ing the abdominal viscera atrophies; the re­
sulting visceroptosis favours excessive 
mobility and torsion. Spinal deformities 
producing changes in anatomic position of 
the abdominal organs also may predispose 
to torsion; indeed, many of the reported 
cases have occurred in elderly women with 
severe scoliosis.7' 8
If there is an anatomic predisposition to 
volvulus one must consider how the acute 
process might be initiated. Several different 
mechanisms have been suggested. Peristalsis 
of the surrounding organs, when sufficiently 
vigorous, might initiate torsion.9 This is more 
likely if the gallbladder contains stones and 
so behaves more as a mobile solid organ.1" 
According to other authors, a tortuous ar­
teriosclerotic cystic artery may initiate tor­
sion.11 Falls or violent movements have also 
been suggested as initiating events.12
Although the condition affects normal 
gallbladders, cholelithiasis is frequently as­
sociated. One might expect the existence of 
cholelithiasis and chronic cholecystitis to re­
sult in chronic inflammation and fibrosis, 
which would tend to reduce the mobility of 
the gallbladder and thus lessen the like­
lihood of torsion.
Volvulus of the gallbladder is more com­
mon in females than in males; it is also 
more common in the old, the peak incidence 
occurring in persons in the 7th and 8th 
decades of life.13
A palpable abdominal mass is a variable 
finding, and in the patient whose case we 
report it was not possible to palpate the 
gallbladder despite its large size, possibly
because of voluntary guarding in the upper 
abdomen. Features considered highly sug­
gestive of acute volvulus of the gallbladder 
are acute pain and vomiting without jaun­
dice in an elderly woman, and the appear­
ance within a few hours of onset of an en­
larged and palpable gallbladder.14 The 
diagnosis of this condition is difficult but it 
should be included in the differential diag­
nosis of the acute abdomen, particularly in 
elderly women with right upper quadrant 
pain.13
The treatment is early cholecystectomy. 
Removal of the gallbladder is facilitated by 
the long mesentery, the great mobility of the 
gallbladder and the absence of inflammatory 
reaction. If the treatment is delayed, the 
natural course of the disease is perforation 
of the gangrenous wall with bile peritonitis, 
which has a high mortality in this group of 
elderly patients.9
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NEGATIVE CHOLECYSTOGRAMS IN 
GALLBLADDER DISEASE
According to D. R. K. Reid and I. M . 
Rogers (Br J Surg 62: 581, 1975), “There is 
a general assumption that the diagnosis of 
gallbladder disease should . . . rest on the 
cholecystogram.” These authors tested the 
validity o f this assumption by studying the 
clinical and radiographic features and the 
surgical findings in 17 patients with typical 
recurrent biliary colic and a negative chole­
cystogram in whom the pain was completely 
relieved after cholecystectomy.
On at least one occasion for each patient 
the cholecystogram had been reported to be 
negative. A ll patients had complained before 
operation of typical biliary colic,- some had 
had- jaundice and some had stones in the 
gallbladder at the time of cholecystectomy 
(in one instance a small stone was found in 
the cystic duct); none had stones, in the com­
mon duct. Positive histologic findings (min­
imal to mild cholecystitis) were noted in all 
patients but two. Follow-up examination 
(range of follow-up. 6 months to 10 years) 
indicated that all patients became free of 
pain after cholecystectomy.
Reid and Rogers believe that clinicians 
should be willing to make a diagnosis of gall­
bladder origin for pain and to recommend 
cholecystectomy in spite o f a negative chole­
cystogram “when there is typical biliary colic, 
when all other causes have been excluded and 
the symptoms are severe” . Clinical or bio­
chemical evidence of obstructive jaundice 
would support such a recommendation but the 
period of observation should be “adequate”, 
fo r  “only then will the clinician become con­
vinced of the need for operation” .
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PANCREATIC PSEUDOCYST AND POLYCYTHEMIA AFTER RENAL
TRANSPLANTATION*
D. M. GRACE, MD and C. R. STILLER, MD
Summary: A 43-year-old man with chronic glo­
merulonephritis received a cadaver renal trans­
plant in 1972, and pancreatitis developed post- 
operatively. A large pseudocyst was noted 1 
year later, when polycythemia was noted, in 
spite of good renal and pulmonary function. The 
polycythemia resolved after cystogastrostomy 
and has not recurred during 18 months of fol­
low-up.
Resume: En 1972, chez un homme de 43 ans 
souffrant de glomerulonephrite chronique, on 
avait pratique la transplantation d'un rein de 
cadavre. L'operation terminee, une pancreatite 
s'etait developpee. Un an plus tard, on avait 
note la presence d'un volumineux pseudo-kyste 
et de polycythemie, malgre la bonne qualite des 
fonctions renale et pulmonaire. Nous avons pu 
vaincre la polyglobulie par drainage du pseudo- 
kyste dans I'estomac. La polycythemie n'a pas 
reapparu durant la periode de 18 mois qui a 
suivi.
A cute pancreatitis is a relatively frequent 
complication of renal transplantation and 
may be related to such factors as uremia, 
hyperparathyroidism, immunosuppression, 
corticosteroids, gallstones and operative 
trauma.1 Pseudocyst may develop after an 
attack of pancreatitis, and polycythemia is 
a complication of renal disease that has been 
observed in renal transplant recipients.2' 3 
In this report we document the development 
of both a pancreatic pseudocyst and poly­
cythemia after renal transplantation. The 
polycythemia regressed and did not recur 
after successful drainage of the pseudocyst.
Case R eport
A 43-year-old man was admitted to hos­
pital in January 1973 because of epigastric 
pain and a mass. Chronic glomerulonephritis 
had been diagnosed in 1957 and renal trans­
plantation from a cadaver donor was carried 
out in September 1971, when the hemoglobin 
value had been 7.2 g/dl and the hematocrit, 
20%. Renal function after operation was good, 
and immunosuppression was maintained by
*From the departments of surgery and medicine, 
University of Western Ontario and University 
Hospital, London, Ont.
Reprint requests to: Dr. D. M. Grace, Depart­
ment of surgery, University Hospital, 339 Win­
dermere Rd., London, Ont. N6G 2K3.
prednisone and athazioprine; furosemide was 
required for control of moderate hypertension. 
Acute epigastric pain and distension in Novem­
ber 1971 suggested the diagnosis of acute pan­
creatitis, but a perforated ulcer could not be 
excluded and therefore laparotomy was per­
formed. This showed extensive pancreatitis 
with fat necrosis; the abdomen was closed 
without further treatment. Renal function re­
mained good (serum creatinine value range, 
1 to 1.5 mg/dl). In June 1972 another attack 
of severe epigastric pain occurred after a meal 
of fried chicken and beer. The hemoglobin 
value at this time was 16.5 g/dl, the hemato­
crit was 53%, the serum creatinine value was 
1.3 mg/dl and the blood urea nitrogen value, 
31 mg/dl. The epigastric pain recurred, a 
weight loss of 22 kg was noted and, in Decem­
ber 1972, an epigastric mass was detected.
Examination in hospital revealed the pre­
sence of a tender mass (diameter, 10 cm) 
beneath the left costal margin. The patient 
weighed 50 kg and his blood pressure was 
160/100 mm Hg. Results of laboratory in­
vestigations were as follows: hemoglobin con­
centration, 18.9 g/dl; hematocrit, 58.5%; leu­
kocyte count, 12.0 x 109//, and the serum 
creatinine concentration, 1.2 mg/dl. Studies 
with 51Cr and RISA indicated a total blood 
volume of 102 ml/kg (normal, 70 ±  10), a 
red blood cell mass of 57.5 ml/kg (normal, 
28 ±  4) and a plasma volume of 44.5 ml/kg 
(normal, 45 =fc 5). Gallbladder radiographs 
were normal, but barium radiographs of the 
stomach showed a large mass compressing the 
lesser curve. The cystic nature of the mass 
was confirmed by an ultrasound study. Re­
sults of liver function tests and of a complete 
coagulation survey were normal. Pulmonary 
function studies revealed some degree of re­
striction and obstruction; the arterial oxygen 
tension was 70 mm Hg.
A phlebotomy (volume, 500 ml) lowered the 
hemoglobin concentration to 17.3 g/dl and 
the hematocrit to 51%; after removal of an­
other 500 ml of blood 2 days later these values 
were 16.4 g/dl and 49.7% respectively. Three 
days later the abdomen was opened through a 
left subcostal incision, and a pancreatic pseu­
docyst containing 800 ml of clear fluid was 
drained into the posterior wall of the stomach. 
A lock stitch of 2-0 silk was used for hemo­
stasis around an opening that admitted three 
fingers. The operation was uneventful and no 
transfusion was required.
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Apart from hiccups, which gradually 
cleared, and some coffee-ground drainage, the 
postoperative course was uneventful. One 
week after operation the hemoglobin value 
was 12.9 g/dl. The hemoglobin value gradu- 
A- ally rose to 13.7 g/dl in May 1973 and 
reached a maximum of 15.9 g/dl in July 1973. 
Thereafter, the hemoglobin concentration has 
not exceeded 15 g/dl.
In June 1974 he was admitted for assess­
ment of epigastric pain. No mass was found 
clinically or radiographically. The total serum 
► <. bilirubin value increased to 3.6 mg/dl and al­
kaline phosphatase was elevated also (163 U//); 
the serum amylase value, however, was nor­
mal. Gastroscopy showed a persistent prepy­
loric opening at the site of pseudocyst drain­
age but no other abnormality. The attacks of 
pain resolved and the final diagnosis was 
chronic pancreatitis. The most recent hemo­
globin value was 14.1 g/dl and the hematocrit, 
40.5%; the serum creatinine value was 1.2 
mg/dl. At this time the patient’s weight was 
7.5 kg more than when the pseudocyst was 
drained.
Co m m ent
The occurrence of polycythemia after 
renal transplantation is unusual, but is more 
common with cadaver renal transplants than 
with living donor kidneys. The explanation 
for its development is not clear. Chronic re­
jection may be a factor, but erythropoietin 
values may not be elevated.2 Hypertension 
is a commonly associated finding, as is
thromboembolism, though the latter did not 
develop in the present case. Polycythemia 
may also occur in patients with renal di­
sease, and erythropoietin-like activity has 
been described in fluid from renal cysts.4 
To our knowledge, polycythemia has not 
been described in association with a pan­
creatic pseudocyst. In our case polycythemia 
may have been related to renal transplanta­
tion alone, and this type of polycythemia 
may resolve spontaneously. However, the 
disappearance of the pseudocyst may have 
been its cause. Recurrent pancreatitis re­
mained a problem in this patient and, in 
the absence of gallstones and alcoholism, 
this might have been related to therapy with 
corticosteroids or azathioprine.5
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CRITIQUE OF ITEM 533 (SESAP II)
On the basis o f the data presented, a state of 
hyperparathyroidism is definite. The diagnosis o f 
parathyroid adenoma at the original operation 
must be questioned, for it is difficult to differen­
tiate, from a single gland, adenoma from hyper­
plasia either grossly or microscopically. Whether 
a second parathyroid adenoma or hyperplasia of 
all three remaining parathyroid bodies will be 
found cannot be predicted without the special 
studies shown in the illustrations. The arterio­
grams taken after injection o f the right inferior 
thyroid artery show a blush which could repre­
sent either an adenoma o f the thyroid itself or a 
parathyroid adenoma lying just inferior and post­
erior to the inferior border o f the thyroid. If the 
latter is true, it must represent an ectopic position 
of the right superior parathyroid since the inferior 
parathyroids migrate into the anterior mediasti­
num, while the superior glands, when ectopic, are 
found posteriorly in the neck or mediastinum.
The selective venous parathyroid hormone stu­
dies show normal levels for all but two samples, 
ie, thyroid ima vein and middle left innominate 
vein samples. Hyperplasia or hyperfunction o f the 
three remaining parathyroids would be expected 
to show increased levels in the venous drainage 
bilaterally, though the rise in parathyroid hor­
mone levels would undoubtedly be less striking.
Therefore, choice (B) is the correct answer. (A) 
and (C) are ruled out by the unilaterality o f the 
elevated venous readings. The arteriographic sha­
dow is only slightly below the level o f the clavi­
cle. Therefore, the tumor which it represents can 
be removed at reexploration o f the neck without 
formal exploration of the posterior mediastinum. 
Choice (D) is incorrect in view of the unilateral 
blush seen in selective arteriography on the level 
of the clavicle.
Special studies such as these should probably 
be reserved for unusual problems, particularly 
cases requiring reexploration. Both tests are ex­
pensive and carry added risk which seems unwar­
ranted except in unusual circumstances. The diag­
nosis of hyperparathyroidism is not dependent on 
these sophisticated methods, and careful, thorough 
surgical exploration of the neck should suffice in 
the majority o f cases.
B
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OPERATIVE CHOLANGIOGRAPHY: EVALUATION AND A PLEA FOR ITS GENERAL USE*
ERIC M. NANSON, MB, FRCS, FRCSfC], FRACS, FACS
Summary: Operative cholangiography should be 
used routinely during operations on the gall­
bladder and biliary tree. The indications for 
operative cholangiography include demonstra­
tion of unsuspected stones, of abnormal biliary 
tree anatomy, and of tumour within intrahepatic 
branches of the biliary tree; determination of the 
nature of periampullary obstruction and of the 
best approach for removal of stones impacted 
low in the common bile duct; avoidance of un­
necessary choledochotomy; assistance in diag­
nosis of stenosing cholangitis, cholangiolytic 
jaundice or choledochal cyst; and to ensure, 
postexploration, that the duct contains no 
stones. These indications were evaluated in a 
review of the records of 151 patients who under­
went biliary tract operations. Operative cholan­
giography was performed in 133 of these pa­
tients. The review disclosed that 5.7% of 
common bile duct stones were totally un­
suspected and that 30% of common bile ducts 
suspected to be abnormal were proven to be 
clear of stones, so that an unnecessary chole­
dochotomy was avoided. The technique of 
operative cholangiography is simple, but suc­
cessful use of it requires meticulous attention 
to detail and frequent use by a regular team.
Resume: Selon nous, on devrait utiliser syste- 
matiquement la cholangiographique operation 
durant les interventions sur la vesicule biliaire 
et I'arbre biliaire. Parmi les indications de cette 
methode figurent la decouverte de calculs igno­
res, d'anomalies anatomiques des voies biliaires 
et de tumeurs au sein de lews ramifications in- 
trahepatiques, la determination de la nature 
d'une obstruction periampullaire et de la meil- 
leure voie pour I'enlevement de calculs qui se- 
raient loges dans le choledoque distal, la pos­
sibility d'eviter une choledochotomie inutile, 
I'aide au diagnostic d'une angiocholite steno- 
sante, d'un ictere de stase ou d un kyste du 
choledoque, enfin, la possibility de s'asswer, 
apres exploration que le conduit ne contient 
pas de calculs. Nous avons evalue ces indica­
tions en passant en revue les dossiers de 151 
malades qui avaient subi des operations du 
tractus biliaire. L'angiocholegraphie operatoire 
a ete pratiquee sur 131 de ces patients. Cette
*From the department of surgery, school of med­icine, University of Auckland, Auckland, New  Zealand.
Reprint requests to: Dr. E. M. Nanson, Professor and head, Department of surgery, Auckland H os­pital, Park Rd., Auckland 3, New Zealand.
revue a permis de mettre a jour que 5%  des 
calculs du choledoque etaient entierement igno­
res et que 30% des choledoques soupgonnes 
d'etre anormaux etaient exempts de calculs, de 
sorte qu'on a evite dans tous ces cas une chole- 
dochotomie absolument inutile. La technique de 
l'angiocholegraphie operatoire est simple mais, 
pour etre couronnee de succes, elle doit etre 
employee souvent par une meme equipe bien 
entrainee et qui exige une attention meticuleuse.
T h e  need for operative cholangiography as 
an adjunct to operations on the biliary tree 
has been stressed by numerous authors,1'4 
beginning with Mirizzi in 1932.° Unless the 
surgeon uses it routinely he is unlikely to 
get good films, and he will not become 
skilled in interpreting them.6 Furthermore, 
if the technique is used only sporadically, 
neither will radiographers become skilled in 
the technique required, nor will operating 
room nurses become accustomed to the 
meticulous attention to detail that is essen­
tial to obtain reproducible and reliable re­
sults. It should be routinely available and 
generally used during cholecystectomy.7’ 8
Operative cholangiography permits the 
surgeon to do one or more of the following:
1. To reveal unsuspected stones in the 
common bile duct.
2. To avoid opening the common bile 
duct unnecessarily.
3. To demonstrate abnormal anatomy of 
the biliary tree.
4. To determine the nature of an ob­
struction in the region of the ampulla of 
Vater.
5. To demonstrate tumour within the in­
trahepatic branches of the biliary tree.
6. To aid in the diagnosis of stenosing 
cholangitis, cholangiolytic jaundice or chole­
dochal cyst.
7. To reveal the best approach for re­
moval of stones impacted at the lower end 
of the common bile duct.
8. To show, in the postexploration stage 
of the operation, that the duct contains no 
stones.
The usefulness of operative cholangio­
graphy is illustrated simply by the fol­
lowing case report.
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Fig. 1.—Two entirely unsuspected stones (ar­
rows) in common bile duct demonstrated by oper­
ative chol angiogram.
A 64-year-old woman had had recurrent 
bouts of epigastric pain for 20 years and had 
also suffered from esophageal reflux. At no 
time had she been jaundiced. A cholecysto- 
gram had shown a nonfunctioning gallbladder. 
Operation revealed a small shrunken gallblad­
der, full of faceted stones. The common bile 
duct was normal in size, and the cystic duct 
was of small calibre. No stones were palpable 
in the common bile duct but operative cholan­
giography (Fig. 1) visualized two quite large 
stones (dimensions, 10 x 5 mm and 8 x 5  mm) 
in the retroduodenal portion of the common 
bile duct. These stones were entirely un­
suspected and impalpable. Without operative 
cholangiography they would have been over­
looked and left in situ to cause trouble later.
This paper provides an evaluation of 
operative cholangiography and a description 
of the technique, together with a recommen­
dation for its wider use.
Evaluation of Indications for
Operative Cholangiography
The indications for operative cholangio­
graphy have been evaluated in two ways: 
first, the records of 151 patients undergoing 
biliary tract surgery were analyzed, and sec­
ond, the indications were reviewed in the 
light of these findings and those reported by 
others.
Analysis of Patient Records
To evaluate the usefulness of operative 
cholangiography, a retrospective analysis 
was made of the records of 151 patients who 
underwent biliary tract surgery over a 3- 
year period. The patients’ ages ranged from 
15 to 75 years (average, 47 years); there 
were 109 females and 42 males. Of the 151 
patients, 133 were admitted for cholecys­
tectomy and 18 were admitted for choledo- 
chostomy, having undergone cholecystec­
tomy previously. Fig. 2 summarizes the dis-
T o ta l  n o . o f  p a t i e n t s
o p e r a t iv e  e x p l o r a t i o n  e x p l o r a t i o n
c h o la n g io g ra m
Fig. 2.—Distribution of 151 patients by radiologic and surgical procedure and by radiologic and 
surgical findings.
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tribution of the 151 patients according to 
the radiologic and surgical procedures, to­
gether with the main findings.
Operative cholangiography was used in 
133 of the 151 patients. Among the 18 in 
whom it was not performed, 14 underwent 
cholecystectomy and 4 underwent choledo- 
chostomy. In 10 of the 14 patients in this 
subgroup undergoing cholecystectomy a 
cholangiogram was considered unnecessary 
by the surgeons—a decision the wisdom of 
which can be questioned, because a surgeon 
never knows when a stone may lie unde­
tected in the common bile duct. In the other 
four patients cholangiography was not done 
for specific reasons: in one use of x-rays 
was contraindicated because of pregnancy; 
in one stones were palpable in a dilated 
common bile duct, which was therefore ex­
plored; in one, percutaneous transhepatic 
cholangiography before operation had given 
sufficient detail; and in one patient cholan­
giography was unsuccessful for technical 
reasons. In the remaining 4 of the 18 pa­
tients in whom an operative cholangiogram 
was not done, a disorder of the common bile 
duct was found; in 2 of these patients a 
percutaneous transhepatic cholangiogram 
had already adequately delineated the com­
mon duct; in 1 a cholecystogram had visual­
ized the common duct and had apparently 
demonstrated stones—-yet at exploration no 
stones were found, so that, had operative 
cholangiography been done, this unneces­
sary choledochostomy could have been ob­
viated; and in 1 cholangiography failed for 
technical reasons. In this subgroup of 18 
patients who did not have operative cholan­
giography, then, it was not done in 3 for 
valid reasons: pregnancy in 1 and technical 
failure in 2. In the others, however, it is 
my opinion that operative cholangiography 
should have been performed. Those who 
had percutaneous transhepatic cholangio- 
grams still required operative cholangio­
graphy after exploration to assure the sur­
geon that the duct had been completely 
cleared as far as a cholangiogram is able 
to do this.
Among the 133 patients in whom oper­
ative cholangiography was used, there were 
119 who underwent cholecystectomy. In 88 
of these patients there was no particular 
reason why the surgeon should suspect
stones in the common bile duct. In the re­
maining 31 patients certain indications sug­
gested the existence of possible stones in 
the common duct. In this subgroup of 119 
patients the findings were as follows:
1. Of the 88 cholecystectomy patients in 
whom no abnormality of the common bile 
duct was suspected, 5 patients (6%) were 
found to have “occult” stones.
2. Of the 31 cholecystectomy patients in 
whom an abnormality in the common bile 
duct was suspected, 10 (30%) were proven 
by operative cholangiography to have no 
abnormality; therefore the common bile 
duct was not opened and a futile choledo- 
chotomy was avoided in these patients. 
Among the 21 patients whose common bile 
duct was explored, stones, gravel, or sludge 
was found in 14, and no abnormality was 
found in 7 in spite of a suspicious cholan- 
giografn.
3. There were no false-negative results; 
that is, there were no patients in whom cho­
langiography was reported to be negative 
but in whom stones in the common bile duct 
were found subsequently.
Indications Based on Review of Present
Study and of Literature
Indications for operative cholangiography 
may be summarized as follows:
1. Demonstration of unsuspected stones 
in the common bile duct. This is particularly 
important in patients undergoing cholecys­
tectomy. Among our patients, 6% were 
found to have stones in the common bile 
duct that had not been suspected previous­
ly. Burnett and Bolton1 reported a yield of 
2.3% unsuspected stones, and Jolly and col­
leagues2 found 6.3% of such “surprise” 
stones in 380 patients. For a relatively sim­
ple procedure, therefore, the yield of such 
stones is not insignificant.
2. Avoidance of unnecessary explora­
tion of the common bile duct. The usually 
accepted indications for opening the common 
bile duct are these: (a) dilated extrahepatic 
ducts; (b) small stones in the gallbladder 
with a wide cystic duct; (c) palpable 
stones in the common duct; (d) a dilated 
common duct visualized by preoperative 
oral cholecystography or intravenous cho­
langiography; (e) a history of jaundice; and 
(f) repeated episodes of biliary colic, cho-
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langitis or pancreatitis. Use of operative 
cholangiography helps the surgeon avoid 
opening the common duct unnecessarily in 
a certain proportion of patients (“avoidance 
rate”).
In our study we found that there were 31 
such patients with a “suspect” common bile 
duct and that an operative cholangiogram 
showed that 10 of these ducts in fact were 
free of stones. Burnett and Bolton1 reported 
an avoidance rate of only 8.7% and Schu- 
lenburg8 a rate of 5.5%.
In our series, a suspicious operative cho­
langiogram led to choledochotomy in 7 of 
21 patients in none of whom were stones 
found—a false-positive rate of 33%. In 
these patients, however, there were clear 
indications for exploring the common bile 
duct, even in the absence of a “suspicious” 
cholangiogram.
3. Demonstration of abnormal anatomy. 
Periodically, an operative cholangiogram will 
demonstrate abnormal anatomy of the bil­
iary tree and hence save the surgeon from 
seriously traumatizing the extrahepatic bil­
iary system.8 The types of anomaly thus 
demonstrated may be aberrant ducts, a gall­
Fig. 3.—Accessory right hepatic duct (arrow) 
entering common bile duct beside cystic duct, 
visualized by operative cholangiogram.
bladder issuing directly from the common 
bile duct, a long tortuous cystic duct filled 
with stones and incorporated in the com­
mon duct wall, congenital stenosis of the 
common duct, a choledochal cyst, and, 
within the liver, a cholangiocele. Sand- 
bloom7 stressed this attribute of operative 
cholangiography. Fig. 3 is an operative 
cholangiogram that reveals a very dange­
rous situation; namely, an aberrant right 
hepatic duct running exactly parallel to and 
beside the cystic duct.
4. Demonstration of the nature of the 
obstruction of the ampulla of Vater. Not in­
frequently it is difficult to determine the 
cause of obstruction at the lower end of the 
common duct that produces jaundice. The 
cause is usually either stone or carcinoma 
of the head of the pancreas, but occasionally 
the cause is carcinoma of the common bile 
duct, carcinoma or papilloma of the ampulla 
of Vater,.a stricture of the ampulla, or a 
diverticulum of the duodenum close to the 
termination of the common duct. Operative 
cholangiography is helpful in establishing 
this diagnosis, so that the appropriate oper­
ation may be done. Fig. 4 is an example of
Fig. 4.—Obstruction of common bile duct by 
carcinoma of head of pancreas revealed by oper­
ative cholangiogram. Note sharp cut-off at lower 
end and gross dilatation of duct above.
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an operative cholangiogram of a gross dila­tation of a common duct caused by carcino­ma of the head of the pancreas; the ap­
pearance of the termination of the common duct is typical.
5. Tumours of the intrahepatic biliary tree. The usual exploration of the biliary 
tree is remarkably ineffective in delineating 
tumours of the hepatic ducts and their ra­
dicles. Operative cholangiography is par­
ticularly useful in this respect and helps the 
surgeon plan an appropriate operative ap­
proach. Figs. 5 and 6 visualize a narrowing 
of the left hepatic duct, with dilatation of 
the left intrahepatic biliary ducts proximal to a malignant stricture.
6. Establishment of the diagnosis of ste- 
nosing cholangitis,9 cholangiolytic jaundice, or choledochal cyst. Patients suffering from 
these conditions present with obstructive jaundice, the nature of which is often ob­
scure. Because of the undilated state of the 
biliary tree in the first two conditions, per­
cutaneous transhepatic cholangiography
Fig. 5.—Narrowing of left hepatic duct (arrow) due to primary carcinoma of duct disclosed by operative cholangiogram.
may be impossible. Laparotomy is necessary 
to prove the absence of any distal obstruct­ing lesion in the biliary tree that may be 
amenable to surgery. Therefore, operative 
cholangiography is required by these pa­tients.
7. Clarification of the approach to stones impacted at the lower end of the common 
bile duct. Stones may be impacted at the 
lower end of the common duct, or they 
may frequently be located in outpouchings 
or diverticula of the duct. They can be ex­
tremely difficult to remove by routine 
supraduodenal choledochostomy and are 
better approached by the transduodenal 
route. An operative cholangiogram is useful to indicate this.
8. Demonstration after exploration that 
the common bile duct contains no stones. 
This is essential when the common duct has 
contained stones, if the surgeon is to be 
certain that the presence of a stone is 
not overlooked and that the radiopaque contrast medium will flow freely into the 
duodenum. The fact that the common duct 
is clear is proven by the free flow of con­
trast medium into the duodenum and the 
outlining of the pancreatic duct. A pancre­atic duct will not be visualized if there is 
residual distal block. However, this postex­
ploration cholangiogram is difficult to per­
form and full of pitfalls. Grossly dilated in-
Fig. 6.—Magnified view of area of narrowing shown in Fig. 5.
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trahepatic radicles cannot be proved to 
contain no stones, and such residual stones, 
undemonstrated at operation, will subse­
quently fall into the common bile duct when 
the patient is upright and ambulant, and 
hence cause further blockage. The only ways 
of obviating this are to perform either a 
large sphincteroplasty or a bypass proce­
dure such as choledochoduodenostomy. An­
other difficulty is to exclude air bubbles 
when contrast medium is injected into a T- 
tube at operation. One way of accomplish­
ing this is to inject the medium by way of 
the small plastic catheter that has been left 
in the cystic duct and to use the T-tube as 
an escape route for any trapped air bubbles. 
A third problem is that, after manipula­
tion, the sphincter of Oddi may go into 
spasm, so that contrast medium does not 
flow freely into the duodenum; hence the 
surgeon cannot be sure that he has cleared 
the distal block. This problem can be over­
come by administering atropine or hyoscine 
butylbromide or by instilling topical anesthe­
tic down the catheter and waiting for phar­
macologic relaxation of the sphincter.
T echnique of Operative
Cholangiography
Although operative cholangiography is 
not invariably successful, the more fre­
quently it is used on a team basis the better 
will be the results. It is therefore essential 
to develop a meticulous technique and to 
adhere to it. The following points are im­
portant:
1. Positioning of the patient. Most 
modern operating tables have an x-ray cas­
sette tunnel, either longitudinal or lateral. 
It is essential that the patient be positioned
Fig. 7.—(a) Cholangiocath tied into cysticduct, (b) Scalp-vein needle in common bile duct.
so that the area of the liver and biliary tree 
lies over this tunnel.
2. Positioning of diathermy body plate. 
The diathermy plate, or indifferent electrode, 
must be placed sufficiently caudad that the 
x-ray field is not obscured.
3. Removal of instruments from the x-ray 
field. Towel clips and other instruments 
and sponges with radiopaque markers must 
be removed before exposure so the essen­
tial structures of the common bile duct and 
duodenum are not obscured.
4. Opacification of duct systems. Figs. 
7 to 9 illustrate equipment required for the 
two methods of opacifying the duct systems: 
catheterization and direct puncture. For ca­
theterization, the catheter must be thin, read­
ily introducible and secure. The disposable 
Cholangiocath (Edwards Laboratories, CA) 
is such a catheter. It has two useful features: 
a stopcock on its base and a flange on its 
top (Fig. 8). When introduced, the catheter 
must be carefully filled with saline to make 
sure that no air bubbles enter the biliary 
tree. The catheter can be left in place until 
the common duct has been explored; it can 
then be used for the postexploration cholan- 
giogram. The catheter can also be left in
Fig. 8.—Tip of Cholangiocath. Note flange and radiopaque marker.
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place to permit drainage of the common bile 
duct if only small-calibre catheters are re­
quired for drainage. If it is difficult to in­
troduce the catheter, a silver probe passed 
down the cystic duct will break down the 
spiral valve of Heister. It is essential to pull 
the catheter back so that its flange impinges 
on the encircling ligature. This will prevent 
the catheter being pushed down too far so 
that its tip projects through the ampulla 
of Vater; it ensures that the cystic duct is 
outlined and that any stones in that duct 
are shown.
For direct puncture, which is necessary 
when the gallbladder has already been re­
moved or when it is not possible to can- 
nulate the cystic duct, a scalp-vein needle 
(Figs. 7 and 9) is useful. As in using the 
catheter, one must be careful to ensure that 
no bubbles lie within the needle or its tub­
ing. This method has three disadvantages: 
(a) the cystic duct is not outlined well in 
patients in whom the gallbladder is still pre­
sent; (b) the needle may slip out at a crucial 
stage; and (c) bile may occasionally leak 
from the puncture hole—a problem that
Fig. 9.—Scalp-vein needle and technique of 
holding it for insertion into common bile duct.
can be dealt with by closing the hole with 
a fine purse-string suture.
5. Scout film and radiographic technique. 
A preliminary scout film is frequently ad­
visable to ensure that the position of the film 
is correct, that the exposure is appropriate 
allowing for the body build of the patient, 
and that the x-ray machine is functioning 
correctly.
6. Injections of contrast medium. The 
usual material is 30% Urografin (sodium 
and meglumine diatrizoate). This may be 
diluted to 15% with either normal saline or 
bile in the common duct. Two injections are 
made. First, 3 to 5 ml is injected, depend­
ing on the calibre of the common duct. 
This is instilled slowly and an exposure 
taken. This small volume of contrast me­
dium is diluted by the bile and hence does 
not obliterate small stones; the main por­
tion of the common bile duct will be de­
lineated. Next, up to 15 to 20 ml of con­
trast medium is injected, again according 
to the calibre of the duct, and as the last 2 
ml of dye is being injected the exposure is 
made. This gives a “functional” or “dyna­
mic” cholangiogram and shows the dye 
flowing through the ampulla of Vater. For 
this last exposure the table is tilted 15° to 
the right so as to let the common duct and 
the ampulla of Vater fall away from the un­
derlying spine. The films then are developed 
rapidly and inspected by the surgeon. If un­
satisfactory more are taken, and a radio­
logist’s opinion may be sought. Image in- 
tensifiers are now used for this work, but 
the definition is not as good as with x-ray 
film. There is no need to wait while the 
films are being processed because the sur­
geon can start to excise the gallbladder at 
this stage.
7. “Completion” cholangiogram. If the 
common duct has been explored and stones 
have been removed, a T-tube is usually 
placed in the duct through the exploration 
incision. Further cholangiography is wise to 
ensure that all stones have been removed 
and that contrast medium flows freely into 
the duodenum. The chief difficulty is to 
ensure that air, introduced during the ex­
ploration or trapped in the T-tube, is evacu­
ated. To overcome this, a large volume of 
saline may be injected through the Cholan- 
giocath in the cystic duct; this forces the air
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bubbles out through the T-tube catheter. 
The radiopaque medium is then injected 
through a Cholangiocath, the T-tube being 
clamped. If dye does not flow freely into 
the duodenum there may be a residual stone 
in the ampulla of Vater or the sphincter of 
Oddi may be in spasm. An injection of 
atropine or hyoscine butylbromide intra­
venously will usually differentiate the two.
Discussion
Operative cholangiography has many ap­
plications. Its use before the common bile 
duct is opened may obviate the need for a 
choledochostomy because the duct is shown 
to be clear. More important, routine oper­
ative cholangiography may reveal un­
suspected stones that would otherwise have 
been missed; a second, later operation is 
thereby obviated. By performing cholangio­
graphy early in the operation a dangerous 
anatomic situation may be revealed. Sim­
ilarly, so that consequent damage to the 
common bile duct is avoided, the most ap­
propriate approach to impacted stones may 
be indicated.
The postexploration cholangiogram is im­
portant in ensuring that no stones have been 
overlooked before the incision is closed. 
However, cholangiography at this stage is 
not infallible for two reasons: (a) when 
hepatic biliary radicles are grossly dilated, 
stones may lie hidden within the liver, only 
to reveal themselves subsequently when they 
fall into the common bile duct when the 
patient becomes ambulant; and (b) spasm 
of the sphincter of Oddi after instrumentation 
prevents contrast medium flowing freely 
into the duodenum, although clear radio- 
graphic detail of the lower end of the com­
mon bile duct will usually distinguish spasm 
from organic obstruction (especially if the 
sphincter has been freely passed with 
probes) and drugs such as atropine or local 
anesthetics may be used to induce relaxa­
tion.
It is always important to get a “func­
tional” cholangiogram; that is, one in which
the radiograph is taken while the contrast 
medium is actually flowing into the duo­
denum. Exposure made as the last 2 ml of 
contrast medium is being injected will en­
sure a good picture of the region of the am­
pulla; if the pancreatic duct is visualized, 
one can be sure the ampulla is clear. The 
fact that contrast medium enters the duct 
of Wirsung does not seem to predispose to 
postoperative pancreatitis.
Operative cholangiography lengthens the 
operation by about 15 to 20 minutes. Even 
so, time need not be wasted while the radio­
graphs are being developed because the sur­
geon may proceed with cholecystectomy in 
the meantime; furthermore, the develop­
ment time of x-ray film with modern radio- 
graphic techniques is short.
Closed-circuit television between the 
operating room and the radiology depart­
ment permits immediate, skilled interpreta­
tion of the films by a radiologist and facil­
itates useful consultation between the sur­
geon and the radiologist.
The use of operative cholangiography has 
largely taken the guesswork out of biliary 
surgery. It carries no significant mortality 
or morbidity, and is an added safeguard to 
the patient.
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RESULTS OF CHOLECYSTECTOMY IN 1000 CONSECUTIVE PATIENTS*
LLOYD D. MacLEAN, MD, FRCS[C], MYRON GOLDSTEIN, MD, IENNIE E. MacDONALD, RN and ROBERT DEMERS, PhD
Summary: Analysis of the results of cholecys­
tectomy in 1000 consecutive patients revealed 
an overall mortality of 0.6%; among patients 
who underwent cholecystectomy only, there 
were no deaths. Wound infection occurred in 
3.4% of all patients but the rate exceeded 8% 
among those in whom another procedure was 
performed or there was acute cholecystitis. 
Cephaloridine given prophylactically was useful 
in decreasing the infection rate in the two latter 
groups.
Cystic duct cholangiography, used in 193 
patients, increased the rate of stone retrieval 
from the bile ducts from 41 to 63%, but the 
incidence of both false-negative and false­
positive cholangiograms was disturbingly high. 
Exploration was performed on clinical grounds 
despite a normal cholangiogram in 15 patients, 
with 5 positive results. Common duct explora­
tion was productive 41% of the time when 
clinical judgement without cholangiography was 
used. While cystic duct cholangiography is use­
ful, improvements in reliability are imperative 
and probably feasible, in view of the results 
achieved in the operating room and those in 
departments of radiology.
Resume: L'analyse des resultats de 1000 pa­
tients consecutifs ayant subi une cholecystecto- 
mie montre un taux de mortalite de 0.6%. Nous 
ne rapportons aucun deces parmi les patients 
qui ont eu une cholecystectomie seulement. 
Une infection de plaie a presente chez 3.4% de 
I'ensemble de patients, et ce taux excedait 8% 
si une autre operation etait faite en meme 
temps ou si le patient souffrait d'une chole- 
cystite aigue. Dans ces deux derniers groupes. 
la cephaloridine administree de fagon prophy- 
lactique a servi a diminuer le taux d'infection.
La cholangiographie peroperatoire du canal 
cystique faite chez 193 patients a augmente le 
taux de calculs enleves du choledoque de 41% 
& 63%. Toutefois I'incidence a la fois de taux 
negatifs et de faux positifs parmi les cholangio­
graphies etait tres elevee.
♦ From the departments of surgery, Royal Vic­toria Hospital and McGill University, Montreal, Que.
Supported by a grant from the Medical Research Council of Canada.
Presented at the annual meeting of the Royal College of Physicians and Surgeons of Canada, Winnipeg, Man., January 1975.
Chez 15 patients, malgre une cholangiogra­
phie normale pour des raisons cliniques nous 
avons procede a une exploration des voies bi- 
liaires et avons obtenu cinq resultats positifs. 
Lorsque nous avons procede a une exploration 
du choledoque sur un jugement clinique sans 
cholangiographie, les resultats se sont averes 
positifs dans 41%  des cas. Alors que la cholan­
giographie peroperatoire est utile, des ame­
liorations pour nous permettre de compter sur 
cet examen, s'rmposent et sont probablement 
possibles d'apres les resultats obtenus a la 
salle d'operation et en radiologie.
As part of a comprehensive assessment of 
the delivery of surgical care in the deter­
mination of areas for improvement or logic­
al prospective trials, the results in 1000 con­
secutive patients undergoing cholecystec­
tomy were scrutinized.
Materials and Methods
Variables Analyzed
The majority of the operations were per­
formed by residents or interns during the 
17-month period from January 1972 to 
May 1973. The 1000 cholecystectomies 
were performed in 724 females and 276 
males (ratio, 2.6:1), whose ages ranged 
from 17 to 91 years (Fig. 1). Of these 1000 
patients, 274 underwent at least one other 
operation in addition to cholecystectomy
AGE (years)
Fig. 1.—Age distribution of 1000 patients un­dergoing cholecystectomy.
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(Table I). The commonest associated proce­
dures were common bile duct exploration 
and appendectomy. All patients were seen 
by one of us (J.E.M.), who recorded 37 vari­
ables that were transcribed to a central pro­
cessing and storage computer for data pro­
cessing by means of conventional Fortran 
language. The following variables were an­
alyzed: mortality; incidence of wound infec­
tion (i.e., pus in the wound as opposed to 
transient nonsuppurating areas of redness 
or inflammation); incidence of wound in­
fection complicating other operations done 
simultaneously; incidence of wound infection 
related to administration of cephaloridine 
prophylactically; pathologic diagnosis; cul­
ture of the bile and gallbladder wall; age of 
the patient and duration of operation; and 
the results achieved with intraoperative 
cholangiography.
The chi-square test was used in statistical 
analysis.
Culture Technique
Samples were taken of gallbladder bile 
and gallbladder wall and implanted imme­
diately into Stuart medium1 for transport 
and thereafter cultured appropriately for the
TABLE I.—P rocedures Associated w ith  C hole­
cystectomy
No. of
Procedure procedures
Common bile duct exploration....... 129*
Appendectomy................................  100
Repair of hiatus hernia................... 14
Vagotomy and pyloroplasty...........  7
Breast biopsy..................................  6
Repair of ventral hernia................. 6
Splenectomy.................................... 6
Gastrojejunostomy.......................... 6*
Duodenotomy.................................. 5
Subtotal gastrectomy.....................  5
Choiedochoenterostomy.................  3*
Repair of umbilical hernia.............  3
Resection of ovarian cyst...............  3
Portacaval shunt.................................  2*
Mitral valve replacement...............  2
Right nephrectomy......................... 2
Intestinal bypass............................. 2
Bilateral adrenalectomy.................  2
Lymph node biopsy........................  2*
Prostatic resection..........................
Resection of Meckel’s diverticulum
Closure of gastric perforation.........
Hemicolectomy...............................  1
Resection of ureter......................
Cystogastrostomy...........................  1*
*One death was associated with each of these pro­
cedures.
detection of aerobic and anaerobic organ­
isms. Preliminary tests indicated that this 
inexpensive transport medium was as ef­
fective as aerobic and anaerobic blood cul­
ture media in preserving organisms for 
culture.
Radiologic Technique
Intraoperative cystic duct cholangio­
graphy was performed using standard tech­
niques with a 100 mA mobile x-ray ma­
chine. The average exposure capability of 
the equipment was 80 mA at 0.3 s at 70 
to 75 kVp. Two 10 x 12 grid cassettes with 
Radelin STF-2 intensifying screens loaded 
with Cronex 4 (par speed) film were used. 
Hypaque (60%), diluted by mixing three 
parts of dye with seven parts of normal 
saline, was injected through a long infant 
feeding tube into the cystic duct. Ap­
proximately 5 ml was injected for the first 
film and 10 to 30 ml, depending on duct 
size, for the second film.
The technique, standardized before the 
study, included availability of an experi­
enced radiology technician assigned to the 
operating theatre, positioning of the patient 
to prevent overlap of the biliary tract and 
spine, and standard practices to prevent 
injection of air bubbles into the biliary tree.
Regimen for Prophylaxis with
Cephaloridine
Cephaloridine, when used, was given ac­
cording to the following regimen:- 1 g was 
injected intramuscularly before operation, 
on call; 1 mg was given 5 hours after oper­
ation and 1 g was given 12 hours after 
operation.
R esults
Mortality
There were no deaths among the 726 pa­
tients who underwent cholecystectomy alone, 
but among the entire group of 1000 there 
were 6 deaths (operative mortality, 0.6%) 
(Table 11) .  The patients who died were 
three who underwent operation for exten­
sive unresectable carcinoma in addition to 
incidental cholecystectomy, one who under­
went emergency portacaval shunt, one in 
whom cystogastrostomy was performed for 
acute severe pancreatitis, and one with sup-
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purative cholangitis in whom emergency 
cholecystectomy, common bile duct explora­
tion and drainage were performed.
Pathologic Diagnosis
The pathologic diagnoses relating to the 
gallbladder are listed in Table III.
Wound Injection
Wound infections developed in hospital 
in 16 females and 18 males (rate, 3.4%). 
Development of wound infection in these 
34 patients was related to various factors; 
the procedure performed, the use of ce- 
phaloridine prophylactically, the gallbladder 
lesion, the result of culture of operative site, 
the age of the patient and the duration of 
the operative procedure were important.
Influence of operative procedure, pro­
phylactic cephaloridine therapy and abnorm­
alities of gallbladder.— The influence on the 
incidence of wound infection of acute inflam­
mation or gangrene of the gallbladder, and 
the risk of additional procedures and the 
control of these risks by use of prophylactic 
antibiotics, is summarized in Table IV.
When cholecystectomy alone was per­
formed for chronic cholecystitis and the 
patient did not receive prophylactic cepha­
loridine (487 patients), the wound infec­
tion rate was 1.4%. Among the 129 pa­
tients in the same category who received 
cephaloridine prophylactically this rate was 
0.7%; the difference was not significant. 
Performance of a procedure in addition to 
cholecystectomy in patients not receiving 
cephaloridine significantly increased the 
wound infection rate from 1.4 to 8.7% 
(P < 0.001). This increased risk of wound 
infection appeared to be prevented by the 
use of cephaloridine prophylactically (8.7 
vs. 0%; P < 0.05).
Acute inflammation of the gallbladder 
also increased the risk of wound infection 
from 1.4 to 8.5% (P <  0.001). This cate­
gory comprised the smallest number of pa­
tients, but prophylactic use of cephaloridine 
did not appear to decrease significantly the 
wound infection rate from this cause. If one 
compares the wound infection rates for 
cholecystectomy for acute cholecystitis and 
for cholecystectomy with an additional pro­
cedure, the infection rate was 8.4% in 283 
patients not receiving cephaloridine. Patients 
undergoing similar procedures but who re­
ceived prophylactic cephaloridine had a 
wound infection rate of 1.67%, and the 
difference is significant (P <  0.05).
Common bile duct exploration.— Because 
the performance of procedures in addition 
to cholecystectomy increases the incidence 
of wound infection, one might expect com­
mon duct exploration, the most frequently 
performed additional procedure to be as­
sociated with an increased rate of infection, 
which is in fact what we found. Among the 
129 patients who underwent common bile 
duct exploration, wound infection occurred 
in 12 (9.3%). This procedure was done on 
104 occasions for the 860 patients with 
chronic cholecystitis (12.1%), 23 times 
among the 125 patients with acute cholecys-
TABLE III.—P athologic D iagnoses for 1000
Patients U ndergoing Cholecystectomy
No. of
Diagnosis patients
Chronic cholecystitis.........................  860
Acute or gangrenous cholecystitis.. 125
Adenocarcinoma of gallbladder. . . .  6
Adenocarcinoma of pancreas........... 2
Adenocarcinoma of common bile
duct.................................................. 2
No abnormality.................................  3
No specimen.......................................  2
TABLE II.—Details of Patients Who D ied After Undergoing Cholecystectomy*
Age
(yr) Sex Diagnosis
Procedure in addition 
to cholecystectomy
Day of death 
(postoperative)
62 M Cancer of pancreas, with metastases Gastrojejunostomy 24
57 F Acute severe pancreatitis Cystogastrostom y 1079 M Cancer of pancreas Choledochoenterostomy 447 M Cirrhosis of liver, esophageal varices Portacaval shunt 4
71 M Cholangitis, sepsis, shock, diabetes
mellitus Common bile duct exploration 4
83 F Cancer of gallbladder Lymph node biopsy 30
*For entire series, mortality was 0.6%; for patients undergoing cholecystectomy only, the mortality was 
zero.
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TABLE IV.— Influence of P rophylactic Cephaloridine Related to P rocedure and Pathology*
Group Procedure Pathology
Prophylactic
cephaloridine
Wound injection
No. of patients with wound 
infection
Infection 
rate, %t
1 Cholecystectomy only 
(n = 487)
Chronicf No 7 1.4
2 Cholecystectomy only 
(n = 129)
Chronic Yes 1 0.7
3 Cholecystectomy +  
another procedure 
(n = 206)
Chronic No 18 8.7
4 Cholecystectomy +  
another procedure 
(n = 38)
Chronic Yes 0 0
5 Cholecystectomy only 
(n = 77)
Acute§ No 6 8.5
6 Cholecystectomy only 
(n = 23)
Acute Yes 1 4.5
7 Groups 3 + 5  
(n = 283)
No 24 8.4
8 Groups 4 + 6  
(n =  61)
Yes 1 1.6
*Does not include 15 patients with cancer or no abnormality of the gallbladder and 25 patients who had 
cholecystectomy +  another procedure but in whom acute cholecystitis was the indication for operation in
til t  ill 9 1  p i d V - t .
■(■Differences are significant for the following groups, as follows: 1 and 3, P <  0.001; 1 and 5, P <  0.001; 3 
and 4, P < 0.05; 7 and 8, P < 0.05.
JChronic cholecystitis.
§Acute cholecystitis.
titis (18.4%) and on 2 occasions for patients 
with intrahepatic biliary obstruction second­
ary to carcinoma (1.6%). Of these patients, 
104 received no cephaloridine prophylac- 
tically and all 12 infections occurred in this 
group, an incidence of wound infection of 
11.5%. However, 25 of the 129 patients 
had acute or chronic cholecystitis and they 
received cephaloridine prophylactically and 
among them were no wound infections; this 
difference is of borderline significance, prob­
ably because of the small sample size, but 
the overall rate of wound infection in this 
group therefore was 9.3%.
Culture of gallbladder wall and bile.— 
Cultures of the gallbladder wall of 235 pa­
tients yielded one or more species of or­
ganism in 67 (28.5%) (Table V). Cultures 
of the gallbladder bile from 419 patients 
grew one or more species in 119 (28.4%) 
(Table V).
With respect to the 27 patients with 
acute cholecystitis from whom cultures were 
obtained from the gallbladder wall, cultures 
in 11 (40.7%) were positive; and with re­
spect to the 52 patients with acute chole­
cystitis from whom bile was cultured, a posi­
tive result was recorded in 21 (40.4%). For
194 patients with chronic cholecystitis, cul­
ture of the gallbladder wall was reported 
as being positive in 48 (24.7%) and culture
TABLE V.—Results of Cultures of Gall­
bladder Wall and Gallbladder Bile
Organism
Source of culture in 
gallbladder
Wall Bile 
(n =  235) (« = 419)
E. coli................................ 16 33
S. epidermidis.................. 15 23
Enterobacler sp................. 7 11
Klebsiella sp...................... 7 13
S. aureus........................... 4 6
Enterococci sp................... 4 3
Proteus mirabilis.............. 3 1
a-hemolytic streptococcus 2 3
Hafnia sp.......................... 2 2
Corynebacterium sp.......... 2 12
Aeromonas sp.................... 1 1
Staphylococcus albuf . . . . 1 0
Cl. welchii......................... 1 0
Streptococcus sp................ 1 4
g-hemolytic streptococcus 1 1
Salmonella sp.................... 0 2
Lactobacillus sp................ 0 2
Cl. tetani........................... 0 1
Achromobader sp.............. 0 1
Total......................... 67* 119f
*No growth was reported for 168 patients. 
(No growth was reported for 300 patients,
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Fig. 2.—Incidence of wound infections related 
to age in 1000 patients who underwent cholecys­
tectomy. Hatched bars: data relating to 737 pa­
tients under 60 years of age, among whom 17 
(2.3%) had infection; solid bars: data relating to 
263 patients over 60 years of age, among whom
of the gallbladder bile was positive in 90 
of 349 (25.8%) so tested. The prominent 
organisms were Escherichia coli and Sta­
phylococcus epidermidis.
Of the 34 patients in whom a wound 
infection developed, intraoperative culture 
either of the gallbladder wall or the bile 
was taken in 23. There was no growth in 
seven, but in six of these patients proce­
dures in addition to cholecystectomy could 
have been the source of the infection. The 
organisms cultured from the infected wound 
were the same as those from the bile or 
gallbladder wall in 14 of the 16 remaining 
patients who had positive cultures at 
operation.
Patient age and length of operation.— In
737 patients under 60 years of age there 
were 17 wound infections (2.3%), whereas 
in 263 patients over 60 there were 17 
(6.4%) (Fig 2). This is a highly significant 
difference (P <  0.002).
The median operating time was between 
75 and 90 minutes. There were 13 wound 
infections in 569 patients whose operations 
took less than 90 minutes (2.3%) and there 
were 21 wound infections among 431 pa­
tients whose operations required more than 
90 minutes (4.9%). This is also a significant 
difference (P <  0.03).
Intraoperative Cystic Duct Cholangio­
graphy and Common Bile Duct Explora­
tion
Intraoperative cystic duct cholangio­
graphy was performed on 193 of the 1000 
patients (Fig. 3). The cholangiogram was 
interpreted as normal in 155 and as posi­
tive or suggestive in 33; there were 5 tech­
nical failures. Of the 33 patients with posi­
tive cholangiograms, 27 underwent common 
bile duct exploration and stones were found 
in 17 (63%). The other six patients did not 
undergo common duct exploration despite 
a positive or suggestive cholangiogram, but 
the result in them was satisfactory on fol­
low-up; none have recurrent symptoms that 
suggest retained stones in the common bile 
duct.
Among the 155 patients in whom cystic 
duct cholangiograms were normal, the com­
mon bile duct was explored in 15, despite
P a t i e n t s
33
POSITIVE
27 6
155
NEGATIVE
15 140
No e x p lo r a t io n  E x p lo r a t io n No e x p l o r a t i o n
S to n e s  No s t o n e s S to n e s  No s t o n e s
(63%) (33%)
Fig. 3.—Results of cystic duct cholangiography in 193 patients. In 63% of patients with positive 
cholangiograms stones were found on duct exploration and the six patients not explored were 
asymptomatic: results in the latter therefore were false-positive. Note false-negative results in 33% 
of 15 patients in whom exploration was performed despite negative cholangiograms. Note also that 
cholangiograms were available in only 188 patients; in remaining 5 patients, cholangiography failed for 
technical reasons.
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the normal radiographic findings, and, in 
5 of these 15 patients, stones were found. 
The indications for cholangiography in these 
five patients were palpable stones in two 
and dilated bile ducts, pancreatitis, jaundice 
or multiple small stones in the gallbladder 
in varying combination in three.
There were 88 patients who did not 
have cystic duct cholangiography but who 
did appear to have a clinical indication for 
common bile duct exploration (Table VI). 
In these patients common duct exploration 
yielded positive findings in 36 patients and 
negative findings in 52. This high incidence 
of positive findings on exploration without 
cholangiography is related to the validity 
of the indications.
In this series 12 patients had proven re­
tained stones in the common bile or hepatic 
ducts after cholecystectomy. In two of these 
patients there was associated malignant di­
sease, both patients dying without further 
surgery; in three the stones were removed 
nonoperatively by a stone basket; in four 
the T-tube was removed, the patients re­
maining well clinically; in one the stone 
disappeared spontaneously; and in two pa­
tients the stones were removed at reopera­
tion (Table VII).
No adverse effects of the prophylactic 
antibiotic used for three doses in this study 
were documented.
D iscussion
The operative mortality for cholecystec­
tomy has continued to decline since 1934, 
when Heuer published the first major re­
port.3 His review of 36 623 patients from 
21 institutions in Europe and North Amer­
ica revealed an operative mortality of 6.6 % .  
For the present series of 1000 patients, the
TABLE VII.—Results of 12 P atients with 
Retained Stones in B ile Ducts
No. of
Result patients
Re-exploration with removal............... 2
Spontaneous disappearance................. 1
Removal of T-tube with good clinical
result.................................................... 4
Nonoperative removal by basket . . . .  3
Died......................................................... 2
Total........................................ 12
overall mortality was 0.6%, with no deaths 
in patients who underwent cholecystectomy 
alone and only three deaths in patients with 
nonmalignant pancreatic or biliary disease. 
All six deaths occurred in patients in whom 
cholecystectomy was incidental and in whom 
operative procedures in addition to chole­
cystectomy were required.
Wound infection rates after cholecystec­
tomy vary widely, from 2.5 to 15%.4- 5 
With respect only to those patients over 70, 
those with jaundice or common bile duct 
stone or those with acute cholecystitis, the 
infection rate reportedly is 27% .6 This study 
confirms other reports in that age of the 
patient, duration of the operation and pres­
ence of acute inflammation of the gallblad­
der are all associated with higher wound in­
fection rates, but it also suggests that addi­
tional procedures, including common bile 
duct exploration performed at the time of 
cholecystectomy, greatly increase the risk of 
infection. The present study has also shown 
that the prophylactic use of cephaloridine, 
starting before the procedure, appears to 
decrease the risk of infection associated with 
acute inflammation and additional proce­
dures; this finding is consistent with that of 
Chetlin and Elliott,6 who showed, in a pro-
TABLE VI.—Indications and F indings in 88 Patients Undergoing Common Bile Duct E xploration
Without Cystic Duct Cholangiography
Positive indication
No. of No. of
patients Negative indication patients
Palpable stones......................................  10
Dilated ducts...............................................  7
Jaundice........................................................ 7
Positive transhepatic cholangiogram.. 6
Small stones.................................................  4
Cancer (?)................................................  1
Retained stone............................................  1
36
Small stones......................................... 28
Dilated ducts.......................................  12
Jaundice................................................ 4
Failed cholangiography...................... 3
Acute cholecystitis.............................. 2
Pancreatitis..........................................  1
No indication....................................... 2
52Total
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spective trial, that patients who are at high 
risk for infection after biliary duct surgery 
benefit from prophylactic use of an anti­
biotic. The wound infection rate associated 
with a regimen similar to that described 
herein was 4%, compared with 27% among 
similar but untreated controls.
We currently recommend, for prophylaxis, 
the use of cephaloridine, as advised by Polk 
and Lopez-Mayor,2 for all patients over 
60 years of age who are scheduled for 
cholecystectomy and in whom additional 
procedures are contemplated and for pa­
tients with acute cholecystitis. The value of 
prophylactic antibiotic therapy in patients 
with chronic cholecystitis in whom chole­
cystectomy only is performed is not estab­
lished.
The importance of infected bile as a 
cause of wound infections is reaffirmed in 
this study.4 Wound cultures might be a fur­
ther guide in patients in whom additional 
procedures are performed at the time of 
cholecystectomy.7
We found no difference in the incidence 
of positive cultures between gallbladder wall 
or bile in the same patients. Quantitative 
cultures of bile might be the best guide to 
the potential risk of bile spillage at opera­
tion. In studies of the bile and gallbladder 
wall at the time of cholecystectomy, Robson, 
Bogart and Heggers4 showed that organisms 
in a concentration of 103 per gram of tissue 
are almost always associated with subcutan­
eous invasion and wound infection.
Recommendations regarding cystic duct 
cholangiography are less obvious from this 
review. Routine cystic duct cholangiography 
at the time of cholecystectomy has been 
widely recommended;8 10 such a recommen­
dation is logically based on the fact that 
there are thereby fewer common bile duct 
explorations and more positive explorations; 
and, besides, the procedure has a lower mor­
bidity than has exploration of the common 
bile duct. On the other hand, it has not 
been demonstrated conclusively that more 
stones are found as a result of the routine 
use of cystic duct cholangiography. In the 
large series of Kakos and colleagues9 the 
use of cholangiography increased from 
2.9% in 1951 to 93% in 1970, yet the in­
cidence of common duct stones found re­
mained between 11.5 and 16% and the
recovery was highest early in the experience 
during the period 1956 to 1960, when 
cholangiography was not commonly per­
formed.
In the present study, false-positive cholan- 
giograms were frequent. Of greater con­
cern is the finding that negative cholangio- 
grams were proven misleading in 5 of 15 
patients in whom exploration was performed 
despite the negative report. These patients 
were included among a total of 155 in 
whom cholangiograms were negative. The 
difference between the incidence of positive 
explorations when cholangiograms were used 
(63%) and when clinical indications were 
used (41%) is significant, but this is not as 
clearly different when one considers the 
findings in patients with common duct stones 
in whom the cholangiograms were negative. 
The explorations were done in these in­
stances on clinical grounds.
Although operative cholangiography as 
currently performed is useful, false-positive 
and false-negative errors are common, the 
techniques are demanding, and use of the 
procedure should not alter routine indica­
tions for choledochotomy. The challenge at 
this institution is to improve the equipment 
and techniques for cystic duct as well as 
those of T-tube cholangiography in the oper­
ating theatre, to reach the standard attained 
in the department of radiology.
Experience concerning the problem of 
retained stones gained since the com­
pletion of this study supports the use of 
a stone basket as the best method for re­
trieval. Spontaneous disappearance of the 
stones is common, due either to false-posi­
tive cholangiography or passage of the cal­
culi. Reoperation is recommended only in 
patients who do not tolerate clamping of the 
T-tube because of jaundice or infection and 
in whom removal by use of the stone basket 
has failed.
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Spray as the gallbladder is raised to 
expose the cystic duct and artery and spray 
each layer as closing.
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TNM CLASSIFICATION OF MALIGNANT TUMOURS 
OF THE BLADDER, PROSTATE, TESTIS AND KIDNEY
W. E. COLLINS, MD, FRCS[C]*
Summary: T N M  classification is a short descrip­
tion of a cancer at a point in its natural history—  
the onset of definitive treatment— and should 
be considered in planning treatment, in assessing 
prognosis, in evaluating end results, in facil­
itating the exchange of information between 
treatment centres and thus in contributing to 
the continuing investigation of human cancer. 
For four cancers of urologic sites there are new 
TN M  classifications. Although previous classifi­
cations of bladder cancer were satisfactory, the 
new classifications for kidney, prostate and 
testis are the first internationally accepted clas­
sifications for these three organs that are clinic­
ally practical. Widespread use of these clas­
sifications is recommended.
Resume: La classification TN M  est une breve 
description du cancer a un instant de son evolu­
tion naturelle— le debut du traitement definitif. 
On devrait y recourir pour projeter le traitement, 
poser le pronostic, evaluer les resultats finals, 
faciliter I'echange de renseignements entre les 
centres therapeutiques et, de la sorte, contribuer 
& I'etude continue du probleme du cancer 
humain. En ce qui concerne quatre cancers uro- 
logiques, on y trouve de nouvelles classifica­
tions TN M . Bien que les classifications ante-
*Professor of surgery (urology), University of 
Ottawa, Ottawa, Ont.
Reprint requests to: Dr. W. E. Collins, Depart­
ment of urology, Ottawa Civic Hospital, 1053 
Carling Ave., Ottawa, Ont. K1Y 4E9.
rieures du cancer vesical aient ete satisfaisants, 
les nouvelles classifications pour les reins, la 
prostate et les testicules sont les premieres qui 
soient acceptees universellement pour ces trois 
organes et qui offrent un interet Clinique pra­
tique. Nous conseillons d'etendre largement 
I'usage de ces classifications.
T he  TNM system, as elaborated by Denoix* 
and used by the committee on TNM clas­
sification of the International Union Against 
Cancer (UICC), is a short description of a 
cancer at a point in its natural history (at 
the onset of definitive treatment) based on 
clinical information in its primary applica­
tion. From it, groupings may be devised to 
indicate stages, but it is not primarily a 
staging system. The basic principles estab­
lished are applicable to all sites, regardless 
of treatment, and the classification may be 
supplemented later by information that be­
comes available from histopathologic 
examination or surgical exploration. Ander­
son* has shown that they are applicable for 
such deep-seated lesions as carcinoma of 
the colon and rectum.
The TNM classification and staging have 
five purposes; the classification and staging
* Anderson WA: Stage classsifications and end 
results reporting for carcinoma of colon and rec­
tum. Cancer 34 (suppl): 909, 1974
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are worth while only if they serve one or 
more of these purposes. They should aid the 
clinician in the planning of treatment; they 
should give some indication of prognosis; 
they should assist in evaluation of treatment 
results; they should facilitate the exchange 
of information between treatment centres; 
and they should contribute to the continuing 
investigation of human cancer.
In the TNM classification the symbol T 
represents the degree of penetration of the 
primary tumour through or beyond the site 
of origin, N denotes the condition of the 
regional and juxtaregional lymph nodes, and 
M the absence or presence of distant me- 
tastases.
Microscopic confirmation of the degree 
of penetration of the primary tumour is 
expressed by the symbol P, and G refers to 
the pathologic grading of the tumour. In the 
classification of renal-cell carcinoma, inva­
sion of veins is important and this informa­
tion is expressed as V; similarly, in the 
bladder classification the invasion of lym­
phatics is expressed by the symbol L.
TNM C lassification of
U rologic Sites
New TNM classifications of tumours of 
four urologic sites (bladder, prostate, kidney 
and testis) have been developed by the 
UICC with the enthusiastic and effective 
help of many national groups, including the 
National Cancer Institute of Canada and 
the American Joint Committee for Cancer 
Staging and End Results Reporting. Revi­
sions and changes in any system may be 
necessary as new data and knowledge are 
available, and a final and ideal system may 
not be achieved until we stop learning more 
about cancer.
Classification of tumours in these four 
urologic sites presents specific problems, 
but they have been classified according to 
a common plan. For this purpose, certain 
modifications to the hitherto accepted rules 
of the TNM system have been necessary as follows :
1. Minimal requirements for the mean­
ingful categorization of a primary tumour, 
the lymph nodes and metastases are neces­
sary; for example, arteriography and lym­
phography may be mandatory.
2. Lymph nodes beyond the regional 
nodes may now be treated; therefore, these 
juxtaregional nodes are also classified.
3. With tumours of the testis, radical or­
chiectomy performed for confirmation of 
the diagnosis provides the necessary infor­
mation for assessment of the extent of the 
primary tumour.
The classifications of these tumours of 
urologic sites are not definitive. Though 
based on experience of large international 
groups of urologists, radiotherapists and 
pathologists, and supported by extensive 
data, they have yet to be fully tested in field 
trials. However, they represent the first 
workable classifications of tumours of the 
kidney, prostate and testis that have been 
acceptable to an international group.
Because these classifications do meet 
most, if not all, of the objectives for which 
they were developed, they are now ideal for 
clinical application. Some groups may wish 
to add designations of a surgical-evaluative 
classification and a postsurgical classifica­
tion; there is no reason why they should not.
For two decades, hormonal therapy was 
used indiscriminately in the treatment of 
prostatic cancer. It was then impossible to 
assess the proper place for hormonal ther­
apy in the management of prostatic cancer. 
Now, therapy is being used indiscriminately. 
Widespread use of TNM classification of 
prostatic cancer at this time will allow the 
place of radiation therapy to be evaluated.
At a recent international meeting on can­
cer of the larynx, presentations were not 
accepted unless the material had been clas­
sified by the TNM system. It is reasonable 
to assume that future end-stage reporting 
will not be acceptable unless the data 
required for TNM classification are collected 
prospectively. Therefore, widespread use of 
TNM classification of malignant tumours of 
these four urologic sites is recommended.
Sellers (personal communication, 1975) 
has developed check sheets for cancers of the 
bladder and prostate. These check sheets 
make classification exceedingly easy.*
Systems for classification of tumpurs follow.
Check sheets are available from the Ontario Can­cer Treatment and Research Foundation, 7 Overlea Blvd., Toronto, Ont. M4H 1A8,
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THE BLADDER
Rules for Classification
1. The classification applies only to epi­
thelial tumours. Papilloma is excluded but 
such cases may be listed under the category 
GO.
2. There must be histologic or cytologic 
verification of the disease.
3. The following are the minimum re­
quirements for assessment of the T, N and 
M categories:
• T categories: Clinical examination,
urography, cystoscopy, 
bimanual examination 
under adequate anesthe­
sia and biopsy or trans­
urethral resection of the 
tum our (if indicated) 
prior to definitive treat­
ment.
• N categories: Clinical examination,
lymphography and uro­
graphy.
• M categories: Clinical examination,
chest radiography and 
biochemical testing. In 
the more advanced pri­
mary tumours or when 
clinical suspicion war­
rants, radiographic or 
isotope studies should 
be done.
If these requirements cannot be met the 
symbol TX, NX or MX will be used.
TMN Classification
T =  Primary tumour
The suffix (m) may be added to the appro­
priate T category to indicate multiple
tumours, thus: T2{m).
T1S Carcinoma in situ. Definite anaplasia 
of surface epithelium without the 
formation of papillary stuctures and 
without infiltration.
TX The minimum requirements to assess 
fully the extent of the primary tu­
mour cannot be met.
TO No evidence of primary tumour.
T1 On bimanual examination a freely 
mobile mass may be felt: this should 
not be felt after complete transure­
thral resection of the lesion and/or, 
microscopically, the tumour does 
not extend beyond the lamina pro­
pria.
T2 On bimanual examination the in­
durated bladder wall is mobile. 
There is no residual induration af­
ter complete transurethral resection 
of the lesion and/or there is micro­
scopic invasion of superficial mus­
cle.
T3 On bimanual examination indura­
tion or a nodular mobile mass is 
palpable in the bladder wall that 
persists after transurethral resection 
of the exophytic portion of the le­
sion and/or there is microscopic in­
vasion of deep muscle or extension 
through the bladder wall.
T3a Invasion of deep muscle.
T3b Extension through the bladder 
wall.
T4 Tumour fixed or invading neigh­
bouring structures and/or there is 
microscopic evidence of such in­
volvement.
T4a Tumour invading prostate, ute­
rus or vagina.
T4b Tumour fixed to the pelvic 
wall and/or infiltrating the ab­
dominal wall.
N =  Regional and juxtaregional lymph 
nodes
The regional lymph nodes are the pel­
vic nodes below the bifurcation of the 
common iliac arteries. The juxtaregional 
lymph nodes are the inguinal nodes, the 
common iliac and para-aortic nodes.
NX The minimum requirements to as­
sess the regional lymph nodes can­
not be met.
NO No evidence of involvement of re­
gional lymph nodes.
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The Bladder (continued)
N1 Involvement o f a single homolateral 
regional lymph node.
N2 Involvement o f contralateral or bi­
lateral or multiple regional lymph 
nodes.
N3 There is a fixed mass on the pelvic 
wall with a free space between this 
and the tumour.
N4 Involvement o f juxtaregional lymph 
nodes.
Subsequent information regarding the 
histologic assessment of the regional lymph 
nodes may be added to the clinical N cate­
gory by means o f negative and positive 
signs, thus: N -  for nodes with no micro­
scopic evidence o f metastasis; or N +  for 
nodes with microscopic evidence o f me­
tastasis (e.g., N 1-, N 0+).
M - Distant metastases
M X The minimum requirements to as­
sess the presence o f distant meta­
stases cannot be met.
MO N o evidence of distant metastases.
M l Distant metastases present.
M ia  Evidence o f occult metastases 
based on biochemical and/or 
other tests.
M lb  Single metastasis in a single­
organ site.
M lc  Multiple metastases in a single­
organ site.
M id  Metastases in multiple-organ 
sites.
Note: The location of metastases should be 
specified. The lymph nodes beyond 
the regional and juxtaregional nodes 
and bone are regarded as single-or­
gan sites.
P =  Histopathologic categories
Assessment o f the P categories is based 
on evidence derived from surgical opera­
tion and histopathology; that is, where 
tissue other than biopsy is available for 
examination. The suffix (m) may be
added to the appropriate P category to
indicate multiple tumours, thus P2(m).
PIS Preinvasive carcinoma (carcinoma 
in situ).
PX The extent o f invasion cannot be as­
sessed.
PO N o tumour found on examination o f 
specimen.
PI Tumour not extending beyond the 
lamina propria.
P2 Tumour with infiltration o f super­
ficial muscle (not more than half­
way through muscle coat or infiltra­
tion o f perivesical tissue).
P3 Tumour with infiltration o f deep 
muscle (more than halfway through 
muscle coat) or infiltration o f peri­
vesical tissue.
P4 Tumour with infiltration o f prostate 
or other extravesical structures.
G  =  Histopathologic grading
G X  Grade cannot be assessed.
GO No evidence o f anaplasia (i.e., papil­
loma).
G1 Low-grade malignancy.
G2 Medium-grade malignancy.
G3 High-grade malignancy.
L =  Invasion o f lymphatics
L X  Lymphatic invasion cannot be as­
sessed.
LO N o lymphatic invasion.
LI Superficial lymphatics invaded.
L2 Deep lymphatics invaded.
Note: The histopathologic categories and 
grading conform to the recommenda­
tions o f WHO. (Ref. Histological Ty­
ping o f Urinary Bladder Tumours, 
Geneva, WHO, 1973).
Stage grouping
N o stage grouping is at present recom­
mended.
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THE PROSTATE
Rules for Classification
1. The classification applies only to carci­
noma.
2. There must be histologic or cytologic 
verification of the disease, to permit division 
of cases by histologic type.
3. The following are the minimum require­
ments for assessment of the T, N and M cate­
gories.
•  T categories: Clinical examination, uro­
graphy, endoscopy and bi­
opsy (if indicated) prior 
to definitive treatment.
•  N categories: Clinical examination, lym­
phography and/or uro­
graphy.
•  M categories: Clinical examination, chest
radiography, skeletal studies 
and determination of the 
acid phosphatase level on 
two or more occasions.
TNM  Classification 
T — Primary tumour
The suffix (m) may be added to the appro­
priate T category to indicate multiple tu­
mours, thus: T2(m).
TX The minimum requirements to assess 
fully the extent of the primary tumour 
cannot be met.
TO No tumour palpable. This category in­
cludes those cases of the incidental 
finding of a carcinoma in an operative 
or biopsy specimen. Such cases should 
be assigned an appropriate P, N or M 
category.
T1 Tumour intracapsular, surrounded by 
palpably normal gland.
T2 Tumour confined to the gland, smooth 
nodule deforming contour but lateral 
sulci and seminal vesicles not involved. 
T3 Tumour extending beyond the capsule 
with or without involvement of the 
lateral sulci and/or seminal vesicles.
T4 Tumour fixed or invading neighbouring 
structures.
N =  Regional and juxtaregional lymph nodes 
The regional lymph nodes are the pelvic 
nodes below the bifurcation of the common 
iliac arteries. The juxtaregional lymph nodes 
are the inguinal nodes, the common iliac 
and para-aortic nodes.
NX The minimum requirements to assess 
the regional lymph nodes cannot be 
met.
NO No evidence of involvement of regional 
lymph nodes.
N1 Involvement of a single regional lymph 
node.
N2 Involvement of multiple regional lymph 
nodes.
N3 There is a fixed mass on the pelvic wall 
with a free space between this and the 
tumour.
N4 Involvement of juxtaregional nodes. 
Subsequent information regarding the his­
tologic assessment of the regional lymph nodes 
may be added to the clinical N category by 
means of negative and positive signs, thus: N - 
for nodes with no microscopic evidence of 
metastasis; or N +  for nodes with microscopic 
evidence of metastasis (e.g., N1-, NO-f).
M =  Distant metastases
If lymphography indicates extension to the 
juxtaregional lymph nodes, a scalene node 
biopsy is recommended.
MX The minimum requirements to assess 
the presence of distant metastases can­
not be met.
MO No evidence of distant metastases.
Ml Distant metastases present.
M ia Evidence of occult metastases by 
biochemical and/or other test.
Mlb Single metastasis in a single-organ 
site.
Mlc Multiple metastases in a single­
organ site.
Mid Metastases in multiple-organ sites. 
Note: The location of metastases should be 
specified. The lymph nodes beyond the 
regional and juxtaregional nodes, and 
bone are regarded as single-organ sites. 
P =  Histopathologic categories
Assessment of the P categories is based on 
available material whether biopsy, transure­
thral resection, enucleation or total prosta­
tectomy; the source is to be stated. The 
suffix (m) may be added to the appropriate 
P category to indicate multiple tumours, 
thus: P2(m).
PX The extent of invasion cannot be as­
sessed.
PO No tumour found on examination of 
specimen.
PI Focal (single or multiple) carcinoma.
P2 Diffuse carcinoma with or without ex­
tension to the capsule.
P3 Carcinoma with penetration through the 
capsule and/or extension to the seminal 
vesicles.
P4 Extension into adjacent organs.
G =  Histopathologic grading 
GX Grade cannot be assessed.
GO No evidence of anaplasia.
G1 Low-grade malignancy.
G2 Medium-grade malignancy.
G3 High-grade malignancy.
Stage grouping
No stage grouping is at present recom­
mended.
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THE TESTIS
Rules for Classification
1. Testis refers to the body of the testis 
and excludes the epididymis.
2. There must be histologic verification o f 
the disease. Cases must be divided by histologic 
type. Malignant lymphoma is excluded.
3. The following are the minimum require­
ments for assessment o f the T, N and M cate­
gories.
• T  categories: Clinical examination and
radical orchiectomy (which 
in this case is considered 
as a biopsy).
• N categories: Clinical examination, lym­
phography and urography.
• M categories: Clinical examination, chest
radiography and biochem­
ical tests.
TNM Classification 
T —j Primary tumour
In the absence o f orchiectomy the symbol 
TX must be used.
TX  The minimum requirements to assess 
fully the extent of the primary tumour 
cannot be met.
TO No evidence o f primary tumour.
T1 Tumour limited to the body o f the 
testis.
T2 Tumour extending beyond the tunica 
albuginea.
T3 Tumour involving the rete testis or 
epididymis.
T4 Tumour invading the spermatic cord 
and/or scrotal wall.
T4a Invasion of spermatic crord.
T4b Invasion o f scrotal wall.
N =  Regional and juxtaregional lymph nodes
The regional lymph nodes are the para­
aortic and paracaval nodes. After surgery on 
the scrotum the homolateral inguinal lymph 
nodes are included with the regional lymph 
nodes. The juxtaregional lymph nodes are 
the intrapelvic nodes, the mediastinal and 
supraclavicular nodes.
N X The minimum requirements to assess 
the regional lymph nodes cannot be 
met.
NO No evidence o f involvement o f regional 
lymph nodes.
N1 Involvement o f a single homolateral re­
gional lymph node, which, if inguinal, 
is mobile.
N2 Involvement o f contralateral or bila­
teral or multiple regional lymph nodes, 
which, if inguinal, are mobile.
N3 A  palpable abdominal mass is present 
or there are fixed inguinal lymph nodes. 
N4 Involvement of juxtaregional lymph 
nodes.
Subsequent information regarding the his­
tologic assessment of the regional lymph 
nodes may be added to the clinical N category 
by means o f negative or positive signs, thus: 
N— for nodes with no microscopic evidence 
o f metastasis; or N-j- for nodes with micro­
scopic evidence of metastasis (e.g., N l—, N0-|-).
M =  Distant metastases
As the primary tumour advances or if clinic­
al suspicion warrants, skeletal or isotope 
studies should be done.
M X  The minimum requirements to assess 
the presence of distant metastases can­
not be met.
MO N o evidence of distant metastases.
M l Distant metastases present.
M ia  Evidence of occult metastases based 
on biochemical and/or other tests. 
M lb  Single metastasis in a single-organ 
site.
M lc  Multiple metastases in a single­
site.
M id  Metastases in multiple-organ sites.
Note: The location of metastases should be 
specified. The lymph nodes beyond the 
regional and juxtaregional notes —  and 
bone are regarded each as single-organ 
sites.
P =  Histopathologic categories
Assessment o f the P categories is based on 
evidence derived from surgical operation and 
histopathologic examination after orchiec­
tomy. The P categories correspond to the 
T  categories.
PO N o evidence of primary tumour.
PI Tumour limited to the body o f  the 
testis.
P2 Tumour extending beyond the tunica 
albuginea.
P3 Tumour involving the rete testis and/or 
epididymis.
P4 Tumour invading the spermatic cord 
and/or scrotal wall.
P4a Invasion of spermatic cord.
P4b Invasion of scrotal wall.
Stage grouping
N o stage grouping is at present recom­
mended.
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Rules for Classification
THE KIDNEY
1. The classification applies only to renal- 
cell carcinoma. Adenoma is excluded but 
such cases may be listed under the category 
GO.
2. There must be histologic and cytologic 
verification of the disease. Any unconfirmed 
cases must be reported separately.
3. The following are the minimum requi­
rements for assessment of the T, N and M 
categories:
• T categories: Clinical examination,
urography and arterio­
graphy prior to defini­
tive treatment.
• N categories: Clinical examination,
lymphography and uro­
graphy.
• M categories: Clinical examination,
chest radiography and 
biochemical testing. In 
patients with more ad­
vanced primary tumour 
or when clinical sus­
picion warrants, radio- 
graphic or radioisotope 
studies should be done.
If these requirements cannot be met the 
symbol TX, NX or MX will be used.
TNM  Classification 
T =  Primary tumour
In the absence of arteriography, the sym­
bol TX must be used.
TX The minimum requirements to as­
sess fully the extent of the primary 
tumour cannot be met.
TO No evidence of primary tumour.
T1 Evidence of a small tumour without 
enlargement of the kidney. There 
is limited calyceal distortion or de­
formity and circumscribed vascular 
deformities, surrounded by renal pa­
renchyma.
T2 Evidence of a large tumour with de­
formity and/or enlargement of the 
kidney or calyceal or pelvic invol­
vement. The continuity of the cor­
tex is preserved on arteriography.
T3 Evidence of spread into perinephric 
fat, peripelvic fat or hilar renal ves­
sels.
T4 Evidence of invasion into neigh­
bouring organs or abdominal wall.
N =  Regional and juxtaregional lymph 
nodes
The regional lymph nodes are the para­
aortic and paracaval nodes. The juxtare­
gional lymph nodes are the intrapelvic
and the mediastinal nodes.
NX The minimum requirements to as­
sess the regional lymph nodes can­
not be met.
NO No evidence of involvement of re­
gional lymph nodes.
N1 Involvement of a single homolateral 
regional lymph node.
N2 Involvement of contralateral or bi­
lateral or multiple regional lymph 
nodes.
N3 Fixed regional lymph nodes (as­
sessable only at surgical exploration).
N4 Involvement of juxtaregional lymph 
nodes.
Subsequent information regarding the his­
tologic assessment of the regional lymph 
nodes may be added to the clinical N cate­
gory by means of negative and positive signs, 
thus: N - for nodes with no microscopic 
evidence of metastasis; or N +  for nodes 
with microscopic evidence of metastasis 
(e.g., N1-, N0+).
M =  Distant metastases
MX The minimum requirements to assess 
the presence of distant metastases 
cannot be met.
MO No evidence of distant metastases.
>
* •
A
September 1975 THE CANADIAN JOURNAL OF SURGERY 475
The Kidney (continued)
M l Distant metastases present.
M ia Evidence of occult metastases 
based on biochemical or other 
tests, or both.
M lb Single metastasis in a single­
organ site.
M lc Multiple metastases in a single­
organ site.
M id Metastases in multiple-organ 
sites.
Note: The location of metastases should be 
specified. The lymph nodes beyond 
the regional and juxtaregional nodes 
are regarded as single-organ sites, as 
is bone.
P =  Histopathologic categories
Assessment of P categories is based on 
evidence derived from surgical operation and 
histopathologic examination—when tissue 
other than biopsy is available for examina­
tion.
PX Extent of invasion cannot be assessed.
PO No primary renal-cell tumour found 
on examination of specimen.
PI Tumour surrounded by renal paren­
chyma.
P2 Tumour extending to the capsule 
and/or invading the renal pelvis 
and/or calyces.
P3 Tumour extending beyond the cap­
sule into the perinephric fat or the 
peripelvic fat or the renal pedicle. 
P3a Extension to perinephric fat. 
P3b Extension to peripelvic fat.
P3c Extension to renal pedicle.
P4 Tumour invading neighbouring or­
gans or fixed to the abdominal wall, 
or both.
G =  Histopathologic grading
GX Grade cannot be assessed.
GO No evidence of anaplasia (i.e., ade­
noma).
G1 Low-grade malignancy.
G2 Medium-grade malignancy.
G3 High-grade malignancy.
V =  Invasion of veins
VX Extent of invasion cannot be as­
sessed.
VO Veins do not contain tumour.
VI Renal vein contains tumour.
V2 Vena cava contains tumour.
Stage grouping
No stage grouping is at present recom­
mended.
when shock 
threatens 
the lung
Abstract v isua liza tion  of lung tissue
• preserves 
lysosome and 
ceil membranes, 
thereby preventing 
the release of destruc­
tive lysosomal enzymes3
• preserves platelets 
thereby reducing the risk
of intravascular coagulation1
•  preserves leukocyte in­
tegrity thereby helping to main­
tain the pulmonary architecture1
solu-Medroi
helps reduce 
pulmonary 
damage 
and increase 
survival rates
The recovery of patients in shock 
is often complicated by a pattern of 
deteriorating pulmonary function. 
This pulmonary insufficiency pro­
gresses despite restoration of haemo­
dynamic balance and apparent stabili­
zation of the acute episode.
Under conditions of prolonged shock, 
lack of oxygen at the cellular level 
causes alterations in the oxygen-carbon 
dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately 
to interstitial oedema and perivascular 
haemorrhage.1 Polymorphonuclear leuko­
cytes aggregate in the pulmonary capillaries 
and obstruct the pulmonary vascular bed. 
As these trapped cells break down, they 
release lysosomes, tiny subcellular par­
ticles containing proteolytic enzymes.1 
These enzymes attack their host cell and 
go on to dafnage or destroy other cells.2 
The resulting tissue damage may not 
readily repair itself even if the shock 
patient survives.
P rescr ib ing  in fo rm ation  
on fo llo w in g  page
When administered in conjunction 
with standard therapeutic measures, 
Solu-Medrol exerts a protective 
effect on the lung and improves 
the patient’s chance 
of survival.
References:
1. W ilson. J.W. (1972). Surg 
Gynec. & Obstet., 734:675. 
2. Janotf. A. (1964). Shock, p, 93. 
3. DeDuve.C. (1964). Injury. 
Inflam m ation and Immunity, p. 283.
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In the treatment 
of shock and its 
pulmonary 
complications
solu-Medroi
soon enough, 
often enough, 
in pharmacologic 
doses
Dosage and Administration:
In treating severe shock, there is a tendency 
in current medical practice to use massive 
(pharmacologic) doses of corticosteroids. (The 
anti-inflammatory activity of 1 mg of Solu- 
Medrol is equal to 4 mg or more of hydrocor­
tisone.)
The suggested dosage of Solu-Medrol for se­
vere shock is 30 mg/kg stat and repeated in 
four hours, if necessary.
Therapy is initiated by administering Solu- 
Medrol intravenously over a period of at least 
ten minutes. In general, therapy should be con­
tinued only until the patient's condition has 
stabilized -  usually not beyond 48 to 72 hours. 
Solu-Medrol may be given by intravenous in­
jection, by intravenous infusion, or by intra­
muscular injection. The preferred method for 
initial emergency use is intravenous injection.
Cautions: The general precautions and con­
traindications to systemic corticosteroid ther­
apy should apply to the use of Solu-Medrol. 
However, when used for medical emergencies, 
or in shock-like states, the possible lifesaving 
effects must be weighed against the possible 
undesired hormonal effects. In the treatment 
of shock, Solu-Medrol should be adjunctive to 
conventional supportive therapy such as fluid 
replacement, etc. Although adverse effects 
associated with high-dose short-term corti- 
coid therapy are uncommon, peptic ulceration 
may occur.
Supplied: In Mix-O-Vials containing Medrol 
(as methylprednisolone sodium succinate), 40 
mg, 125 mg, 500 mg, and 1 g vials with water 
for injection.
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TESTING FOR COMPLETENESS OF 4
VAGOTOMY
O f tests designed to assess the completeness 
of vagotomy, the Hollander insulin hypogly­
cemia test is the most widely used, though it 
is o f no value during operation. A different 
approach is that o f T. R. Weber, T. A. Miller 
and S. M. Lindauer (J Surg Res 18: 491, 1975) 
who used a combination o f 2-deoxy-D-glucose 
(2DG) and neutral red (NR) both during and 
after operation.
A potent vagal stimulant, 2DG is thought 
to be associated with hypothalamic glucocyto- 
penia, which in turn stimulates the dorsal mo­
tor nucleus of the vagus. Vagotomy abolishes 
this response. Neutral red is secreted selective­
ly by the gastric parietal cells and, if NR is 
injected intravenously in the presence of vagal 
stimulation, the gastric juice turns pink, then 
purple. The appearance o f NR in the gastric 
juice is prevented by vagotomy.
Weber and his colleagues used the combin­
ation o f 2DG and NR diagnostically in 18 
patients, all o f whom also underwent Hollan­
der’s test. Tests were performed preoperative- 
ly, intraoperatively and postoperatively. 
Among six patients who had not undergone 
peptic ulcer surgery, the 2DG-NR test was 
positive preoperatively in all six as opposed to 
the Hollander test, which was positive in five; 
intraoperatively, there was no difference in 
these six patients between the two tests; and 
3 montns postoperatively the 2NG-NR test 
was positive in none o f four patients who un­
derwent vagotomy whereas the Hollander test 
was positive in one o f these four. A second 
group comprised 12 patknts with a possible 
recurrence o f ulcer after surgery. In these, 
the only difference was that in two patients 
preoperatively the 2DG-NR test was positive 
and the Hollander test was negative. These 
two patients were found to have intact vagus 
nerves and evidence o f recurrent ulceration. 
Among the other 10 in this group, both the 
2DG-NR and Hollander tests were negative 
in 7 (none of whom underwent a further oper­
ation) and were positive in 3, all o f whom 
were found to have recurrent ulceration.
The 2DG-NR test is useful as a postoper­
ative test in assessing the completeness of va­
gotomy, but its value as an intraoperative test 
needs further evaluation.
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SOLITARY EPIDIDYMAL SCHISTOSOMIASIS*
L. H. HONORE, MB, ChB, FRCP[C]t
Summary: A 54-year-old Canadian presented 
with a 1-month history of painless swelling in 
the right testis. The diagnosis was thought to be 
a sperm granuloma, a leiomyoma, or an adeno­
matoid tumour of the epididymis; histologic 
examination, however, revealed evidence of 
schistosomiasis, probably due to Schistosoma 
haematobium. Solitary schistosomiasis of the 
epididymis has been reported previously in only 
two cases. Epididymal schistosomiasis has ne­
ver been diagnosed preoperatively because it is 
so rare, but even if it were suspected preoper­
atively and confirmed by biopsy, chemotherapy 
alone would not prevent impairment of epididy­
mal function due to scarring. Surgical excision 
of the lesion, therefore, is recommended.
Resume: Nous avons observe, chez un Cana- 
dien de 54 ans, une tumefaction indolore du 
testicule droit, datant d'un mois. Au point de vue 
diagnostique, on pensa d'abord a un granulome 
seminal, a un leiomyome ou a une tumeur ade- 
nomatoide de Tepididyme, jusqu'a ce qu'un 
examen histologique eut revele qu'il s'agissait 
d'une schistosomiase probablement attribuable 
a Schistosoma haematobium. Jusqu'alors on 
n'avait signalee que deux cas de schistosomiase 
epididymaire isolee. Cette infestation n'a jamais 
ete diagnostiquee avant ('intervention en raison 
de sa rarete. Toutefois, meme si elle etait soup- 
gonnee avant I'operation et confirmee par biop- 
sie, la chimiotherapie seule ne pourrait empecher 
('alteration de la fonction epididymaire par des 
cicatrices. Nous conseillons done I'excision 
chirurgicale de la lesion.
Schistosomiasis is endemic in Africa and 
is hyperendemic in the Nile valley, where 
the incidence of infestation of the popula­
tion at large may attain 100% .1 In these 
areas, schistosomiasis of the epididymis is 
not rare, but it is usually associated with 
overt rectal or vesical disease. As the sole
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pital, and University of British Columbia, Van­
couver, BC.
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and G. U. COLEMAN, MD, FRCS[C]t
presenting manifestation of schistosomiasis, 
however, epididymal schistosomiasis is ex­
tremely rare, even in these areas of high 
infestation, and only two cases of solitary 
epididymal schistosomiasis have been re­
ported. The first case1 was that of a 10- 
year-old Sudanese boy who had an orchiec­
tomy for suspected orchioblastoma; path­
ologic examination revealed a normal testis 
with extensive granulomatous epididymitis 
due to Schistosoma haematobium. The 
second case2 concerned a 23-year-old Su­
danese who presented with a painless swell­
ing in the tail of the epididymis; the lesion 
was shown to be that of schistosomiasis, 
though it was impossible to differentiate the 
infestation histologically between that of 
S. haematobium and that of S. mansoni. In 
addition, schistosomiasis of the spermatic 
cord without epididymal involvement has 
been reported.3 The patient, a 50-year-old 
Ghanaian, presented with a bilateral, slowly 
enlarging, painless swelling in the scrotum 
and underwent a bilateral orchiectomy for 
presumptive seminoma; in this man severe 
schistosomiasis affected the cord, so that 
the veins were plugged and both testes be­
came infarcted.
In these cases, the diagnosis of schisto­
somiasis typically was not even suspected 
before operation, and was made only after 
the surgical specimen had been studied path­
ologically. The patients have all been Afri­
cans and, to our knowledge, there is no 
record of solitary epididymal schistosomia­
sis presenting as a painless scrotal mass in a 
Caucasian. We report such a case in order 
to draw attention to this rare lesion, which 
we believe will become more common in 
Canada as a result of world travel and im­
migration.
Case R eport
A 54-year-old minister, who had spent 17 
years in Africa with the Sudan Interior Mis­
sion, presented with a 1-month history of a 
painless swelling in the right testis. There were 
no other complaints and specifically none 
referable to the urinary or alimentary tracts, 
He had a history of recurrent urolithiasis and 
had passed a small stone about 3 months pre-
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viously. He looked fit. The only physical ab­
normality that was found was a slightly ir­
regular, firm, nontender nodule (dimensions, 
2 x 2  cm) in the globus major of the epididy­
mis, separable from the testis. Intravenous pye­
lography showed only a small calculus in the 
left kidney. Results of urinalysis, urine smears 
and urine cultures were negative. Examinations 
of the blood revealed no abnormalities except 
for a mild eosinophilia (absolute count, 438 to 
803 x 106/ /). The lesion was thought to be a 
sperm granuloma, a leiomyoma or an adeno­
matoid tumour of the epididymis; the globus 
major of the right epididymis was excised. The 
postoperative course was uneventful. Histo­
logically, the diagnosis was schistosomiasis; 
as a result, urine and stool specimens were 
examined, though no parasites were found, and 
a course of niridazole (Ambilhar, CIBA; 750 
mg bid for 7 days) was given.
H istopathologic F indings
Gross inspection showed diffuse fibrous 
thickening of the epididymis with tiny yel­
low spots, but no caseation necrosis was 
noted. The serosal membrane was smooth 
and devoid of tubercles. Microscopic ex­
amination revealed extensive granulomatous 
inflammation of the epididymal and parae- 
pididymal connective tissues. The epididy­
mal tubules and vasa efferentia were lar­
gely spared but a few tubules showed intra­
mural inflammation and focal ulceration 
due to rupture of a nearby granuloma into 
their walls (Fig. 1). Three types of tuber­
culoid granuloma were present. The first 
type was solid, with a central Langhans type 
of giant cell, palisading epithelioid cells and 
peripheral infiltration with lymphocytes, 
plasma cells and eosinophils. The second 
type contained one or two ova lying free 
among the epithelioid cells or within the 
cytoplasm of a foreign-body giant cell (Fig. 
2). The third type, made up of single or a 
few coalescent units, was characterized by 
central eosinophilic necrosis with entrap-
Fig. 1.—Inflammation in wall of epididymal tubule with focal ulceration (hematoxylin and eosii 
x 210).
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Fig. 2.—Interstitial tuberculoid granulomas with many schistosomal ova (arrow) (hematoxylin 
and eosin, x 210).
ment of degenerating ova (Fig. 3). These 
granulomas showed little fibrosis and no 
calcification; they were distributed widely 
throughout the epididymis, but tended to lie 
close to small blood vessels and lymphatic 
spaces. The small and medium-sized veins
Fig. 3.—Granulomas with central eosinophilic 
necrosis. Note rupture into nearby tubule (arrows) 
(hematoxylin and eosin, reduced by 37% from 
x 52).
showed no intraluminal deposition of ova 
or intramural inflammation. Granulomas, 
particularly the small compact units, were 
abundant in the paraepididymal tissues, es­
pecially around blood vessels and under­
neath the tunica vaginalis. The serosa itself 
was not involved. Many schistosomal ova 
were seen, with varying degrees of degenera­
tion. Some were well preserved with large 
numbers of conspicuous miracidia and a 
clear-cut refractile cell wall, while others 
showed a variable loss of detail and shrink­
age. A few ova bore sharp terminal spines 
consistent with the appearance of S. haema­
tobium (Fig. 4).
D iscussion
Pathologically, the diagnosis in this case 
was clearly schistosomiasis of the epididy­
mis, and the presence of terminal spines in 
many of the ova suggested that the organism 
was S. haematobium. The first reported case 
of epididymal schistosomiasis1 was also 
that of infestation with S. haematobium, 
which appears to be the only form that can 
mature outside the portal system and cause 
disease, as in the conjunctiva4 and the 
larynx.5
482 THE CANADIAN JOURNAL OF SURGERY Vol. 18
Schistosomal infestation is considered to 
evolve through three stages:1’ (a) skin pene­
tration by the larvae with or without local 
symptoms and signs; (b) deposition of ova 
in veins, mostly in the portal and vesical 
venous systems with intestinal or urinary 
symptoms; and (c) progressive irreversible 
damage to organs as a result of venous oc­
clusion. During the phase of parasitemia the 
ova can be seen in every organ, though 
rarely in the testis, epididymis and sperma­
tic cord.7 This relative sparing of these 
areas was noted by Alves, Woods and Gel- 
fand,8 who also noted that, in contrast, the 
seminal vesicles, prostate and terminal vas 
deferens are common sites of egg deposi­
tion. Whatever the cause of this differential 
distribution in the male genital tract, it 
probably underlies the rare involvement of 
the upper part of the tract. Why the epididy­
mis should on occasion be selectively in­
volved as in the present case is not clear, 
especially when there is no subjective or ob­
jective evidence of involvement of bowel 
or bladder. In fact, as in the two previous 
cases1' -  and in the present case, the ab­
sence of ova in urine and stool appears to 
be a distinct feature of solitary epididymal 
schistosomiasis. In sharp contrast, Honey 
and Gelfand'-1 noted that hard painless 
swellings can be felt in the testes, epididy-
Fig. 4.—Ovum with miracidia and terminal spine 
(hematoxylin and eosin, reduced by 34% from 
x 890).
mes and spermatic cords of patients ex­
creting ova in the urine, though biopsy of 
these organs fails to show any deposition 
of ova.
Our pathologic material does not allow us 
to draw any conclusion as to the peculiar 
vulnerability of the epididymis in this pa­
tient. The spread clearly was not ductal; 
most likely it was vascular. Though no large 
vein was seen containing intraluminal ova, 
the venular basis of the lesion is suggested 
by the predominantly interstitial inflamma­
tion and the abundance of granulomas in 
para-arterial locations in the epididymal in- 
terstitium and in the highly vascular tissues 
underlying the tunica vaginalis.
Though the diagnosis is easily made 
pathologically, the clinical diagnosis is reg­
ularly missed because of the general un­
awareness of this condition in western coun­
tries. The clinical forms of epididymal schis­
tosomiasis have recently been summarized 
by Boulos and Karim,2 as follows:
1. The granular or miliary form, in which 
hard tubercles are scattered along the sper­
matic cord, epididymis and their coverings.
2. The solitary form, commonly seen in 
the globus major and not uncommonly as­
sociated with nodules scattered along the 
cord— the “bilharzial rosary”. (These nodu­
les were absent in the present case.)
3. The massive form, with extensive in­
filtration of the spermatic cord in part or in 
all of its intrascrotal course, spreading down 
to the epididymis and testis, covering and 
matting them together. The spermatic fascia 
and cremasteric muscle may be affected and 
all structures are plastered together into one 
irregular solid mass.
Because of the rarity of this condition, 
no critical evaluation of therapy is available. 
In all the cases reported, treatment has been 
surgical excision, because the lesion was 
never recognized preoperatively. Theore­
tically, if the lesion was suspected before or 
at exploration, a diagnostic biopsy could 
precede any decision on whether to operate 
or to prescribe chemotherapeutic agents. 
Many objections can be raised against this 
basically rational approach. First, a sample 
biopsy, whether examined by means of a 
frozen section or by multiple routine sec­
tions, may fail to show the telltale ova, and 
the presence of tuberculoid granulomas may
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lead to an erroneous pathological diagnosis of 
tuberculosis and subsequent inappropriate 
therapy. Second, in the absence of any pre­
vious experience with biopsy, one cannot ex­
clude a serious potential complication— for 
example, spread of the infection into the 
nearby tissues with aggravation of local di­
sease. Third, even if the correct diagnosis 
were made by biopsy, it is doubtful whether 
chemotherapy alone should be the treat­
ment of choice. In all the cases so far re­
ported, the epididymis has been severely 
affected, and chemotherapy, even if this 
was parasitocidal (which is by no means cer­
tain), could be expected to cause scarring 
and severe impairment of epididymal func­
tion. For these reasons we believe that, ir­
respective of whether or not the diagnosis is 
suspected preoperatively, the treatment of 
choice should be surgical excision with anti- 
parasitic drug coverage.
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HEMORRHOIDS, VARICOSE VEINS AND DEEP VEIN THROMBOSIS: 
EPIDEMIOLOGIC FEATURES AND SUGGESTED 
CAUSATIVE FACTORS*
DENIS P. BURKITT, MD, FRS, FRCS(Edin)
Summary: Three venous disorders— hemor­
rhoids. varicose veins and deep vein thrombo­
sis— are common in Western societies, but 
are relatively rare in other societies. Impres­
sions gained by the author from 20 years of 
surgical experience in Africa and answers to 
questionnaires sent to more than 100 hospitals 
in 20 African countries have led to formation 
of an etiopathogenetic hypothesis for these 
three disorders. Hemorrhoids and varicose veins 
may well be related to the occurrence of consti­
pation, which, in turn, is related to a deficiency 
of fibre in Western diets. Deep venous throm­
bosis may be related to both valvular incom­
petence and an alteration in blood coagulability; 
the latter is related to alterations in the intes­
tinal concentration of vitamin K. It is therefore 
possible that the occurrence of these three con-
*Presented at surgical grand rounds, Royal Vic­
toria Hospital, Montreal, Que., Feb. 6, 1975.
Reprint requests to: Dr. D. P. Burkitt, Medical 
Research Council, External staff, 172 Tottenham 
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ditions might be prevented by adding cereal fi­
bre to Western diets.
Resume: On sait que trois troubles veineux, les 
hemorroides, les veines variqueuses et la 
thrombose des veines profondes, sont chose 
courante dans les societes du monde occidental, 
mais relativement rare dans d'autres popula­
tions. Apres 20 annees d'experience chirurgi- 
cale en Afrique et avoir cotlige les reponses aux 
questionnaires qu'il a envoyes a plus de 100 
hopitaux dans 20 pays Africains. I'auteur a for- 
mule une hypothese etiopathogenique suscep­
tible d'expliquer ces trois pathologies. Les he­
morroides et les varices peuvent fort bien 
avoir un rapport avec la constipation qui, a son 
tour, peut relever d'une insuffisance d’aliments 
fibreux dans les regimes de nos societes. La 
thrombose des veines profondes peut etre cau- 
see a la fois par une incompetence vahzulaire et 
une alteration de la coagulabilite, cette derniere 
etant due a des alterations de la concentration 
intestinale de la vitamine K. II devrait done etre 
possible de prevenir ces trois pathologies en 
ajoutant des aliments fibreux aux regimes ali- 
mentaires du monde occidental.
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Hemorrhoids are among the commonest of 
the diseases of Western man, varicose veins 
affect nearly one in five North American 
adults and deep vein thrombosis (DVT) is 
one of the commonest of all postoperative 
complications.
These three venous disorders are consi­
dered together because they have closely 
similar epidemiologic features. The same 
factor is postulated as a cause of the first 
two and a closely related factor as a cause 
of the third.
The understanding of these problems has 
been hampered by the assumption of West­
ern medical authors, too often held, that 
diseases common in their experience must 
also be common elsewhere. This erroneous 
approach has regrettably preserved hypo­
theses that are untenable in the light of epi­
demiologic evidence.
My convictions are based on 20 years of 
surgical experience in Africa, where I 
worked mainly in a large teaching hospital 
but had surgical responsibilities that entailed 
regular visits to nearly every hospital in 
Uganda. Subsequent research interests led 
me to visit over 100 hospitals in some 20 
different African countries, and to make 
several prolonged tours visiting hospitals in 
the Indian subcontinent. Impressions thus 
gained have been reinforced by replies to 
questionnaires sent monthly to more than 
160 hospitals in Africa and Asia asking for 
the number of patients seen with any of 
these three diseases. The information de­
rived from these questionnaires forms the 
basis of this communication.
G eographic D istribution
The prominence of these three diseases in 
the Western world contrasts with their re­
lative rarity within rural communities in de­
veloping countries. This rarity has been 
largely hidden from Western medicine be­
cause physicians tend to report what is 
common in their experience rather than 
what is rare.
The prevalence of these three venous 
disorders is highest in affluent countries in 
the Western world, lowest among peoples 
living traditionally in developing countries 
and intermediate in countries with stand­
ards between these extremes.
All these conditions have a similar
prevalence in black and white Americans.
Hemorrhoids
In this communication hemorrhoids will 
be considered as dilatations of the veins in 
the superior hemorrhoidal plexus; the 
present definition does not include such con­
ditions as perianal hematomas and mucosal 
prolapse, which are often included loosely 
in a broader term.
A diagnosis of hemorrhoids has only been 
accepted if there was some prolapse or 
bleeding lest almost any perianal condition 
be included.
Monthly returns from 77, mainly rural, 
hospitals in Africa indicate that, for each 
hospital, less than three patients with bleed­
ing or prolapsed hemorrhoids are diagnosed 
annually.
Hemorrhoids appear to be considerably 
more prevalent in India than in Africa.
Varicose Veins
Africans rarely suffer from varicose 
veins. Physicians specifically searching for 
the condition usually estimate the rate to 
be less than 1 %, sometimes much less than 
this. Many with over 20 years’ experience 
have reported that they see barely one pa­
tient annually,1'3 though a few have re­
ported much higher prevalences.4
Replies to questionnaires received from 
more than 140 hospitals in Africa reveal 
that more than 50% of them estimated an 
annual incidence of less than five cases. In 
only 10 hospitals were more than 20 cases 
reported, and in 21 not even 1 case a year 
was noted.
Varicose ulceration is almost unknown in 
Africa. I saw no case in 20 years in a 600- 
bed teaching hospital. Only 4 of 60 doctors 
in different hospitals in Africa who replied 
to a questionnaire had ever seen a case.
Deep Vein Thrombosis
The frequency of DVT appears to be 
similar to that of varicose veins. Monthly 
reports from 47 African hospitals show that 
fewer than one case is diagnosed clinically 
per hospital per year. This rarity has been 
confirmed by autopsy findings5 and also by 
the paucity of clinical or radiologic evidence 
of its dreaded sequel, pulmonary embolism.
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The diagnosis of DVT has inevitably rested 
on clinical grounds. Admittedly it has been 
suggested that in 50% of cases diagnosed 
clinically no thrombosis exists, but on the 
other hand the diagnosis is not made clinic­
ally in 50% of patients with thrombosis. 
This possible error in overdiagnosis or un­
derdiagnosis suggests that prevalence estim­
ates made on clinical findings by those alert 
for the condition may not be too inaccurate.
In communities in which DVT is rare, 
pulmonary embolism is exceedingly rare, 
and this complication is unlikely to be con­
sistently missed.
T he E f f e c t  on Prev a len ce  of
Westernization
The prevalence of each of the three di­
seases increased in non-western countries 
after contact with Western culture. Though 
still rare among traditionally living commu­
nities, their incidence is increasing among 
the more highly educated and in urban 
communities. Hemorrhoids almost invaria­
bly become more common preceding the 
development of varicose veins. I. A. M. 
Prior (personal communication, 1975) has 
demonstrated the steady increase in the pre­
valence of the latter, from that in Polynesian 
peasants, who are little affected, through the 
prevalence in Polynesians living in urban 
communities to that of New Zealand 
Maoris, in whom the prevalence of varicose 
veins exceeds even that of their white com­
patriots. The changing prevalence related 
not to genetic factors but to manner of life. 
Similar observations have been made in 
Africa and India.
The incidence of DVT appears to in­
crease at about the same time as that of 
varicose veins increases.
R elated  D isea ses  and Physiologic
Ph enom ena
Not only do patterns of geographic dis­
tribution throw light on the etiology of di­
sease but so also do observed relations be­
tween diseases. The three venous disorders 
considered are related epidemiologically to 
such bowel diseases as diverticulosis, ap­
pendicitis and cancer, and to such appa­
rently unrelated conditions as hiatus hernia, 
gallstones, and ischemic heart disease. Di­
verticular disease never occurs in a commu­
nity until several decades after varicose 
veins have become relatively common. 
Moreover, patients with demonstrable colon 
diverticula are more than twice as likely as 
expected to have varicose veins also.6 These 
observations suggest a shared causative fac­
tor.
A high prevalence of each of these three 
diseases is generally associated with pro­
longed intestinal transit times and the pas­
sage of small firm stools, whereas the re­
verse is true for communities with low pre­
valences. Moreover, the amount of fibre 
eaten is related directly to stool bulk and 
softness, and indirectly related to intestinal 
transit time.7
C onventional Co n c epts  of C ausation
in th e  L ight of E pidem io lo gic
E vidence
Hemorrhoids
Incrimination of anatomic features such as 
the absence of valves in the portal venous 
system and the manner of emergence of 
venules through the wall of the anal canal 
must be discounted. There is no evidence of 
anatomic differences between areas of high 
and low prevalance.
The same applies to the blaming of any 
other factors not related to geographic distri­
bution.
Varicose Veins
The widely held hypothesis that man’s 
erect posture is a fundamental cause of vari­
cose veins is quite untenable in the light of 
its geographic distribution. Gravity, however, 
may contribute after valve failure.
Nor can heredity be considered a primary 
cause in view of the epidemiologic features. 
No longer can constrictive clothing be 
blamed, and certainly not pregnancy— a 
normal physiologic process that is most 
common in communities among whom vari­
cose veins are rare. Reports from India and 
parts of Africa suggest that the occurrence 
of varicose veins is higher in men than in 
women.
Deep Vein Thrombosis
It is generally assumed that DVT is the 
result primarily of the circumstances of hos­
pitalization, and in particular of surgery and 
of obstetric delivery. This attitude takes no
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account of the fact that similar surgical 
operations and obstetric deliveries using the 
same techniques and anesthetic methods are 
associated to a much smaller degree with 
DVT in developing countries than they are 
in the Western world.
The contrast between the prevalence of 
DVT in developing countries and in the af­
fluent West is well illustrated by the fre­
quency of 1.7 per 10 000 deliveries in 
Thailand compared with 134.7 per 10 000 
deliveries in the United States.8
A n  A l t e r n a t iv e  H y p o t h e sis
Cleave0’ 10 was the first to relate all 
these venous disorders to constipation, al­
though he postulated mechanisms different 
from those suggested herein.
These venous disorders, together with the 
associated diseases already listed, have all 
been related to the fibre-depleted diets char­
acteristic of modem Western civiliza­
tion.10"13 Fibre-depleted diets are the fun­
damental cause of constipation.7' 14 Consti­
pation results in both the increased pres­
sures within the bowel that are believed to 
cause diverticular disease15, 16 and appen­
dicitis17 and the increased intra-abdominal 
pressures that occur with straining during 
evacuation of firm feces. These increased 
pressures tend to force the gastroesophageal 
junction upwards into the thoracic cavity, 
and with, it has been postulated, the de­
velopment of hiatus hernia.18 These pres­
sures are also believed to be an important 
cause of both hemorrhoids and varicose 
veins.
A different but related cause will be 
postulated with respect to DVT.
Hemorrhoids
The superior hemorrhoidal plexus drains 
into the superior hemorrhoidal veins. All 
forms of abdominal straining force blood 
retrogradely down these veins, thus increas­
ing the pressures within the veins of the su­
perior hemorrhoidal plexus. In all ab­
dominal straining, with the single exception 
of that required for evacuating hard stools, 
these raised intravascular pressures are com­
pensated for by extravascular pressures sup­
plied by reflex contraction of the anal 
sphincters (Fig. 1). It is only during de­
fecation that raised intravascular pressures
Fig. 1. —External pressure from contraction of 
anal sphincters counteracting increased pressure 
within the superior hemorrhoidal venous plexus. 
(Reproduced by permission from Burkitt DP: 
Dietary fibre and pressure diseases. J R Coll Phys 
Lond 9: 138, 1975.)
Fig. 2.—Relaxation of anal sphincters, during 
defecation, leaving raised intravenous pressures 
unopposed with resultant dilatation of veins. (Re­
produced by permission from Burkitt DP: Diet­
ary fibre and pressure diseases. J R Coll Phys Lond  
9: 138, 1975.)
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are unopposed by pressures from without. 
During defecation the anal sphincters relax 
(Fig. 2). Oft-repeated, increased and un­
opposed intravenous pressures are believed 
to be the underlying cause of hemorrhoids. 
Tenesmus, even with an empty rectum, has 
the same effect.19
Varicose Veins
Increased intra-abdominal pressures are 
readily transmitted through incompetent 
saphenous valves, as is demonstrated by the 
standard cough-impulse test for valve com­
petence. It must therefore be assumed that 
such pressures, which can well exceed 200 
mm Hg, must be sustained by these valves 
so long as they remain competent (Fig. 3). 
It is reasonable to suppose that oft-repeated 
pressures exerted in all directions in a liquid 
medium might lead to dilatation of the 
veins and that the increased circumference 
would become too great for the valve cusps 
to occlude. And more than 25 years ago it 
was shown that varicose veins were un­
accompanied by any pathologic changes in 
the valves, and that instead they were as­
sociated with stretching of the circumference 
so that there was a gap between the attach­
ments of the valve cusps (Fig. 4).20
An additional causative factor is possibly 
the adoption of raised toilets. In the tradi­
tional squatting position, leg veins are, by 
means of pressures between the abdomen 
and thighs, protected from the effects of in­
creased intra-abdominal pressure. A raised 
toilet seat exposes the valves to these pres­
sures by minimizing flexion of the thighs.
VEIN
VALVE
Fig. 3.—Competent venous valves sustaining transmitted abdominal pressure (>  200 mm Hg).
These factors may not account for the 
development of all varicose veins but they 
are believed to be important in the majority.
Deep Vein Thrombosis
At least two factors are believed to be 
important in the pathogenesis of DVT. It 
seems reasonable to assume that, if the su­
perficial and perforating veins undergo 
changes, including dilatation in the presence 
of valvular incompetence, the deep veins 
may also be affected.21 If so, retarded 
venous circulation during enforced recum­
bency could predispose to thrombosis.
A more important factor is likely to be a 
change in blood coagulability. The pre­
valance of DVT is maximal in communities 
whose residents have retarded intestinal 
transit and small stool volume, and minimal 
when the reverse obtains.
In clinical estimation, the prevalence of 
DVT and resultant pulmonary embolism 
can apparently be appreciably reduced if the 
fibre intake of surgical patients before and 
after operation is increased (C. Latto, per­
sonal communication, 1975; N. J. Black- 
lock, personal communication, 1975). The 
following possible mechanism is postulated 
and is being investigated.
Stools of persons living in western coun­
tries, where the incidence of DVT is maxi­
mal, contain a relative preponderance of 
anaerobic rather than aerobic organisms, in 
comparison with stools from developing
STRETCHING 
OF WALLS
SEPARATION 
OF CUSPS
Fig. 4.—Dilated veins with incompetent valves transmitting raised intra-abdominal pressures.
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countries where DVT is minimal. Anaerobic 
organisms have been implicated in the pro­
duction of vitamin K, and in fact hemor­
rhagic states resulting from excessive doses 
of antibiotics have been treated by the ad­
ministration of vitamin K. Vitamin K, in 
turn, is essential for the synthesis of ac­
tivated factor X, which is required in the 
conversion of prothrombin to thrombin. 
Therefore the abnormal intestinal behaviour 
associated with Western civilization may in­
deed alter clotting factors.
Moreover, removal of all fibre from the 
diet can radically alter patterns of intestinal 
bacteria within a few days.22
It is not known whether the demonstrated 
difference between the types of fecal bac­
teria in Western and developing countries 
is due to increased fat or diminished fibre 
intake, or to some other dietary changes. 
It has, however, been suggested (I. Mc­
Donald, personal communication, 1975) 
that prolonged transit favours the develop­
ment of anaerobes, and that hardness of 
feces, which ensures that the centre of a 
mass does not become exposed to the sur­
face, has a similar effect.
Cleave9’ 10 postulated that hemorrhoids 
resulted from the direct pressure of hard 
fecal masses on the hemorrhoidal veins, with 
consequent obstruction of venous return, 
and that varicose veins and DVT were re­
lated to obstruction of venous return from 
the lower limbs caused by pressures on the 
common iliac veins by a loaded cecum or 
pelvic colon.
Po ssibilit y  of Prevention
If these various hypotheses can be con­
firmed, all these three common disorders 
could be partially eliminated by restoring 
sufficient fibre to our diet and thus prevent­
ing constipation. Available knowledge sug­
gests that the restoration of cereal fibre is 
the simplest and least costly. Cereal fibre 
can be restored to the diet by replacing 
white by wholemeal bread, or adding about 
30 g (1 oz) of millers’ bran to our food daily, 
or by doing both.
This is highly effective in the treatment 
not only of constipation and diverticular di­
sease but also of first-degree hemorrhoids; 
and clinical evidence has shown that it may 
also reduce the prevalence of DVT.
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UNUSUAL CASE OF MASSIVE GASTROINTESTINAL BLEEDING — 
PSEUDOANEURYSM OF THE HEAD OF THE PANCREAS
J. K. PRASAD, MB, BS, FRCS,* K. S. CHATTERJEE, MB, BS, FRCS(Edin)* and 
D. W. B. JOHNSTON, MD, FRCS[C], FACSt
Summary: Massive and repeated gastrointestinal 
bleeding with hemobilia arising from pseudo­
aneurysm of the pancreas occurred in a 58-year- 
man. The usual surgical methods of treatment 
were not practical because of peripancreatitis 
and difficulties in exposure. Catheterization of 
the gastroduodenal artery facilitated making the 
diagnosis of the pseudoaneurysm, but the ac­
companying necrosis of the duodenum and the 
proximal jejunum contraindicated the usual 
methods of embolization; instead, hemorrhage 
from the feeding vessel was stopped by trans- 
arterial electrocoagulation.
Resume: Chez un homme de 58 ans, est surve- 
nue une hemorragie massive et recidivante ac- 
compagnee d'hemobilie, provenant d'un pseudo- 
anevrysme du pancreas. Les techniques opera- 
toires habituelles n'etaient pas pratiques, par 
suite d'une peripancreatite et de difficultes 
d'acces du champ. Le sondage de I'artere gas- 
tro-intestinale avait facilite le diagnostic de 
pseudo-anevrysme. Malheureusement, la ne­
crose concomitante du duodenum et du jejunum 
proximale constituait une contre-indication aux 
modes habituels d'embolisation. Nous avons 
done, a la place, enraye I'hemorragie par elec­
trocoagulation transarterielle du vaisseau nour- 
ricier.
B ecause  gastrointestinal bleeding second­
ary to pancreatitis is relatively rare, pan­
creatitis is not often considered in the dif­
ferential diagnosis of massive gastrointestinal 
bleeding. In an analysis of 1500 cases of 
gastrointestinal bleeding Palm er1 observed 
only one case that originated from the pan­
creas. Wolstenholme2 reported three cases 
of major gastrointestinal hemorrhage as­
sociated with pancreatic pseudocyst treated 
successfully in intracystic suture-ligation 
of the feeding vessel together with cysto- 
gastrostomy; one case was treated with pan­
creaticoduodenectomy. Spanos, Kloppedal
*Resident surgeon, Westminster Hospital, Lon­
don, Ont.
tChief of service - surgery, Westminster Hos­
pital, and clinical professor in surgery, Univer­
sity of Western Ontario, London, Ont.
Reprint requests to: Dr. D. W. B. Johnston, 
Chief of service - surgery, Westminster Hospital, 
PO Box 5701, London, Ont. N6A 4S2.
and M urray8 reported two cases of aneu­
rysm of the gastroduodenal artery treated 
successfully by operation, one by ligation 
and one by excision.
We report a case of massive gastrointes­
tinal bleeding from a pseudoaneurysm of the 
head of the pancreas, with successful treat­
ment by selective, closed electrocoagulation 
of the feeding artery.
Case R eport
A 58-year-old man with a 12-year history 
of pancreatitis was admitted to hospital with 
complaints of upper abdominal pain, weak­
ness and fatigue. He gave a history of tarry 
stools for 2 months. He was pale and ema­
ciated, the epigastrium was tender and the 
liver was enlarged (liver edge, 2 finger-breadths 
below the costal margin). The hemoglobin 
concentration was 3 g/dl and the hematocrit 
was 11%; occult blood was detected in stool 
samples. Barium and endoscopic examinations 
of both the upper and lower gastrointestinal 
tract were negative.
Laparotomy 6 weeks after admission did 
not reveal the source of bleeding, but a hard 
mass was felt in the head of the pancreas. Fur­
ther endoscopic examinations were negative. 
An arteriogram 1 month after laparotomy 
(Fig. 1) indicated that the source of the bleed-
Fig. 1.—Arteriogram showing collection of con­
trast medium in pseudoaneurysm of pancreas 
(arrow).
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ing was either a duodenal ulcer or a pseudo­
aneurysm of the head of the pancreas.
A massive gastrointestinal hemorrhage 3 
months after admission necessitated a second 
laparotomy. An extensive gastroduodenotomy 
revealed no evidence of duodenal or gastric 
ulceration, but blood mixed with bile was ob­
served to be coming from the duodenal papil­
la. A Whipple’s operation was started but the 
operation had to be abandoned because the 
portal vein was surrounded by acutely in­
flamed tissue and extensive fibrosis.
The postoperative course was complicated 
by peritonitis. A third laparotomy was per­
formed. Gangrene and sloughing of the an­
terior duodenal wall were observed; these were 
not associated with the duodenotomy incision, 
which had healed well. The duodenum was 
necrotic and gangrenous; two Foley catheters 
were inserted into the second part of the 
duodenum with suction drainage. Necrosis of 
the proximal jejunum also required resection. 
Hyperalimentation was instituted. Recovery 
from the operation was satisfactory, but pro­
fuse bleeding recurred; he required a total of 
64 units of blood.
Arteriography, repeated with the intention 
of occluding the pseudoaneurysm with Gel- 
foam emboli, showed that the pseudoaneurysm 
had doubled in size since the first arteriogram 
(Fig. 2). A direct branch of the gastroduodenal 
artery was identified as feeding the pseudo­
aneurysm, but this arterial branch could not
Fig. 2 •—Second arteriogram. Note increased size 
of pseudoaneurysm, before electrocoagulation.
be entered selectively because of the acute 
angle it made with the gastroduodenal artery. 
It was realized that Gelfoam embolization of 
the gastroduodenal artery might cause duo­
denal ischemia, and this, in view of the pre­
vious gangrene of the duodenum, was consi­
dered too hazardous. Instead, a guide wire 
(diameter, 0.95 mm) with a J-shaped tip was 
advanced through the catheter in the gastro­
duodenal artery, and the tip of the catheter 
was positioned in the artery leading to the 
pseudoaneurysm.* A clinical electrocoagula­
tion unit (Valley-Lab SSE2-K, Boulder, CO 
60301, USAf) (setting, 7) was used for 2.5 
seconds. The guide wire was withdrawn. In­
jection of contrast medium demonstrated com­
plete occlusion of the artery leading to the 
aneurysm (Fig. 3).
Since this procedure there has been no 
bleeding into the gastrointestinal tract. Length 
of follow-up is presently 40 weeks.
D iscussion
A pseudoaneurysm of the pancreas is 
probably formed by digestive erosion of an 
artery close to the pancreas (e.g., splenic, 
gastroduodenal, or pancreaticoduodenal) by 
the enzyme activity of the contents of a
*Dr. R. E. Gold, department of radiology, Uni­
versity Hospital, London, Ont. performed this 
procedure.
tCanadian distributor: Sterisystems Ltd., 47
Baywood Rd., Rexdale, Ont. M9V 3Y9.
Fig. 3.—Third arteriogram. Note decreased size 
of pseudoaneurysm, after electrocoagulation.
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Trasylol® was shown to reduce mortality in acute pancreatitis to a significant 
extent:
Placebo................................................  25.0% Mortality
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“ Because the number of deaths were reduced, the spectrum of the disease 
as a whole was altered.” *
Trapnell’s recent double-blind clinical trial 
involving 105 patients confirmed the 
effectiveness of Trasylol in acute 
pancreatitis. In addition to reducing 
mortality and altering the spectrum of the 
disease, Trasylol largely abolished the usual 
effect of increasing age in this condition. 
Trasylol should be given concurrently with 
usual measures for the treatment of 
pancreatitis, such as pain relief, 
fasting, gastric suction, etc. “ It 
(Trasylol) can therefore now be 
regarded as a drug which is both 
effective and beneficial in the 
treatment of acute pancreatitis.” *
*Trapnell, J.E. et al, British 
J. Surg., March 1974.
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pseudocyst. The wall of the pseudoaneurysm 
is subjected to arterial pressure and may 
either perforate into an adjacent segment of 
the gastrointestinal tract or, as in this case, 
into the pancreatic ductal system, leading to 
a severe hemorrhage.
Bleeding into the upper gastrointestinal 
tract can also result from gastric mucosal 
erosion during acute pancreatitis, but in 
such cases conservative treatment with blood 
transfusion is usually successful, and endos­
copy confirms the pathologic basis of the 
lesion.
The introduction of selective angiography 
of the celiac and superior mesenteric ar­
teries has been a major advance in the diag­
nosis and treatment of pseudoaneurysm of 
the pancreas. Not only is the diagnosis con­
firmed but also the feeding vessel is iden­
tified. Once the diagnosis has been made, 
treatment has generally been either a pan­
creaticoduodenectomy for a lesion in the 
head of the pancreas, or intracystic ligation 
of the feeding vessel, combined with cysto- 
gastrostomy or cystoduodenostomy. How­
ever, Greenstein, DeMaio and Nabseth4 
successfully treated a case by wiring the 
cystic cavity to induce thrombosis, and 
transcatheter occlusion of the feeding vessel 
with Gelfoam or clotted blood has also been 
successful. In the present case transarterial 
electrocoagulation of the artery leading to 
the pseudoaneurysm provided the selectivity 
of the vascular occlusion that was required.
We thank Dr. R. E. Gold of the department of 
radiology, University Hospital, London, Ont., 
for performing the diagnostic arteriography and 
the therapeutic electrocoagulation.
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BOOK REVIEWS
THE CERVICAL SPINE. Robert Wayne Bai­
ley. 263 pp. Must. Lea & Febiger, Philadel­
phia; The Macmillan Company of Canada 
Limited, Toronto, 1974. $21.75.
This book contains a remarkable amount of 
valuable information. It begins with coherent 
accounts of basic embryology and anatomy, 
and excellent reviews of neuroanatomy and 
neurologic diagnoses. The chapter on conge­
nital anomalies by Poznanski particularly is 
detailed and informative.
The anterior approach to the spine, which 
Bailey helped to pioneer, is graphically il­
lustrated in detail.
An interesting suggestion is made that at 
least some flexion deformities due to anky­
losing spondylitis can be treated by skull trac­
tion followed by fusion, rather than by osteo­
tomy as has been popularized by Urist and 
Simmons.
In the chapter on neurologic aspects of 
spinal injuries by Kahn one could question the 
advisability of laminectomy. In most instances, 
it seems that anterior decompression and 
stabilization is a more logical approach.
In summary, there is little extraneous ma­
terial in this book which, as the author points 
out, is the first of its kind devoted entirely to 
the cervical spine, and as such is a most valu­
able source of information.
G. W. D. Armstrong
Department of surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
FLUID, ELECTROLYTE AND NUTRIENT 
THERAPY IN SURGERY. Edward E. Ma­
son. 352 pp. Must. Lea & Febiger, Phila­
delphia; The Macmillan Company of Can­
ada Limited, Toronto, 1974. $13.50.
This book covers a wider area than the title 
suggests. The opening chapters outline clearly 
the subjects of water balance, extracellular 
solute, carbon dioxide, and nonrespiratory de­
fence of neutrality, with problems encountered 
in surgery. The author uses simple tests and 
clinical observations for abnormalities of 
volume, concentration and chemical composi­
tion. The chapter on water balance in parti­
cular is comprehensive yet succinct.
The ensuing chapters reflect the interests 
and works of the author. A valuable chapter, 
packed with important facts concisely but 
comprehensively, covers basic nutrition, and 
then intravenous hyperalimentation. Next fol­
lows a clear review of the various bypass op­
erations used to treat extreme obesity. Among 
these, the gastric bypass, developed and used 
by the author is, in his opinion, the procedure 
of choice; and with respect to the intestinal 
bypass, Mason emphasizes too strongly fluid 
and electrolyte problems, which are actually
not a general occurrence, with the procedure 
of Scott. Ileal bypass for hyperlipidemia is dis­
cussed, with an excellent presentation on the 
control of hyperlipidemia.
The chapters on circulation and shock and 
on acute renal failure are brief, fairly com­
prehensive, and up-to-date. A superb section 
on calcium and phosphorus metabolism comes 
next; it is packed with facts relevant to the 
surgeon. The book ends with a chapter on 
fluid resuscitation in the burned patient, by 
one of the author’s colleagues, C. E. Hartford; 
it is an excellent summary of fluid replace­
ment, covering all electrolyte changes includ­
ing those resulting from topical treatment.
The bibliographies are pertinent and up-to- 
date. The book serves as a useful, concise and 
stimulating review of current electrolyte 
therapy and physiology in surgery.
M. Deitel
Department of surgery,
St. Joseph’s Hospital,
Toronto, Ont.
INSTRUCTIONAL COURSE LECTURES.
Volume XXIII 1974. The American Acade­
my of Orthopaedic Surgeons. 274 pp. Must.
The C. V. Mosby Company, St. Louis, 1974.
$25.75.
The “Instructional Course Lectures” are well 
known to orthopedic residents and surgeons. 
This volume contains, as the editors have 
pointed out in their preface, a great deal of 
variety from the point of view of subject ma­
terial and much that is of contemporary im­
portance with regard to total joint replace­
ment of the hip and knee.
Now that total replacements of the hip and 
knee are standard operative procedures for 
many orthopedic surgeons, it is becoming ob­
vious that complications, some of which have 
been unpredictable, must be recognized and 
managed. There is much overlap in the large 
number of articles presented by surgeons from 
the United States who have been performing 
joint replacements since the concept was in­
troduced in that country. However, this is not 
necessarily a fault at a time when the scope 
and concept of joint arthroplasty are expanding 
at an extremely rapid rate.
The series of articles on the role of the or­
thopedist in the management of juvenile rheu­
matoid arthritis attempts to be comprehensive 
and is reasonably successful in achieving this 
goal. An article by Fuller and Duthie on the 
timed appearance of some congenital mal­
formations in orthopedic abnormalities is 
unique. White and his collegues have attempted
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to make the biomechanics of the spine under­
standable for those without a biomechanical or 
engineering background. Much of the literature 
on biomechanics of the locomotor system is 
simply unintelligible to most orthopedic sur­
geons and residents, and this article deserves 
commendation for its approach.
This volume is highly recommended for its 
timing and for its content.
R. H. Yabsley
Section of orthopedic surgery,
Victoria General Hospital,
Halifax, NS.
INTRAVENOUS ANAESTHESIA. John W.
Dundee and Gordon M. Wyant. 341 pp.
Illust. Churchill Livingstone Edinburgh;
Longman Canada Limited, Toronto, 1974.
$34.25.
Since Dundee’s book “Thiopentone and Other 
Thiobarbiturates” was published in 1956, an 
immense amount of literature concerning in­
travenous anesthetic agents, both barbiturate 
and nonbarbiturate, has accumulated. Both 
Wyant, joint author of this new book, and 
Dundee have made substantial contributions 
to the investigation of many of these agents; 
and as experienced anesthetists and inves­
tigators they have collaborated in a timely and 
comprehensive review of the present state of 
intravenous anesthesia.
The barbiturates, eugenols, steroids, tran­
quillizers, drugs used in neuroleptic techniques 
and those used to produce dissociative anes­
thesia are considered in turn. The chemistry 
and pharmokinetics of each group are dis­
cussed, followed by presentation and analysis 
of the laboratory and clinical evidence, and a 
thorough review of the clinical applications.
Thiopentone and methohexitone have been 
thoroughly investigated and extensively used 
for many years, yet the experimental evidence 
concerning them is often conflicting. The 
authors are to be congratulated for giving each 
item of evidence its due weight, indicating 
areas—particularly in relation to the newer 
agents—where knowledge is incomplete and 
further investigation is required. By drawing 
on their combined clinical wisdom and in­
vestigational experience, the authors have suc­
ceeded in summarizing a wealth of detail. The 
use of historical data reminds us that newer 
techniques have their origins in the past, and 
that the place of some of the newer agents in 
anesthetic practice has yet to be finally evalu­
ated.
This book offers a useful perspective to 
those already in clinical anesthetic practice and 
is a useful reference source for those engaged 
in research. It should also be required reading 
for all residents in anesthesia.
I. E. PURKIS
Department of anesthesia,
Victoria General Hospital,
Halifax, NS.
KAZANJIAN & CONVERSE’S SURGICAL 
TREATMENT OF FACIAL INJURIES. 
Vols. 1 and 2. 3rd ed. John Marquis Con­
verse. 1482 pp. Illust. The Williams & Wil­
kins Company, Baltimore; Burns & Mac- 
Eachern Limited, Toronto, 1974. $74.25.
The third edition of this book has been pub­
lished in two volumes— a practical improve­
ment since each volume is now handy to read 
— and the whole text of this work has been 
revised and updated.
The first volume is divided into chapters 
on the comparative phylogeny of the face, 
wound healing, and a resume of plastic sur­
gical techniques as adapted to maxillofacial 
surgery.
There follow sections on the treatment of 
facial fractures, on the mandible, the maxilla, 
the nose, the zygoma and the orbit. Indications 
for the simple closed, or operative open reduc­
tion of fractures, and more elaborate treat­
ments are detailed.
The coverage of external fixation devices 
(Roger Anderson, acrylic resin splint) is now 
more complete, though outmoded plaster head 
splints are still advocated. Chapters concern­
ing facial fractures in children, naso-orbital 
and fronto-ethmoidal fractures are more de­
tailed and contain practical case histories.
In the field of craniofacial surgery for con­
genital malformations the author has been 
greatly influenced by advances made by fel­
low workers.
It was a pleasure for me to see that in the 
traumatic Lefort I osteotomy, immediate bone 
grafting at the pterigomaxillary junction is 
proposed for the comminuted, middle third 
fractures. Also, techniques of craniofacial sur­
gery are applied to traumatic lowering of one 
orbital frame or hypertelorism.
The second volume is dedicated to recon­
structive surgery. The chapter on rhinoplasty 
is improved by the accompaniment of coloured 
drawings. Also included are the extramucous 
rhinoplasty and correction of septal perfora­
tions. Concerning mandibular and maxillary 
deformities, contemporary methods of vertical 
osteotomies with bone grafting, sagittal split 
of the mandible, Lefort I, II and III osteoto­
mies with their relative indications, have all 
been added with due credit to their initiators. 
More delicate and complex segmental and in­
frabasilar osteotomies are well explained and 
demonstrated. Soft-tissue reconstructions are
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also covered, with special attention to the 
burned face.
This work is a basic textbook that should 
be in the library of every resident interested in 
or dealing with plastic surgery and facial frac­
tures. Every plastic and maxillofacial surgeon 
would be well advised to own this new edition.
H. C iaburro
Department of surgery,
Hopital Notre-Dame,
Montreal, Que.
PROGRESS IN CARDIOLOGY. 3. Edited by
Paul N. Yu and John F. Goodwin. 349 pp.
Illust. Lea & Febiger, Philadelphia; The
Macmillan Company of Canada Limited,
Toronto, 1974. $18.95.
“Progress in Cardiology” is a relatively new 
addition to the growing number of publications 
in cardiology that attempt to review existing 
knowledge in this field. This book, an annual 
publication, maintains the excellent standard 
set in previous years. The range of topics 
covered is broad enough that major sections 
should have wide appeal for the student, re­
searcher, or practitioner of cardiology. Al­
though it appears to be more suitable for the 
cardiologist, the book includes subjects that 
should be of immediate interest to the prac­
tising cardiovascular surgeon. The areas 
covered by this monograph include: reviews 
of the epidemiologic considerations in coronary 
artery disease; the anatomy and physiology of 
cardiac impulse formation and conduction; 
the physiology of ventricular arrhythmias; the 
use of exercise stress testing; the early clinical 
course following acute myocardial infarction; 
the renin angiotensin system in hypertension; 
the Eisenmenger syndrome; the effects of 
adrenergic blockade on the heart; cardiac valve 
replacement; prevention of thrombosis; echo­
cardiography; and measurement of pulmonary 
water.
Each subject is timely and detailed. Most 
bibliographies are well referenced and provide 
a good source for further study. The editors 
appear to have given each of the contributors 
considerable latitude in preparing their reviews. 
As a result, most of the subjects dealt with are 
complete and up-to-date.
This monograph is an excellent source of 
current information. The price is quite reason­
able considering its size.
M. B. W axman
Cardiovascular unit,
Toronto General Hospital,
Toronto, Ont.
SURGICAL DISEASE IN PREGNANCY. 
Hugh R. K. Barber and Edward A. Graber. 
763 pp. Illust. W. B. Saunders Company, 
Philadelphia; W. B. Saunders Company 
Canada Limited, Toronto, 1974. $32.45.
This comprehensive, complete review of the 
subject deals with every aspect of pregnancy, 
especially within the realm of surgery en­
countered by obstetricians and gynecologists. 
It also includes discussions on every other sub­
specialty of surgery, as each relates to preg­
nancy, including general topics on body fluids, 
radiation and chemotherapy. The editorial com­
ments included with each chapter add to the 
excellent format of the book. The contributing 
authors are well known in their fields. I highly 
recommend this text as a reference book, espe­
cially for those preparing for final examina­
tions.
S. C. M acL eod
Endocrine and Infertility Clinic,
Dalhousie University,
Halifax, NS.
VASCULARIZATION AND TISSUE DIF­
FERENTIATION. F. A. Kiss. 167 pp. Il­
lust. Akademiai Kiado, Budapest, 1975. 
$9.50. Paperbound.
This paperback reviews the current status of 
tissue revascularization into newly growing 
tissues. Although its title will not attract the 
attention of physicians unfamiliar with this 
particular field, the relevant research attains 
great import in view of our great and conti­
nual dependence on angiogenesis and tissue 
neosynthesis in surgical practice, in which 
wound healing, fistula closure and osseous 
union, for example, are so important.
What accounts for the successful repair and 
regrowth of tissues following injury? Avail­
able evidence, the author informs us, leans 
heavily toward the view that the initial step 
is the appearance of mesenchymal cells, which 
differentiate into capillary and red blood cells. 
These primitive cells then differentiate into the 
appropriate tissue being repaired. This intro­
duction to the subject is followed by a series 
of sophisticated short papers that summarize 
much of the important experimental data from 
the field. The experiments described, many of 
which are the author’s own work, are artfully 
detailed with regard to technique and method; 
they are also arranged in a logical, orderly 
sequence and each develops a cogent point, 
neatly and succinctly summarized, before being 
applied in the development of the hypothesis 
for the subsequent experiment. All of these
September 1975 THE CANADIAN JOURNAL OF SURGERY 499
data are adroitly illustrated with simple and 
easily decipherable light and electron photo­
micrographs.
The book’s main theme centres around the 
effects of adrenal extract, which appears to 
have potent angiogenic and osteogenic proper­
ties and which also is capable of stimulating 
vascularization in scar keloid, cornea, cartilage 
and even the myocardium. Hence, the num­
ber of potentially interested readers of this 
monograph would have to be expanded to in­
clude orthopedic and plastic surgeons who are 
interested in ways of bringing new blood sup­
ply to nonhealing bones or soft tissue.
Overall I rate the book as good, with lim­
ited usefulness for the clinician who reads this 
journal; but for anyone particularly interested 
in wound healing I rate it as excellent. Un­
fortunately the binding of my copy was of 
extremely poor quality and split with the first 
reading.
J. B. F reeman
Department of surgery,
University of Iowa,
Iowa City, IA.
THE YEAR BOOK OF PLASTIC AND RE­
CONSTRUCTIVE SURGERY 1975. Edi­
tor: Frederick J. McCoy, Associate editors: 
Reed O. Dingman, John C. Gaisford, B. W. 
Haynes, Jr. and others. 351 pp. Iilust. Year 
Book Medical Publishers, Inc., Chicago, 
1975. $25.00.
This book contains chapters on: the head; the 
skin, subcutaneous tissue and hair; the neck 
and thorax, the abdomen and genitalia; the 
extremities; burns; surgical management, in­
cluding shock, and wound healing; neoplasms; 
transplantation; and general topics. The selec­
tion of the content reflects the fact that the 
overall choice of articles submitted to the med­
ical editors for their consideration in this book 
was not originally done by specialists in the field 
There is a great emphasis on articles chosen 
from the two journals, Plastic and Recon­
structive Surgery and the British Journal of 
Plastic Surgery—an emphasis that is probably 
unnecessary, as specialists in this field read 
these journals already. There is also too much 
emphasis on case reports, but not enough on 
general review articles. The abstracts are too 
detailed to be skimmed through quickly and 
yet not detailed enough to obviate reading 
the original article if there is an interest in 
that subject. The indexing is sometimes dif­
ficult to follow.
Although this book does not cover well the 
entire world literature, it will be useful to 
the surgeon who cannot readily consult a large 
medical library, because it does contain ab­
stracts from journals that are not readily ac­
cessible.
I. R. M unro
Division of plastic surgery,
Sunnybrook Medical Centre,
Toronto, Ont.
NOTICES
LENS IMPLANTATION SEMINAR
A seminar on intraocular lens implantation 
will be held on Nov. 15, 1975, at the Queen 
Elizabeth Hotel, Montreal. Speakers in­
clude Miles Galin, Henry Hirschman, Nor­
man Jaffe, Marvin Kwitko and Donald 
Praeger. The seminar covers the basic prin­
ciples and indications of the intraocular 
lens. The lens models presently used (Bink- 
horst, Copeland, Worst, Fiederov) will be 
described and the means used in im planta­
tion at the time of intracapsular, extracap- 
sular, and phacoemulsification cataract ex­
traction will be demonstrated. T he tech­
nique of implanting an intraocular lens in 
an aphakic eye will be covered. Preoper­
ative, operative and postoperative care will 
be emphasized. The long-term results of 
the faculty members will be detailed. F or­
mal lectures will be combined with indivi­
dual instruction. For further information, 
write to: Dr. M. L. Kwitko, 5591 Cote des 
Neiges Rd., Suite 1, Montreal, Que. H 3T 
1Y8.
SURGICAL RESEARCH
The 11 th Congress of the European Society 
for Surgical Research (formerly the Euro­
pean Society for Experimental Surgery) 
will be held in Dublin, Ireland, on Apr. 
27-30, 1976. Further information concern­
ing this meeting may be obtained from: The 
Irish Medical Association, Conference Cen­
tre, 10, Fitzwilliam Place, Dublin 2, Ire­
land.
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